<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        14-37-97
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LANZOR 30 MG CAPSUL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LANSOPRAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        15
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        49.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SANOFI WINTHROP INDUSTRIE" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SANOFI WINTHROP INDUSTRIE
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 4901]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Opella Arabia Limited Co
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SANOFI WINTHROP INDUSTRIE
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group<br />The active substance in LANZOR is lansoprazole, which<br />is a proton pump inhibitor. Proton pump inhibitors<br />reduce the amount of acid excreted by your stomach.<br />Therapeutic indications<br />Your doctor may prescribe LANZOR for:<br />- treatment of duodenal and stomach ulcer,<br />- treatmentof inflammation of theesophagus(reflux esophagitis),<br />- prevention of reflux esophagitis,<br />- treatment of heartburn and acid regurgitation,<br />- treatment of infections caused by Helicobacter pylori bacteria<br />when given in combination with antibiotic therapy,<br />- treatment or prevention of duodenal or stomach ulcer<br />in patients requiring continuous NSAID treatment<br />(NSAIDs are used to treat pain or inflammation),<br />- treatment of Zollinger-Ellison syndrome.<br />Your doctor may have prescribed LANZOR for another<br />indication or prescribed a dose that is different from the<br />one stated in this package leaflet. Follow your doctor&rsquo;s<br />instructions for taking your medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>If your doctor has told you that you are intolerant to<br />certain sugars, contact him/her before taking this medicine.<br />Contraindications<br />Never take LANZOR in the following situations:<br />- if you are allergic (hypersensitive) to lansoprazole or<br />to any of the other ingredients of LANZOR.<br />- if you are taking a medicine containing the active<br />substance atazanavir (used in the treatment of AIDS).<br />Appropriate precautions for use; special warnings<br />Take special care with LANZOR:<br />- Tell your doctor if you have serious liver disease. The<br />doctor may have to adjust the dosage.<br />- Your doctor may ask or may already have asked you<br />to have an additional examination called an endoscopy<br />in order to diagnose your condition and/or exclude<br />malignant disease.<br />- If diarrhea occurs during treatment with LANZOR,<br />contact your doctor immediately, as the drug has been<br />associated with a slight increase in infectious diarrhea.<br />- If your doctor has given you LANZOR in addition to<br />other medicines intended to treat Helicobacter pylori<br />infection (antibiotics), or together with anti-inflammatory<br />medicines to treat your pain or rheumatic disease, also<br />read the package leaflets of these medicines carefully.<br />- If you have been taking LANZOR for a long time (over<br />a year) your doctor will probably regularly monitor<br />your condition. You should report any unusual new<br />symptoms to your doctor.</p><p>Use of a proton pump inhibitor such as LANZOR,<br />particularly for over a year, can slightly increase the risk<br />of hip, wrist or spine fracture. Inform your doctor if you<br />have osteoporosis or if you are taking corticosteroids<br />(which can increase the risk of osteoporosis).<br />Use of this medicine is not recommended if you have<br />fructose intolerance, glucose and galactose malabsorption<br />syndrome or sucrase-isomaltase deficiency (rare hereditary<br />diseases).<br />Taking/using other medicines<br />Tell your doctor or pharmacist if you are taking or have<br />recently taken any other medicines, including medicines<br />obtained without a prescription.<br />In particular tell your doctor if you are taking medicines<br />containing any of the following active substances, as<br />LANZOR may affect the properties of these medicines:<br />- ketoconazole, itraconazole, rifampin (used to treat infections),<br />- digoxin (used to treat heart problems),<br />- theophylline (used to treat asthma),<br />- tacrolimus (used to prevent transplant rejection),<br />- fluvoxamine (used to treat depression and other<br />psychiatric diseases),<br />- antacids (used to treat heartburn or acid regurgitation),<br />- sucralfate (used for healing ulcers),<br />- St John&rsquo;s wort (Hypericum perforatum) (used to treat<br />mild depression).<br />Food and drink<br />For best results, take LANZOR at least 30 minutes before<br />a meal.<br />Pregnancy &ndash; Breast-feeding<br />If you are pregnant, if you are breast-feeding or if you<br />may be pregnant, ask your doctor for advice before<br />taking this medicine.<br />Driving and using machines<br />Side effects such as drowsiness, dizziness, tiredness and<br />visual disturbances sometimes occur in patients taking<br />this medicine. If you experience these effects, be careful<br />as your alertness may be decreased. You alone are<br />responsible for deciding whether you are capable of<br />driving or performing other tasks that require a high<br />level of concentration. Because of these effects or side<br />effects, taking this medicine may reduce your ability to<br />do these things safely.<br />A description of these effects can be found in other sections.<br />Read all the information in this leaflet for guidance.<br />Discuss with your doctor, nurse or pharmacist if you are<br />still unsure of anything.<br />Important information about some of the ingredients<br />of LANZOR:<br />Excipient with known effect: sucrose.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Swallow the hard capsule whole with a glass of water.<br />If you find the hard capsules difficult to swallow, your<br />doctor may recommend other ways of taking the medicine.<br />Do not crush or chew the hard capsules or capsule<br />contents since this would affect their properties.<br />If you are taking LANZOR once a day, try to take it at<br />the same time each day. Best results can be obtained<br />if you take LANZOR when you get up in the morning.<br />If you are taking LANZOR twice a day, take the first dose<br />in the morning, and the second in the evening.<br />The dosage depends on your condition. The usual doses<br />of LANZOR for adults are given below. Your doctor may<br />sometimes prescribe you a different dose and will tell<br />you how long your treatment will last.<br />Treatment of heartburn and acid regurgitation:<br />One 15 mg or 30 mg hard capsule every day for 4 weeks.<br />Consult your doctor if symptoms persist. If your symptoms<br />are not relieved within 4 weeks, contact your doctor.<br />Treatment of duodenal ulcer:<br />One 30 mg hard capsule every day for 2 weeks.<br />Treatment of stomach ulcer:<br />One 30 mg hard capsule every day for 4 weeks.<br />Treatment of inflammation of the esophagus (reflux<br />esophagitis):<br />One 30 mg hard capsule every day for 4 weeks.<br />Long-term prevention of reflux esophagitis:<br />One 15 mg hard capsule every day; your doctor may<br />adjust your dose to one 30 mg hard capsule every day.<br />Treatment of Helicobacter pylori infection:<br />The usual dose is one 30 mg hard capsule in combination<br />with two different antibiotics in the morning, and one<br />30 mg hard capsule in combination with two different<br />antibiotics in the evening. Treatment should be taken<br />every day, usually for 7 days.<br />The recommended combinations of antibiotics are:<br />- LANZOR with 250 to 500 mg of clarithromycin and<br />1 000 mg of amoxicillin;<br />- LANZOR with 250 mg of clarithromycin and 400 mg<br />to 500 mg of metronidazole.</p><p>If you are being treated for infection because you have<br />an ulcer, it is unlikely that your ulcer will return if the<br />infection is successfully treated. To obtain the best results<br />with your medication, take it at the right time and do<br />not miss a dose.<br />Treatment of duodenal or stomach ulcer in patients<br />requiring continuous NSAID (Non-Steroidal<br />Anti-Inflammatory Drugs) treatment:<br />One 30 mg hard capsule every day for 4 weeks.<br />Prevention of duodenal or stomach ulcer in patients<br />requiring continuous NSAID (Non-Steroidal<br />Anti-Inflammatory Drugs) treatment:<br />One 15 mg hard capsule every day; your doctor may<br />adjust your dose to one 30 mg hard capsule every day.<br />Zollinger-Ellison syndrome:<br />The recommended initial dose is two 30 mg hard capsules<br />every day to start with, then depending on how you<br />respond to the treatment, your doctor may decide to<br />adjust the dose.<br />USE IN CHILDREN:<br />LANZOR must not be given to children.<br />Always take the dose prescribed by your doctor. If you<br />are not sure, consult your doctor.<br />If you take more LANZOR than you should:<br />If you take more LANZOR than you should, consult your<br />doctor rapidly.<br />If you forget to take LANZOR:<br />If you forget to take a dose, take it as soon as you<br />remember unless it is nearly time for your next dose. If<br />it is almost time, skip the missed dose, and take the<br />remaining hard capsules as planned. Do not take a<br />double dose to make up for the dose you forgot to take.<br />If you stop taking LANZOR:<br />Do not stop treatment because your symptoms have<br />improved. Your condition may not have been fully cured<br />and symptoms may reoccur.<br />If you have any further questions on how to use this<br />medicine, ask your doctor for more information.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, LANZOR can cause side effects,<br />although not everybody gets them.<br /> The following side effects are common (more than<br />1 in 100 patients):<br />- headache, drowsiness,<br />- diarrhea, constipation, stomach pain, nausea, bloating,<br />dry or sore mouth or throat,<br />- extensive skin rash, itching,<br />- changes in liver function test values,<br />- tiredness.<br /> The following side effects are uncommon (less than<br />1 in 100 patients):<br />- depression,<br />- joint or muscle pain,<br />- water retention or edema,<br />- changes in blood cell counts.<br /> The following side effects are rare (less than 1 in<br />1 000 patients):<br />- fever,<br />- restlessness, drowsiness, confusion, hallucinations,<br />insomnia, visual disturbances, dizziness,<br />- changes in taste, loss of appetite, inflammation of the<br />tongue (glossitis),<br />- skin reactions such as burning or pricking sensations,<br />bruising, reddening and excessive sweating,<br />- sensitivity to light (strong skin reaction on exposure to<br />sun and UV rays),<br />- hair loss,<br />- tingling (paresthesia), tremor,<br />- anemia (paleness),<br />- kidney problems,<br />- pancreatitis,<br />- hepatitis, jaundice,<br />- breast swelling in men, impotence,<br />- candidiasis (fungal infection affecting skin or the mucosa),<br />- angioedema; contact your doctor immediately if you<br />experience symptoms of angioedema such as swollen<br />face, tongue or pharynx, difficulty swallowing, hives or<br />difficulty breathing.<br /> The following side effects are very rare (less than<br />1 in 10 000 patients):<br />- severe allergic reactions including shock. Symptoms of<br />an allergic reaction may include fever, extensive skin<br />rash, edema and sometimes a drop in blood pressure,<br />- inflammation of the mouth (stomatitis),<br />- bowel inflammation (colitis),<br />- changes in blood sodium, cholesterol and triglyceride<br />levels,<br />- very severe skin reactions with reddening, blistering,<br />severe inflammation and peeling,<br />- very rarely LANZOR may reduce the number of white<br />blood cells affecting resistance to infection. If you</p><p>develop an infection with symptoms such as fever and<br />serious deterioration of your general condition, or<br />fever with local infection symptoms such as sore<br />throat/pharynx/mouth or urinary problems, you should<br />consult your doctor immediately. A blood test will be<br />done to check possible reduction of white blood cells<br />(agranulocytosis).<br /> Unknown frequency:<br />If you have been taking LANZOR for more than 3 months,<br />magnesium levels in your blood may decrease. Low<br />magnesium levels can result in tiredness, involuntary<br />muscle contractions, disorientation, seizures, a feeling of<br />being dizzy and accelerated heart rate. If you have any<br />of these symptoms, tell your doctor immediately. Low<br />magnesium levels can also cause a decrease in potassium or<br />calcium levels in the blood. Your doctor may ask you to<br />have regular blood tests to monitor your magnesium levels.<br />To report any side effect(s):<br />Saudi Arabia<br />National Pharmacovigilance &amp; Drug Safety Centre (NPC):<br />Fax: +966-11-205-7662<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />Sanofi - Pharmacovigilance:<br />KSA_Pharmacovigilance@sanofi.com</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.<br />Do not use LANZOR after the expiry date which is stated<br />on the blister or box. The expiry date refers to the last<br />day of that month.<br />Do not store above 25 &deg;C.<br />Keep the bottle tightly closed and away from moisture.<br />Keep the blisters in their box and away from moisture.<br />Medicines should not be disposed of via wastewater or<br />household waste. Ask your pharmacist how to dispose<br />of unused medicines. These measures will help protect<br />the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What LANZOR 15 mg gastro-resistant hard capsules contain<br />The active substance is:<br />Lansoprazole&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;.15 mg<br />for one gastro-resistant hard capsule.<br />The other ingredients are:<br />heavy magnesium carbonate, neutral microgranules<br />(sucrose, maize starch), sucrose, maize starch,<br />low-substituted hydroxypropyl cellulose, hydroxypropyl<br />cellulose, copolymer of methacrylic acid and ethyl acrylate<br />(1: 1) (30% dispersion) (Eudragit L30 D-55), talc, macrogol<br />6000, titanium dioxide, polysorbate 80, colloidal anhydrous<br />silica.<br />Hard capsule coating: capsule cap (orange): gelatin,<br />titanium dioxide, erythrosin, yellow iron oxide.<br />Capsule body (blue): gelatin, titanium dioxide, indigotin.<br />What LANZOR 30 mg gastro-resistant hard capsules contain<br />The active substance is:<br />Lansoprazole&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;.30 mg<br />for one gastro-resistant hard capsule.<br />The other ingredients are:<br />heavy magnesium carbonate, neutral microgranules<br />(sucrose, maize starch), sucrose, maize starch,<br />low-substituted hydroxypropyl cellulose, hydroxypropyl<br />cellulose, copolymer of methacrylic acid and ethyl acrylate<br />(1: 1) (30% dispersion) (Eudragit L30 D-55), talc, macrogol<br />6000, titanium dioxide, polysorbate 80, colloidal anhydrous<br />silica.<br />Hard capsule coating: capsule cap (orange): gelatin,<br />titanium dioxide, erythrosin, yellow iron oxide.<br />Capsule body (white): gelatin, titanium dioxide.<br />What LANZOR 15 mg gastro-resistant hard capsules<br />look like and contents of the pack<br />This medicine is available as hard capsules; each hard<br />capsule contains white to brownish-white gastro-resistant<br />microgranules.<br />Boxes of 7, 14, 15, 28, 30 and 60 hard capsules in blisters.<br />Boxes of 14, 15, 28 and 30 hard capsules in bottles.<br />Some pack sizes may not be marketed.<br />What LANZOR 30 mg gastro-resistant hard capsules<br />look like and contents of the pack<br />This medicine is available as hard capsules; each hard capsule<br />contains white to brownish-white gastro-resistant microgranules.<br />Boxes of 7, 14, 28 and 60 hard capsules in blisters.<br />Boxes of 14 and 15 hard capsules in bottles.<br />Some pack sizes may not be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicine is available as hard capsules; each hard capsule
contains white to brownish-white gastro-resistant microgranules.
Boxes of 7, 14, 28 and 60 hard capsules in blisters.
Boxes of 14 and 15 hard capsules in bottles.
Some pack sizes may not be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder and Operating Company<br />sanofi-aventis France<br />1-13, boulevard Romain Rolland<br />75014 Paris - France</p><p>Manufacturer<br />Sanofi Winthrop Industrie<br />56, route de Choisy au Bac<br />60205 Compi&egrave;gne - France<br />This leaflet was last approved in: July 2013.</p><p>Secondary Packaging<br />Sanofi Aventis Arabia Co. Ltd, KSA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                July 2013
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>المادة الفعالة في لانزور هي اللانسوب ا رزول، وهو مثبط لمضخة البروتون. مثبطات مضخة البروتون تقلل من كمية<br />الحمض الذي تفرزه المعدة.<br />دواعي الاستعمال العلاجية<br />قد يصف طبيبك لانزور في الحالات التالية:<br />معالجة القرحة الاثناعشرية والقرحة المعدية، -<br />معالجة التهاب المريء )الارتداد المريئي(، -<br />منع الارتداد المريئي، -<br />معالجة حرقة المعدة والتجشؤ الحمضي، -<br />معالجة العدوى الناجمة عن الجرثومة المَلْوية بوابية ) - Helicobacter pylori ( مشاركة مع المضادات الحيوية،<br />لمعالجة أو الوقاية من القرحة الاثناعشرية أو القرحة المعدية لدى المرضى الخاضعين لعلاج مطول بمضادات -<br />الالتهاب غير الستيروئيدية )المستخدمة لعلاج الألم أو الالتهاب(،<br />معالجة متلازمة زولينجر إليسون. -<br />قد يكون طبيبك قد وصف لك لانزور لسبب آخر أو بجرعة مختلفة عن تلك المشار إليها في هذه النشرة. اتبع تعليمات<br />طبيبك الخاصة بتناول الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>إذا أخبرك طبيبك بعدم تحملك بعض السكريات، اتصل به قبل تناولك هذا الدواء.<br />موانع الاستعمال<br />لا تستعمل أبدا لانزور في الحالات التالية:<br />إذا كانت لديك حساسية )فرط الحساسية( للانسوب ا رزول أو لأي من مكونات لانزور الأخرى، -<br />إذا كنت تتناول دوا ءً يحتوي على المادة الفعالة اتا ا زنافير )المستخدمة في علاج الإيدز(. -<br />احتياطات الاستعمال؛ تحذي ا رت خاصة<br />كن حذ ا ر عند استعمال لانزور:<br />إذا كان لديك مرض وخيم في الكبد، أخبر طبيبك. قد تحتاج إلى ضبط المقدار. -<br />قد يطلب منك طبيبك أو يكون قد طلب إج ا رء فحص إضافي يسمى التنظير الداخلي لتشخيص حالتك المرضية و/أو -<br />استبعاد أي مرض خبيث.<br />في حالة حدوث إسهال خلال المعالجة مع لانزور، اتصل بطبيبك على الفور. بالفعل، فإن الزيادة الطفيفة في الإسهال -<br />الخمجي قد تكون مرتبطة باستعمال لانزور.<br />إذا كان طبيبك قد وصف لك لانزور إضافة لأدوية لمعالجة العدوى بجرثومة المَلْوية بوابية ) - Helicobacter pylori )<br />)المضادات الحيوية( أًو مع مضادات للالتهاب لمعالجة الألم أو مرض روماتزمي: يرجى ق ا رءة أيضا بعناية نش ا رت<br />هذه الأدوية.<br />إذا كنت تتناول لانزور لفترة طويلة الأجل )أكثر من سنة واحدة(، سوف تخضع على الأرجح لإش ا رف طبي منتظم. عليك -<br />بإعلام طبيبك عن أي أع ا رض غير عادية قد تتظاهر.<br />إن تناول مثبط لمضخة البروتون مثل لانزور، وخصوصا لمدة تتجاوز السنة واحدة، قد يزيد قليلا من خطر الاصابة<br />بكسور الورك أو المعصم أو الفق ا رت. أخبر طبيبك إذا كان لديك مرض هشاشة العظام أو إذا كنت تتناول القشريات<br />الستيروئيدية )التي قد تزيد من خطر هشاشة العظام(.<br />ينصح بعدم استعمال هذا الدواء لدى المرضى الذين يعانون من عدم تحمل الفركتوز، أو من متلازمة سوء امتصاص<br />الغلوكوز أو الغالاكتوز أو من نقص في أنزيم السوك ا رز/ إيزومالتاز )أم ا رض و ا رثية نادرة(.<br />تناول أو استعمال أدوية أخرى<br />إذا كنت تتناول أو تناولت مؤخ ا ر دوا ءً آخ ا ر، بما في ذلك دوا ءً حصلت عليه من دون وصفة طبية، أخبر طبيبك أو<br />الصيدلاني بذلك.<br />على وجه الخصوص، أخبر طبيبك إذا كنت تتناول أدوية تحتوي على واحد أو أكثر من المواد الفعالة التالية، لأن لانزور<br />قد يغير من خصائص هذه الأدوية:<br />كيتوكونازول، ايت ا ركونازول، ريفامبيسين )تستخدم لمعالجة العدوى(، -<br />ديجوكسين )يستخدم لمعالجة اضط ا ربات القلب(، -<br />ثيوفيلين )يستخدم لمعالجة الربو(، -<br />تاكروليموس )يستخدم لمنع رفض العضو المزروع(، -<br />فلوفوكسامين )يستخدم لمعالجة الاكتئاب واضط ا ربات نفسانية أخرى(، -<br />مضادات الحموضة )تستخدم لمعالجة حرقة المعدة أو التجشؤ الحمضي(، -<br />سوك ا رلفات )يستخدم لإلتئام القرحة(، -<br />عشبة الأوفاريقون )تستخدم لمعالجة الاكتئاب الخفيف(. -<br />الأطعمة والمشروبات<br />للحصول على أفضل النتائج، تناول لانزور قبل وجبة الطعام ب 3030 دقيقة على الأقل.<br />الحمل والإرضاع<br />إذا كن تً حاملا ، أو ترضعين طفل كً أو هناك احتمال أن تكوني حاملا ، استشري طبيب كً قبل أخذ هذا الدواء.<br />القيادة واستخدام الآلات<br />تظهر أحيانا لدي المرضى الذين يتناولون لانزور تأثي ا رت غير مرغوبة مثل النعاس والدوار والتعب واضط ا ربات بصرية.<br />انتبه، إذا واجهتك هذه التأثي ا رت غير المرغوبة فقد يؤدي ذلك إلى انخفاض اليقظة لديك. أنت وحدك المسؤول عن تحديد<br />ما إذا كان يصلح لك القيادة أو أداء المهام الأخرى التي تتطلب تركي ا ز عاليا. بسبب هذه التأثي ا رت أو التأثي ا رت غير<br />المرغوب فيها، فإن تناولك لهذا الدواء يمكن أن يقلل من قدرتك على القيام بهذه الأمور بسلامة.<br />يمكن العثور على وصف هذه التأثي ا رت في بنود أخرى. اق أ ر كامل هذه النشرة للحصول على كافة المعلومات. إذا ما ا زل<br />عندك شكوك، استشر طبيبك أو الممرضة أو الصيدلاني.<br />معلومات هامة عن بعض مكونات لانزور:<br />سواغ ذو تأثير معروف: ساكاروز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ينبغي بلع الكبسولة كاملة مع كوب من الماء. إذا وجدت صعوبة في ابتلاع الكبسولات، يمكن لطبيبك أن يشير عليك<br />بطرق أخرى لتناول الدواء. لا تسحق أو تمضغ الكبسولات أو محتوياتها لأن ذلك سوف يغير من خصائصها.<br />إذا كنت تتناول لانزور مرة واحدة في اليوم، حاول أن تتناوله يوميا في نفس الوقت. قد تحصل على نتائج أفضل إذا كنت<br />تتناول لازور بمجرد استيقاظك في الصباح.<br />إذا كنت تتناول لانزور مرتين في اليوم، تناول الجرعة الأولى في الصباح والجرعة الثانية في المساء.<br />يعتمد مقدار لانزور على حالتك المرضية. الجرعات المعتادة للبالغين من لانزور مبينة أدناه. سوف يصف لك طبيبك<br />أحيانا جرعة مختلفة ويحدد لك مدة المعالجة.<br />معالجة حرقة المعدة والتجشؤ الحمضي:<br />كبسولة واحدة من 15 ملغ أو 30 ملغ يوميا لمدة أربعة أسابيع. إذا استمرت الأع ا رض، استشر طبيبك. إذا لم تتحسن<br />الأع ا رض خلال 4 أسابيع، اتصل بطبيبك.<br />معالجة القرحة الاثناعشرية: كبسولة 30 ملغ كل يوم لمدة أسبوعين.<br />معالجة القرحة المعدية: كبسولة 30 ملغ كل يوم لمدة 4 أسابيع.<br />معالجة التهاب المريء )الارتداد المريئي(: كبسولة 3030 ملغ كل يوم لمدة 44 أسابيع.<br />الوقاية طويلة الأمد من الارتداد المريئي: كبسولة واحدة 1515 ملغ يوميا. قد يقوم طبيبك بتعديل الجرعة إلى 3030 ملغ<br />كبسولة يوميا.<br />معالجة العدوى بالجرثومة المَلْوية بوابية )) Helicobacter pylori :)<br />الجرعة المعتادة هي كبسولة واحدة 3030 ملغ مشاركة مع مضادين حيويين مختلفين في الصباح وكبسولة واحدة 3030 ملغ<br />مشاركة مع مضادين حيويين مختلفين في المساء. يتم تناول العلاج كل يوم عادة لمدة 77 أيام.<br />المضادات الحيوية المشاركة الموصى بها هي:<br />لانزور مع كلاريثروميسين - 250250 - 500500 ملغ وأموكسيسيلين 10001000 ملغ،<br />لانزور مع كلاريثروميسين - 250250 ملغ وميترونيدازول 400400 - 500500 ملغ.<br />إذا كنت تتعالج من أجل العدوى في حالة القرحة، فإنه من غير المحتمل أن تعود القرحة إذا تم التعامل مع العدوى بنجاح.<br />ليحقق علاجك أفضل النتائج الممكنة، تقيد تماما بمواعيد تناول الدواء، ولا تنسى أي جرعة.<br />معالجة القرحة الاثناعشرية أو القرحة المعدية لدى المرضى الذين يحتاجون إلى معالجة بمضادات الالتهاب غير<br />الستيروئيدية بشكل مستمر: كبسولة 3030 ملغ كل يوم لمدة 44 أسابيع.<br />الوقاية من القرحة الاثناعشرية أو القرحة المعدية لدى المرضى الذين يحتاجون إلى معالجة بمضادات الالتهاب غير<br />الستيروئيدية بشكل مستمر: كبسولة واحدة 1515 ملغ يوميا. قد يقوم طبيبك بتعديل الجرعة إلى 3030 ملغ كبسولة يوميا.<br />متلازمة زولينجر إليسون: للبدء المقدار الأولي الموصى به هو كبسولتان 3030 ملغ في اليوم، ثم وفقا لمدى استجابتك<br />للانزور سوف يقرر طبيبك الحاجة لضبط الجرعة.<br />الاستعمال عند الأطفال:<br />يمنع استعمال لانزور لدى الأطفال.<br />تقيد دائما بالجرعة التي وصفها طبيبك. في حالة الشك، استشر طبيبك.<br />إذا تناولت أكثر مما يجب من لانزور:<br />إذا تناولت أكثر مما يجب من لانزور، يجب استشارة طبيبك على الفور.<br />إذا نسيت تناول لانزور:<br />إذا فاتك تناول جرعة، تناولها فور تذكرك بذلك، ما لم يكن قد اقترب موعد تناول الجرعة التالية. إذا كان هذا هو الحال، لا<br />تتناول الجرعة المنسية وتناول الكبسولات الأخرى بشكل طبيعي. لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيت<br />تناولها.<br />إذا توقفت عن تناول لانزور:<br />في حالة تحسن الأع ا رض، لا توقف العلاج. قد لا تكون شفيت تماما والأع ا رض قد تعود للظهور مرة أخرى.<br />إذا كان لديك أسئلة أخرى بخصوص استعمال هذا الدواء، اطلب المزيد من المعلومات من طبيبك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كافة الأدوية يمكن أن يسبب استعمال لانزور تأثي ا رت غير مرغوبة، مع أنه ليس من الضرورة تعرض الجميع لذلك.<br />&bull; التأثي ا رت غير المرغوبة التالية شائعة )تحدث عند أكثر من مريض واحد من 100 :)<br />الصداع، النعاس، -<br />الإسهال، الإمساك، آلام المعدة، الغثيان، الانتفاخ، الاجتفاف أو آلام الفم / الحلق، -<br />الطفح الجلدي الشامل، الحكة، -<br />شذوذ في نتائج اختبا ا رت وظائف الكبد، -<br />التعب. -<br />&bull; التأثي ا رت غير المرغوبة التالية قليلة الشيوع )تحدث عند أقل من مريض واحد من 100100 :)<br />الاكتئاب، -<br />الألم العضلي أو الألم المفصلي، -<br />احتباس السوائل أو الوذمة )إديما(، -<br />شذوذات في صيغة الدم. -<br />&bull; التأثي ا رت غير المرغوبة التالية نادرة )تحدث عند أقل من مريض واحد من 10001000 :)<br />الحمى، -<br />الهياج، النعاس، التخليط، الهلوسة، الأرق، الاضط ا ربات البصرية، الدوار، -<br />تغير المذاق، فقدان الشهية، التهاب اللسان، -<br />التفاعلات الجلدية مثل الحرقان أو الوخز، الكدمات، الاحم ا رر أو التعرق المفرط، -<br />الحساسية للضوء )تفاعل جلدي شديد عند التعرض لأشعة الشمس والأشعة فوق البنفسجية(، -<br />تساقط الشعر، -<br />التنميل )الخدر(، الرعشة، -<br />فقر الدم )شحوب(، -<br />اضط ا ربات كلوية، -<br />التهاب البنكرياس، -<br />التهاب الكبد، اليرقان، -<br />تورم الثديين لدى الرجال، العنانة )العجز الجنسي(، -<br />داء المبيضات )خمج في الجلد أو الأغشية المخاطية ناجم عن الفطريات(، -<br />وذمة وعائية. اتصل بطبيبك على الفور إذا كان لديك أع ا رض وذمة وعائية مثل تورم في الوجه أو اللسان أو -<br />البلعوم، صعوبة في البلع، شري أو صعوبة في التنفس.<br />&bull; التأثي ا رت غير المرغوبة التالية نادرة جدا )تحدث عند أقل من مريض واحد من 1000010000 :)<br />فرط الحساسية الشديد بما في ذلك حالة الصدمة. قد تتضمن أع ا رض فرط الحساسية الحمى، الطفح الجلدي الشامل، -<br />الوذمة وأحيانا نقص الضغط،<br />التهاب الفم، -<br />التهاب القولون )التهاب الامعاء(، -<br />التغي ا رت في مستويات الصوديوم والكوليسترول وثلاثي الغليسيريد في الدم، -<br />تفاعلات جلدية وخيمة مع احم ا رر، تنفط، التهاب شديد، تقشر، -<br />ناد ا ر ما قد يسبب لانزور انخفا ضا في عدد خلايا الدم البيضاء التي يمكن أن تضعف المقاومة للعدوى. إذا ظهرت -<br />لديك عدوى مع أع ا رض مثل الحمى وتدهور خطير في حالتك، أو حمى مع أع ا رض عدوى موضعية مثل التهاب<br />الحلق/البلعوم/الفم أو اضط ا ربات بولية، استشر طبيبك فو ا ر. سيتم إج ا رء فحص للدم للتحقق من نقص محتمل لتعداد<br />خلايا الدم البيضاء )ندرة المحببات(. &bull; اٍلتأثي ا رت غير المرغوبة التالية وتيرة حدوثها غير معروفة:<br />إذا كنت تتناول لانزور لأكثر من 33 أشهر، فمن الممكن أن يكون معدل المغنيسيوم في الدم قد انخفض لديك. النقص في<br />مستويات المغنسيوم قد يتظاهر على شكل تعب، تقلصات عضلية غير إ ا ردية، تَوَهان، اختلاجات، احساس بالدوار، تسرع<br />في ضربات القلب. إذا كنت تشعر بأي من هذه الأع ا رض عليك بإبلاغ طبيبك على الفور. النقص في مستويات المغنسيوم<br />قد تؤدي أيضا إلى انخفاض في مستويات البوتاسيوم أو الكالسيوم في الدم. قد يقرر طبيبك إج ا رء فحوصات دم منتظمة<br />لم ا رقبة مستوى المغنيسيوم لديك.<br />للإبلاغ عٍن اٍلأع ا رض اٍلجانبي ة<br />المملكة اٍلعربية اٍلسعودية<br />المركز اٍلوطني لٍلتيقظ وٍالسلامة اٍلدوائية :<br />فاكس: 00966112057662<br />الهاتف اًلمجاني: 8002490000<br />npc.drug@sfda.gov.sa :البريد اًلإلكتروني<br />www.sfda.gov.sa/npc :الموقع اًلإلكتروني<br />سانوفي - التيقظ اٍلدوائي :<br />KSA_Pharmacovigilance@sanofi.com</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدا عن مجال نظر الأطفال وعن متناول أيديهم.<br />يجب عدم استعمال لانزور بعد تاريخ انتهاء الصلاحية المذكور على الشريط أو العلبة. تاريخ انتهاء الصلاحية يشير إلى<br />اليوم الأخير من الشهر المذكور.<br />يُحفظ في درجة ح ا ررة لا تتجاوز 25 درجة مئوية.<br />احفظ العلبة محكمة الإغلاق بعيدا عن الرطوبة. احفظ الأشرطة المشكلة ح ا ررياًُ داخل العبوة الخارجية بعيدا عن الرطوبة.<br />لا ينبغي التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلاني عن كيفية التخلص<br />من الأدوية التي لم تعد بحاجة إليها. وسوف تساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>على ماذا يحتوي لانزور 15 ملغ، كبسولات مقاومة لعصارة المعدة<br />المادة الفعالة هي:<br />لانسوب ا رزول .ًً................................... 15 ملغ لكل كبسولة مقاومة لعصارة المعدة.<br />المكونات الأخرى هي:<br />كربونات المغنيسيوم الثقيل، حبيبات دقيقة متعادلة )سكاروز، نشا الذرة(، سكاروز، نشا الذرة، هيدروكسي بروبيل السليلوز<br />ضعيف الاستبدال، هيدروكسي بروبيل السليلوز، كوبوليمر حمض ميثاكريليك واكريلات الإيثيل ) 1:1 ( )تشتت بنسبة 30<br />في المئة( ) Eudagrit L30 DEudagrit L30 D--5555 (، تالك، ماكروغول 60006000 ، ثاني أكسيد التيتانيوم، بوليسوربات 8080 ، سيليكا غروية<br />لامائية.<br />غلاف الكبسولة:<br />الغطاء )برتقالي اللون(: جيلاتين، ثاني أكسيد التيتانيوم، إريثروسين، أكسيد الحديد الأصفر.<br />الجسم )أزرق اللون(: جيلاتين، ثاني أكسيد التيتانيوم، إنديجوتين.<br />على ماذا يحتوي لانزور 3030 ملغ، كبسولات مقاومة لعصارة المعدة<br />المادة الفعالة هي:<br />لانسوب ا رزول ................................ 3030 ملغ لكل كبسولة مقاومة لعصارة المعدة.<br />المكونات الأخرى هي:<br />كربونات المغنيسيوم الثقيل، حبيبات دقيقة متعادلة )سكاروز، نشا الذرة(، سكاروز، نشا الذرة، هيدروكسي بروبيل السليلوز<br />ضعيف الاستبدال، هيدروكسي بروبيل السليلوز، كوبوليمر حمض ميثاكريليك واكريلات الإيثيل ) 1:11:1 ( )تشتت بنسبة 3030<br />في المئة( ) Eudagrit L30 DEudagrit L30 D--5555 (، تالك، ماكروغول 60006000 ، ثاني أكسيد التيتانيوم، بوليسوربات 8080 ، سيليكا<br />غروية لامائية.<br />غلاف الكبسولة:<br />الغطاء )برتقالي اللون(: جيلاتين، ثاني أكسيد التيتانيوم، إريثروسين، أكسيد الحديد الأصفر.<br />الجسم )أبيض اللون(: جيلاتين، ثاني أكسيد التيتانيوم.<br />ما هو لانزور 1515 ملغ، كبسولة مقاومة لعصارة المعدة وما هي محتويات العلبة<br />هذا الدواء متوفر على شكل كبسولات، كل كبسولة تحتوي على حببيات دقيقة بيضاء إلى أبيض مسمر اللون مقاومة<br />لعصارة المعدة.<br />علبة تحوي 77 كبسولات أو 1414 ، 1515 ، 2828 ، 3030 أو 6060 كبسولة في ش ا رئط مشكلة ح ا رريا .<br />علبة تحوي 1414 ، 1515 ، 2828 أو 3030 كبسولة في قارورة.<br />يمكن ألا تكون كل العبوات مسوقة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            هذا الدواء متوفر على شكل كبسولات، كل كبسولة تحتوي على حببيات دقيقة بيضاء إلى أبيض مسمر اللون مقاومة
لعصارة المعدة.
علبة تحوي 7 كبسولات أو 14 ، 28 أو 60 كبسولة في ش ا رئط مشكلة ح ا رريا .
علبة تحوي 14 أو 15 كبسولة في قارورة.
يمكن ألا تكون كل العبوات مسوقة.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>حامل رخصة التسويق والمُسوِّق<br />sanofi<br />aventis France<br />1<br />13 , boulevard Romain Rolland<br />75014<br />Paris France</p><p><br />المُصنِّع<br />Sanofi Winthrop Industrie<br />Sanofi Winthrop Industrie<br />56<br />56 , route de Choisy au Bacroute de Choisy au Bac<br />60205<br />60205 Compi&egrave;gne Compi&egrave;gne &ndash;&ndash; FranceFranc</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تموز 2013
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                LANZOR 30 mg gastro-resistant capsules.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains 30 mg of lansoprazole.
Excipient: Each capsule contains 59.8 mg of sucrose.
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gastro-resistant capsules .
Each capsule contains microgranules white to brownish - gastro-resistant capsule head is orange and the capsule body is white.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Treatment of duodenal ulcer and gastric ulcer.<br />&bull; Treatment of reflux esophagitis .<br />&bull; Prevention of reflux oesophagitis .<br />&bull; Eradication of Helicobacter pylori (H. pylori) by concomitant administration of appropriate antibiotic therapy for the treatment of ulcers associated with H. pylori .<br />&bull; Treatment of duodenal ulcer and gastric ulcer Benin , NSAID in patients requiring continuous NSAID treatment .<br />&bull; Prevention of duodenal ulcer and gastric ulcer induced by NSAIDs in patients at risk ( see section 4.2 ) requiring continued NSAID treatment .<br />&bull; Gastroesophageal reflux disease symptoms .<br />&bull; Zollinger -Ellison syndrome.<br />4.2 . Dosage and administration<br />For optimal effect , LANZOR must be taken once daily in the morning , except in the case of eradication of H. pylori for which the treatment must be taken twice a day , once in the morning and once in the evening . LANZOR must be taken at least 30 minutes before meals (see section 5.2). The capsules should be swallowed whole with liquid.<br />For patients with swallowing difficulties , education and clinical practice suggest that the capsules can be opened and mixed with a small amount of water , apple juice or tomato or sprinkled on a small amount of food not microgranules solid (eg yogurt, applesauce ) to facilitate administration. Capsules can be opened and mixed with 40 ml of apple juice for administration via nasogastric tube microgranules (see section 5.2). After preparation of the suspension or mixture , the drug should be administered immediately .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of duodenal ulcer :<br />The recommended dose is 30 mg once a day for 2 weeks. Patients whose healing is not complete after this period, treatment can be continued at the same dose for another two weeks .<br />Treatment of gastric ulcer :<br />The recommended dose is 30 mg once daily for 4 weeks . The ulcer usually heals within 4 weeks , but in patients whose healing is not complete after this period, the treatment can be continued at the same dose for another 4 weeks.<br />Reflux oesophagitis:<br />The recommended dose is 30 mg once daily for 4 weeks . Patients whose recovery is not complete after this period, the treatment can be continued at the same dose for another 4 weeks.<br />Prevention of reflux oesophagitis:<br />15 mg once per day. The dosage may be increased to 30 mg daily if needed .<br />Eradication of Helicobacter pylori :<br />Choosing the right combination therapy should be according to official local guidance regarding bacterial resistance, duration of treatment (usually 7 days but sometimes up to 14 days ) , and the appropriate use of antibacterial agents .<br />The recommended dosage is 30 mg twice daily LANZOR for 7 days in combination with one of the following combinations :<br />&bull; 250-500 mg twice daily clarithromycin + 1 g amoxicillin twice daily ,<br />&bull; 250 mg twice daily clarithromycin + metronidazole 400-500 mg twice daily .<br />The eradication rate of H. pylori up to 90% are obtained when clarithromycin is associated with LANZOR and amoxicillin or metronidazole.<br />Six months after successful eradication treatment, the risk of re-infection is low and relapse is therefore unlikely .<br />The use of a dose comprising 30 mg of lansoprazole twice daily , amoxicillin 1 g twice a day and 400-500 mg of metronidazole twice daily was also studied . Using this combination , there was lower than for the eradication rate regimens involving clarithromycin . They can be adapted for patients unable to take clarithromycin in the eradication therapy , when local resistance rates to metronidazole are low.<br />Treatment of duodenal ulcer and gastric ulcer Benin , NSAID in patients requiring continued NSAID treatment :<br />30 mg once a day for four weeks. Patients whose healing is not complete , the treatment can be continued for an additional four weeks. In patients at risk or with ulcers difficult to heal, a longer treatment duration and / or a higher dose may be used.<br />Prevention of duodenal ulcer and gastric ulcer induced by NSAIDs in patients at risk ( older than 65 years or with a history of gastric or duodenal ulcer) requiring prolonged NSAID treatment :<br />15 mg once per day. In case of treatment failure , the dose of 30 mg once daily should be used.</p><p>Symptomatic gastroesophageal reflux :<br />The recommended dose is 15 mg or 30 mg per day . Relief of symptoms is obtained rapidly. An individual dose adjustment should be considered. If symptoms are not relieved within 4 weeks with a daily dose of 30 mg , further examinations are recommended.<br />Zollinger- Ellison :<br />The recommended starting dose is 60 mg once daily . The dose should be individually adjusted and treatment should be continued for as long as necessary. Daily dosages up to 180 mg have been used . If the required daily dose exceeds 120 mg , it should be divided and administered in two divided doses .<br />Renal or hepatic impairment :<br />No dose adjustment is necessary in patients with renal insufficiency.<br />Patients with moderate or severe liver disease should be kept under regular supervision and a 50% reduction of the daily dose is recommended (see sections 4.4 and 5.2).<br />Elderly:<br />Due to the reduced lansoprazole in the elderly , clearance individual dose adjustment may be necessary. A daily dose of 30 mg should not be exceeded in the elderly unless there are relevant clinical indications.<br />children:<br />In the absence of sufficient clinical data using LANZOR is not recommended in children ( see also section 5.2).<br />Treatment in infants less than 1 year should be avoided , the available clinical data do not demonstrate a beneficial effect of lansoprazole in the treatment of gastro -oesophageal reflux.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients .
• Lansoprazole should not be administered with atazanavir ( see section 4.5) .
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with all other anti-ulcer therapies, the possibility of malignant gastric tumor should be excluded when treating a gastric ulcer with lansoprazole because lansoprazole can mask the symptoms and delay diagnosis .<br />hypomagnesemia :<br />Cases of severe hypomagnesemia have been reported in patients treated with inhibitors of the proton pump inhibitors ( PPIs) such as lansoprazole for at least three months and in most cases for a year. The hypomagnesemia may occur with severe clinical signs such as fatigue, tetany , hot delusional , convulsions , dizziness ventricular arrhythmia but may begin insidiously and unnoticed. In most patients, hypomagnesemia improved after magnesium supplementation and off PPI .<br />In patients requiring prolonged or when combining PPIs with digoxin or drugs that may induce hypomagnesemia (eg, diuretics) , a dosage of blood magnesium therapy should be considered by health professionals before starting PPI therapy and periodically during treatment.<br />4<br />Lansoprazole should be used with caution in patients with moderate and severe hepatic impairment ( see sections 4.2 and 5.2).<br />Decreased gastric acidity due to lansoprazole may increase rates of bacteria normally present in the gastrointestinal tract . Treatment with lansoprazole may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter .<br />In patients with peptic ulcers , the possibility of infection with H. pylori as an etiological factor should be considered.<br />If lansoprazole is used in combination with antibiotics for eradication therapy of H. pylori , then the conditions of use of these antibiotics should also be followed.<br />Because of limited safety data for use in patients under maintenance treatment for over a year , regular monitoring of the treatment and a thorough evaluation of the benefit / risk should be routinely performed in these patients.<br />Very rare cases of colitis have been reported in patients taking lansoprazole . Therefore, in the case of severe diarrhea and / or persistent , treatment discontinuation should be considered.<br />The treatment for the prevention of peptic ulceration of patients requiring continued NSAID treatment should be restricted to high-risk patients ( eg previous gastrointestinal bleeding , perforation or ulcer, advanced age, drug combination known to increase the likelihood occurrence of adverse upper gastrointestinal events [ eg corticosteroids or anticoagulants ] , the presence of a serious co-morbidity factor or prolonged use of NSAID maximum recommended doses)<br />Inhibitors Proton Pump , especially when used in high doses over a long (&gt; 1 year ) term , may moderately increase the risk of hip fracture , wrist and vertebrae , mainly in patients age or the presence of other risk factors identified . Observational studies suggest that inhibitors Proton pump can increase the risk of fracture overall 10 to 40 %. This increase may be in part due to other risk factors. Patients at risk for osteoporosis should be supported in accordance with current recommendations , and receive appropriate vitamin D and calcium intake.<br />Due to the presence of sucrose , this drug is not recommended in patients with fructose intolerance, malabsorption of glucose and galactose or sucrase / isomaltase ( rare hereditary metabolic diseases).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects of lansoprazole on other drugs<br />Drugs with pH dependent absorption<br />Lansoprazole may interfere with the absorption of drugs where gastric pH dependent bioavailability .<br />&bull; Atazanavir :<br />A study has shown that concomitant administration of lansoprazole (60 mg once daily ) with atazanavir 400 mg to healthy volunteers significantly reduces exposure to atazanavir ( down about 90% of AUC (area under curve ) and Cmax ( maximum concentration). lansoprazole should not be associated with atazanavir (see section 4.3).<br />&bull; Ketoconazole and itraconazole :<br />The absorption of ketoconazole and itraconazole from the gastrointestinal tract is increased in the presence of gastric acid . Administration of lansoprazole may result in lower concentrations of ketoconazole and itraconazole and the combination should be avoided.<br />&bull; Digoxin:<br />The combination of lansoprazole and digoxin may lead to increased plasma concentrations of digoxin. Plasma concentrations of digoxin must therefore be<br />5<br />monitored and the dose of digoxin adjusted if necessary at the beginning and the end of treatment with lansoprazole.<br />Drugs metabolized by cytochrome P450 enzymes<br />Lansoprazole may increase plasma concentrations of drugs metabolized by CYP3A4 . Caution is advised when combining lansoprazole with drugs metabolized by this enzyme and have a narrow therapeutic margin .<br />&bull; Theophylline:<br />Lansoprazole reduces the plasma concentration of theophylline , which may decrease the expected clinical effect. Caution is advised when combining the two drugs .<br />&bull; Tacrolimus:<br />Coadministration of lansoprazole increases the plasma concentrations of tacrolimus ( a CYP3A substrate and P- gp) . Lansoprazole increases the mean exposure of tacrolimus by up to 81 %. Monitoring plasma concentrations of tacrolimus is recommended at the beginning and end of treatment with lansoprazole.<br />Medicinal products transported by P-glycoprotein<br />Inhibition of P-glycoprotein (P -gp) Lansoprazole has been observed in vitro. The clinical relevance is unknown.<br />Effects of other drugs on lansoprazole<br />Medicinal products that inhibit CYP2C19<br />&bull; Fluvoxamine :<br />A dose reduction may be considered when combining lansoprazole with fluvoxamine , an inhibitor of CYP2C19. Plasma concentrations of lansoprazole increase up to 4 times normal.<br />Drugs which induces CYP2C19 and CYP3A4<br />Enzyme inducers affecting CYP2C19 and CYP3A4 such as rifampicin and St John&#39;s wort (Hypericum perforatum ) can markedly reduce the plasma concentrations of lansoprazole.<br />other<br />&bull; Sucralfate / Antacids:<br />Sucralfate, antacids may reduce the bioavailability of lansoprazole. Therefore, lansoprazole should be taken at least 1 hour after taking these drugs.<br />No significant interaction clinically between lansoprazole and nonsteroidal anti -inflammatory drugs has been demonstrated , although no formal interaction studies have not been performed .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>pregnancy<br />No clinical data on exposed pregnancies are available to lansoprazole . The animal studies do not indicate direct or indirect harmful effects with respect to pregnancy , embryonal / fetal development, parturition or postnatal development .<br />Therefore, for safety reasons , the use of lansoprazole is not recommended during pregnancy.<br />nursing<br />Excretion in breast milk of lansoprazole is not known . Studies in animals have shown excretion of lansoprazole in milk.<br />The decision to continue / discontinue breast-feeding or to continue / discontinue therapy with lansoprazole should take into account the benefit of breast-feeding to the child and the benefit of lansoprazole therapy to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Side effects, such as dizziness, vertigo, visual disturbances and somnolence may occur (see section 4.8). Under these conditions , the ability to react may be decreased.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Frequencies are defined as common (&gt; 1/100 , &lt; 1/10) , uncommon ( &gt; 1:1000 , &lt; 1/100) , rare ( &gt; 1:10,000 ; &lt; 1/1.000) , very rare (&lt;1 / 10,000) .<br />Frequencies are defined as common (&gt; 1/100, &lt;1/10), uncommon (&gt; 1:1000, &lt;1/100), rare (&gt; 1:10,000; &lt;1/1.000), very rare (&lt;1 / 10,000).</p><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/4RESRXhpZgAATU0AKgAAAAgABAE7AAIAAAAYAAAISodpAAQAAAABAAAIYpydAAEAAAAwAAAQ2uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAE11aGFtbWVkLCBVc21hbiAvU0EvRVhUAAAFkAMAAgAAABQAABCwkAQAAgAAABQAABDEkpEAAgAAAAM4MgAAkpIAAgAAAAM4MgAA6hwABwAACAwAAAikAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMDowMToyMyAxMzozMDoxNAAyMDIwOjAxOjIzIDEzOjMwOjE0AAAATQB1AGgAYQBtAG0AZQBkACwAIABVAHMAbQBhAG4AIAAvAFMAQQAvAEUAWABUAAAA/+ELKmh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMDEtMjNUMTM6MzA6MTQuODIzPC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPk11aGFtbWVkLCBVc21hbiAvU0EvRVhUPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAnUDGAMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiiubm8XT/wBr6jYab4Y1jU/7OmWCee2e0SPe0SS4Hmzoxwsq84xmgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqP+Eo1f8A6ETxB/3/ANP/APkqgDpKK5v/AISjV/8AoRPEH/f/AE//AOSqrWHji91O2eex8E+IJYkmlgZvNsFw8UjRuObns6MM9DjIyKAOtorm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KoA6Siub/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqgDpKK5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+SqAOkorm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KoA6Siub/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqgDpKK5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+SqAOkorm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KoA6SiuStfHF7e3N7BbeCfEDy2MwguF82wGxzGkgHNzz8kiHIyOcdQas/8JRq/wD0IniD/v8A6f8A/JVAHSUVzf8AwlGr/wDQieIP+/8Ap/8A8lUf8JRq/wD0IniD/v8A6f8A/JVAHSUVzf8AwlGr/wDQieIP+/8Ap/8A8lUf8JRq/wD0IniD/v8A6f8A/JVAHSUVzf8AwlGr/wDQieIP+/8Ap/8A8lUf8JRq/wD0IniD/v8A6f8A/JVAHSUVzf8AwlGr/wDQieIP+/8Ap/8A8lUf8JRq/wD0IniD/v8A6f8A/JVAHSUVzf8AwlGr/wDQieIP+/8Ap/8A8lUf8JRq/wD0IniD/v8A6f8A/JVAHSUVzf8AwlGr/wDQieIP+/8Ap/8A8lUf8JRq/wD0IniD/v8A6f8A/JVAHSUVzf8AwlGr/wDQieIP+/8Ap/8A8lVWtfHF7e3N7BbeCfEDy2MwguF82wGxzGkgHNzz8kiHIyOcdQaAOtorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorkpPHF7FqsGmv4J8QC7uIZJ4o/NsPmSNkVzn7TgYMqcE5O7jocWf+Eo1f/oRPEH/f/T//AJKoA6Siub/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqgDpKK5v/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSqAOkorm/+Eo1f/oRPEH/AH/0/wD+SqP+Eo1f/oRPEH/f/T//AJKoA6Siub/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqgDpKK5v/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSqAOkorm/+Eo1f/oRPEH/AH/0/wD+SqP+Eo1f/oRPEH/f/T//AJKoA6Siub/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqgDpKK5K18cXt7c3sFt4J8QPLYzCC4XzbAbHMaSAc3PPySIcjI5x1Bqz/wlGr/9CJ4g/wC/+n//ACVQB0lFc3/wlGr/APQieIP+/wDp/wD8lUf8JRq//QieIP8Av/p//wAlUAdJRXN/8JRq/wD0IniD/v8A6f8A/JVH/CUav/0IniD/AL/6f/8AJVAHSUVzf/CUav8A9CJ4g/7/AOn/APyVR/wlGr/9CJ4g/wC/+n//ACVQB0lFc3/wlGr/APQieIP+/wDp/wD8lUf8JRq//QieIP8Av/p//wAlUAdJRXN/8JRq/wD0IniD/v8A6f8A/JVH/CUav/0IniD/AL/6f/8AJVAHSUVzf/CUav8A9CJ4g/7/AOn/APyVR/wlGr/9CJ4g/wC/+n//ACVQB0lFc3/wlGr/APQieIP+/wDp/wD8lUf8JRq//QieIP8Av/p//wAlUAdJRXN/8JRq/wD0IniD/v8A6f8A/JVRTeM7qza3bU/CGuWNvNdQWv2iWSyZI2mlWJCwS4ZsbnXOAaAOpooooAK5vwv/AMjF4z/7DUf/AKb7OukrhNM8WeHNB8W+MLXXNf0vTbh9WikWK8vY4XZTYWgDAMQcZBGfY0Ad3RXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lc34D/wCRduv+w1qv/pwuKP8AhY/gj/ocvD//AINIP/iq5/wX4+8H2ug3Md14s0OF21bUpAsmpQqSr307K2C3QqwIPcEHvQB6JRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAGVq3i+4tfHs2iHxJ4d0WKOG3eKLUoS810ZC4IQ+fH/dAGFbk/hWk3jqyjl1dprDUIrLR2dLu/eNPJDqAdqjfvcncMbVPPBwaz7Txf4ItfEmo6r/wnPh9vtsMEXlf2jANnl7+c7+c7/QYxWbd6p8PtR8P67pF9460GSDWZ5JnK6jADFuC4HLkHBUHnr6Uf5fjp/wRa/j+Gv8AwDpI/G1olteSappuo6XNaRJMba6SMySo7bUKeW7A5b5cZBBxkDIqNPHtqi6it/pOqafcabBFcT29xHHu2SOyrtKSMrfdJ4bj65A4vTj4EtNLvrM+MPAVk1wIjHcaLBb2UivG4dWc+e4fDBTjAHX1qvH4g8Pal4k8RWuv+P8Aw/ML7SbWJL22nhgiRlknOEUyNkjKkgsevYECq0H9l/12Ou8YePbfw54k0qxkkmijW5Vr0rEriaKS2uzHGvU7jLAnQDsM8kVel8eWlppt7calpWp2VxZeSZbCSON5ysr7I2URuysC2ejZ4PGeK8y8T2nh7xRqljPrXj3QtXSa4iF+9kYUgsoooLvy5XUyPhDLNEp3nBZlXPzAVtWD+BrXR7uy/wCEw8AWTXE1vL5ujW8FlnypRJhx57b84wOmMnrR7v8AXr/kPS/9dl/wTqNY8e3Fp4c1W6stCv01LTvKMljdCHcqyH5ZCRLtKnB6NkEciutsriS6sop57SaykdctbzlC8fsSjMv5E157q2s+CNUfXX/4WB4fhOrWsMC/6fA3ktEXIb/WfMCWHHHTrzxvWXxE8JR2US6j448Mz3QX95LBfRRIx9QhlYj6bjUkK99Tq6K5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKoKOkorm/+Fj+CP+hy8P8A/g0g/wDiqP8AhY/gj/ocvD//AINIP/iqADwv/wAjF4z/AOw1H/6b7OreuavcaZqmhW0CRsmo3xtpS4JKqIZZMrg9coOueM1ynhzx94Pg17xZJP4s0ONLjVo5IWfUoQJF+w2q7lJbkblYZHdSO1Wtf8W+CtYgtXtfHnh60vbGcXNrO1/BIqPtZfmTeNylWYEZB54IPNC3Gra/P8jR1Xxh/Yutayl9A0lhpmm295i3jLTO0kkqkAZwfuLgdevWnDx3p8NvqMmq2V/pcmnxxyyQXUaGSRJGKxsgjZgdzKQFJDA9QK5aXVfCN/Y6qdX+I3hqbUtTiige4guYYoo442LKqxmZj1Zskuck9ulP13UfAWvXmpzzeP8AQYvt1pbQIE1CAmF4JXlSTJfDfMw4x/D709A0bfy/T/gs6mfxnFZ6ZHcX+j6paXc1wtrb6dLHGZp5GGVCFXMZ4BOd+Bg5IxUB+IWnjT0mXTtSe6N//Z0mnpEhniuNhfaw37cbRncGK8g5xkjmr/XPD+rWNnJqHxQ8MHVrC8W7tLmGWFIY2ClNpiMxZlKs2fnzzwRSWN/4JtpILq4+Ifh+a+Orf2rdyrewIs0nkmLaq+YdihSuMljxznOaFbr/AFt/wfwF/X5/8D8TpbT4gWtzcRxy6Nq1on2sWVxNcRRhLa4JAWNiHO7JK/Mm9fmGSKZL8RbOK4kX+xNaeBL19PF1Hbo0b3CsVCKA+45I4bbtHcrzjFn1jwRNZ3MH/CwPD6+frEWqbvt8Hy7JI38v/Wd/Lxu9+nFKms+CEs44P+E/8PnZrDapu+3wc5lMnl/6z/axu/ShbK/z/C/3e99y+aezt8vx/PT738uibx1YRaLLe3NnfQXEV4tidOZENwbhsbYxtcoSQykHdtwckgZqI/EGwXT5ppNO1JLq3vo7CfT/ACka4jmfBUEK5UghgdysRg+xrmNSvvBN8t9JD8RNAt7ubVo9VtZvtsDC3lSNECsvmDepCHPK8NjjGaLXUPBaNJdXvxF8Oz6hc6pDqN1NHeQxxsY1CrGieaSq7VHVmPXrQrdfL9L/APt34A7pO3n+tv0/E73Qtei1yK6xaXNjc2c3kXNrdBPMifaGAJRmU5VlOVYjn1rVrh9K8W+CNM1TWLz/AITnw/L/AGndLcbP7RgHlYiSPbnfz/q85464rU/4WP4I/wChy8P/APg0g/8AiqHYZ0lFc3/wsfwR/wBDl4f/APBpB/8AFUf8LH8Ef9Dl4f8A/BpB/wDFUgOkrm/C/wDyMXjP/sNR/wDpvs6P+Fj+CP8AocvD/wD4NIP/AIquf8OePvB8GveLJJ/FmhxpcatHJCz6lCBIv2G1XcpLcjcrDI7qR2oA9Eorm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KoA6Siub/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qgDpK+XYPEem3P9tfbPiR4zg8VR392tjpNlcTywuVdvKUII2BBwARuxj0r37/AIWP4I/6HLw//wCDSD/4quCisvh03ge/8PX/AI+0Gdri+nv7e9jv4I5LSV3LqyfvD8yk9cjPtml1v5fqth9vX/M6HV/Gfinwz4J0e+n8LJqd89msupGXVILKO3cIC/MhyTnPAGPeqVx8X7m4t/DB8M+FbjWJ/EVpNcQW/wBsSBojHjKsWG3HJ+bPboc1i6rH4e1XVtH1V/jHo8F/ZWJsbuaKa0IuoycsyK7t5TtxlhnoMYqXw9b+B9AvfC06/Ejw/Mnh21ubZE+1wqZ1mOQSfNO0rj3z7Vejk2+/+f4beZGqSt2/y/4Jb1747WGheJptNl0uOS2sXWLUbhtUt45IXIBIjgY75gucErjoeuK9VjkWWJZI2DI4DKw7g14Zrfhr4ean40uNcs/iJ4VtoL6YTXtrcw6des7YAPlyTbjGDjJGCM16fH8Q/A0Uaxp4x8PKqgKANTgAAHtupL4Vff8Ar+l+JT+LTb+v6f4HTUVzf/Cx/BH/AEOXh/8A8GkH/wAVR/wsfwR/0OXh/wD8GkH/AMVSA6Siub/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiqAC+/wCSp6F/2BdS/wDR9jXSV53eePvB7fEnRrpfFmhm3j0m/jeUalDsVmmsyqk7sAkIxA77T6Gug/4WP4I/6HLw/wD+DSD/AOKoA6Siub/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiqAJdS1y60zxpo+nTLD/ZuqRTRpJtIkW5QB1XOcYZA/GM5XrzWZZ+O2kt5bmSxmuxd6lLZ6TaWaDzrlIhh3JdwgG5JDuJUbdvc85/jHxH4M8U+H2sbX4haFpd5HLHPa30eoQO0EiNkMFLjPGRjPQmsrWB8N9S8P6JpsfjDwo50QAWw1Ce3u4JPk2HzIjIN2euQwIIBzQtv69b/p6DOvl8d2iW9gbfStTurq+nltlsoY4/NjljBLo5Zwi4wed208c4INSr4208wSM1vdrcR6kmmPaFUMqzMRjgNjbtYPnP3cn2rl9J1fwPp39jsPGfg22/s2SZzDpbwWkEnmKV4j85tpGck5Ofasv/AISHwTc/Gh9WHi/SEsreyjnkVtQhEMt2d8aurbuWWIsDjplaatzf1/XderROtm/67f5fcz0TXfE6aJqNhYJpl/qV3frI0MNksfSPbu3M7qq/eHJOPxwC2TxSkOtQWFxpWpQRXE32eO+kjQQtLgnZ9/f/AAnDbdp7NWLdeL/BFz4k07Vv+E58Pr9ihni8r+0YDv8AM2c538Y2ehzmuZI8DN4uh1uTx74TkaC+N4krvbteHO790bgy58sbsKoUYAA5pLdX/r+kU7cum52UXxBsZLK9vn0zUobK1uGtVuZI49txOJvK8uNQ5ZiW6HaF565yBraLryaw9zBJY3WnXlqV860vNnmIGGVbMbMpBweQx6EHBFcHeXHw91HwVP4dvvHPh6aOS9kvVka9tyoY3BnVWQuQygnaQfvDPTNW/CWv+BvDNvcx/wDCVeAoWmZSf7GSCwU4H8Y859x54ORinpr/AF/XUT8j0aiub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KpAdJRXN/8ACx/BH/Q5eH//AAaQf/FUf8LH8Ef9Dl4f/wDBpB/8VQAeF/8AkYvGf/Yaj/8ATfZ10led+HPH3g+DXvFkk/izQ40uNWjkhZ9ShAkX7DaruUluRuVhkd1I7V0H/Cx/BH/Q5eH/APwaQf8AxVAHSVyWo+Nf7G13XIb+2eWy023spEFrEXmd55HTGM4PKrgDnr14qz/wsfwR/wBDl4f/APBpB/8AFVy2qan4I1LVdUvP+Fg+H4v7QWxGz7dAfL+zSmTr5nO7OO2OvNNAdQnjezWzvpL/AE/ULC5smiV7KdIzK5lOItux2U7jwPm4PXFZlr46eHVtdl1q1vrC2so7NIrGeKMzebKzrtUozByx2AYYjPpzWbq2reB9UvdSuh8QdBglu/sjwlb+A+RJbuzoxy/zAkjI44HXnIzb9vBeu2uqr4k+I3hq+m1H7Kx2TW6QxNAxZR5bStuQk8qxOeeeRg0/r5fjv+AtdDovEvji9h8LXr6ZpGpWmrQzwQSW0gtjLbiZwqycyGNgckDDN83UABsTr4ufQ7a6/tgahdm0FlEYWtYjdeZOdo3GJ/Lc5IyEVQMHG6uasbjwNbaDdad/wmPgKyae5t5zJo0UFmp8qRXw6+e24nbgHIxnoav6lrHgjUNQu7r/AIWB4fj+03Vlcbft8B2/ZnD7c+ZzuxjPb3oVr/Nfdp/wQ1t9/wDwDem8Z+Zp7utrc6XeQahbWc9te26SunnOgX/Vy7SCHHzBzjuCRtqtZePZkufEba5pF1ZWOkXfkx3P7phJ8kZVNqysxdjJkYUDBUHDZFZWoax4Iv7y9n/4WB4fj+1X1nd7ft8B2/Z2Q7f9Zzu2de2ehqnql14H1ddes7z4geGX0vWZUuWt2uYGkinURgHeZdrJ+6X5CnOT82OKFa2v9fD/AMEf9fn/AMA77RfEKavcXFpNYXmmX1uqSSWl75e8I+drgxu6kHaw65BByBWvXm3hHW/A3hj7V/xVPgCJp9o3aNFBYbsZ+/8Av339eOmOfWul/wCFj+CP+hy8P/8Ag0g/+KodugjpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qkM6Siub/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qgDpK5vx5/wAi7a/9hrSv/Thb0f8ACx/BH/Q5eH//AAaQf/FVh+LPGvhXV9LsbHSvEuj313LrWl+Xb21/FJI+L+AnCqxJwAT9BQB6BRRRQAVzfhf/AJGLxn/2Go//AE32ddJXN+F/+Ri8Z/8AYaj/APTfZ0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc34D/wCRduv+w1qv/pwuK6Sub8B/8i7df9hrVf8A04XFAHSUUUUAFFFFABRRRQBHLbQTyQyTwxyPbuZIWdATG20ruUnodrMMjsxHepKKKACiiigAooooAKKKKAOb8L/8jF4z/wCw1H/6b7Oukrm/C/8AyMXjP/sNR/8Apvs66SgAooooAKKKKACiiigAooooAKKKKACiiigArm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm77/AJKnoX/YF1L/ANH2NdJXN33/ACVPQv8AsC6l/wCj7GukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACub8L/8AIxeM/wDsNR/+m+zrpK5vwv8A8jF4z/7DUf8A6b7OgDpKKKKAMm88V+HtO1RdN1DXtMtb9toW1nvI0lO7phCc89uKv/brQX62JuoftbRmZbfzB5hQHBbb125IGelcNc6/4b07xV4rsPEd9YqboQbbGZ1aS5XyQMJF9589MAGsfRjquneG7HTtW1l9DePw0Wea7n2LbN5wClySArBSFz1HrSTv/Xk3+gPT+vNL9T1iivJJNfjPh/RV+23NhoL6s9vqmpRazPcxsnkllZL12DiIvtXcCuCCOKfp8l/q9rodlJrGqHTLjxBdQ21zHdyRy3VmsErJmUEMykrw+ckAHOeatRb/AK9P8xXsr/11/wAvyPT9R1C10rTp7/UJfKtrdC8j7S20DvgAk1Z614942ntBaeJrLVdZ1C2vbVUi0uxF7L+/t/KjJby8kTAuXDSMGK4+8uM0uvazrK+ONUgudW07SZobmJdJOo+IJbFGj2ISVtxGUuAWLA7jnPA24zSSvbz/AOB+Ov5g21e/Q9gorz5LaS5vfGmoXXiK8057S4aC1nmvXW2sVNrES/llghwWJ+bOOowc1qfD3ULe90S6WzZ51guChuhqsuow3B2qd0U8pJK84IHCsGHPUltL+Sf3jOtrO03XdP1e6u4NOklmNnIYpZPs8ixbwSCqyFQrkEEHaTg8HFeYeHtXvL3WNEC6xfT+IbjUriLXdNa6kKW1uBJjMOdsKjEe1wFLZHJzXWfDPSbex8LXQgkvG87ULxG8+9mmwFuZVG3ex2nHUjBJ5OTzRbS/9f8ADA9NP66/5HTT63ptvZpdyXkbQPcLarJGfMBlaTywny553nafQ9cYq9XjNnY6bF4GudNstSuhfJ4lhjuom1GSaa2B1E+WdkjN5ZZec4G7qc9a0vEFzq+haXrtho17eSWttqNmryXd/KXt7eRVMp+0EPIi+rfMVBJGMDA7W+dvy/zDrb+uv+R6pRXG/Dm7lu9Pv2GradqNotwBbix1p9U8gbRuRp3VWJzyA2SAeuMAdlQ1YSCub8B/8i7df9hrVf8A04XFdJXN+A/+Rduv+w1qv/pwuKQzpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/8jF4z/wCw1H/6b7OtrUdTsNIsXvdWvbextY8B57mVY0XJwMsxAGScVi+F/wDkYvGf/Yaj/wDTfZ10lAHPxePPCdyrmy8SaXelCgZLO6Sdl3OqKSqEnG5lGcY5roK8wniM/wAIbuISPEX12RRJGQGTOpnkZzyKXXPtmlw+I9JsNW1OOGN9NaGZ7x5ZoTNPtk2yOS2CF+7nAyQBjinb+vu/zD/M9OorzLxM1poviSy0nWdd1PS9BXTZZba4bVZ0ee73/dacvvZgpysZYg5PBwAI9Mh1fxAmix+I9R1a0uP+EcNzcQ211JaFpt64dwhBDAduOpBBHFK6tf8ArS/+X5B1t6fjb/P8z02eeO2t5J522xRIXdsZwAMk8UlrcxXlnDdWz74Z41kjbBG5SMg4PPQ15fpkt7Fpej3U+qX95Jrnhy4ub0XVyzo0ixxFWRPux43sPkAB75PNQ+ENSUXuiReE9avdVkbRXbU7a4uXmSGRY08ncjHEDFsgKAu4ZODjNNrlck+n/wBtf8g35fP/AIH+Z63RXjvhfW9QuZtHl0TV73U9Xm0y4k12zuLh5VtrgR5QNExIgbzMqFAXIzwcZqzYXv2rwG2oeHfEepaj4htLWK+v7Rr15B50bK0sToeIScOnljaOfu8ZA1Z6/wBb/hp+QvT+v6ueqzXMFts+0TRxeY4jTewXcx6KM9SfSpK8i1Ca38SeF7fxXrN/fW2k3euwz2zG/mtUtrQERq5KuuwNgvk4I3jpUXibWp49Q19IdbvYNVtUg/4Ri0hvZNt6hjU7ggbFzucsGLBsAZ460JN6P+tF+Ov4PsF9dP61a+7Q9ioryDxRrKw6l4sSXxFqFrrdt5J0axhvJEV5jboQqRAgS5c8odwAOcDOSzxTrOuR+LNQhvtW07RpY4Yf7Kk1DxBLp0W4xgu4iWNkuPnJBDE4AAwM5Ilewz2Kub8L/wDIxeM/+w1H/wCm+zroo9xjXeQWwMlemfaud8L/APIxeM/+w1H/AOm+zpBudJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzd9/yVPQv+wLqX/o+xrpK5u+/5KnoX/YF1L/0fY10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf/kYvGf8A2Go//TfZ10lc34X/AORi8Z/9hqP/ANN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP+Rdtf+w1pX/pwt66Sub8ef8AIu2v/Ya0r/04W9AHSUUUUAFc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ0AdJRRXL/EC7ubLw7ayWdxLbyNqtjGWicqSrXMasuR2IJBHcGmldpd2l94HUUVydn45F7NZWiaeRfz6lPYz2/nf8e4hDM0hO3kYCEcDPmLWfYePde1CHSpIvCsCjWY3ay3aoOCo3Ey/u/kUjJBXefVRSA7yiuNj8b396ulQ6Vokc97qC3QeOa98uO3e3cI4LhGLLuJAIXPTjk4zR4u1bWNb0GbRtObz5E1C3ubCe9MUKywvGhLOFbcoIOCEJ+boOcA7HolFchdeOjD4TtdZW2sLUzSPFJ/amqJaQQujlGUylWJJKnbhecc4qjYeMNb1vxT4efSLSzOj6lpcl3Ik15hwRJEpYbYmBKhiAAwDbiSRgZaV3b+tr/oTfS53tFcLY+NL6X7Lp2m2banql3NfOq3t0sKRwwTmMkvHF7qFGwn1bjceg1vXp9G8LnVW05mnAj3W0koURFiATI6hgFXOWYBsAE4NLZXH1sbVFcrF41WCbTV1aKyjh1CznuY7uxvftMBMWGKq5RN2UJbOB91h2zVbS/HF7qeqaZZtpVnYNe2sd0UvtQMcrK4JxCgiPmlRjdyuCfxp2/r7/APJiuv6/rzOzorzm18f6to3hnUdU8WW2noqarJY2rJqG1S3nMgV2aJFRFA+/ySASRng27f4lpd+Hrq9sbOy1G7tb+3smi07U1ngkaZ0VWSfaAcb+QVU5BHoaFrt5fjb/ADRTVm0/P8P+GO7orhz461m3e+/tDw3BDHpU8cWoSx6lvVQ4VlaL92DJgOCwYJjsWruKQutgrm/Af/Iu3X/Ya1X/ANOFxXSVzfgP/kXbr/sNar/6cLigDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAorC8S6/eaNNpdtpumpqF1qVy1vGklz5CoRE8m5m2tx8mDgE88A9Dmw+Kbm+udESWCWxnm1SexuoIZkkj3RxSMfmaPLIdgIx5bcjPdS0rg9P6/rsdfVfULT+0NNubMzzW4uImjM0BAdMjGVJBGR2yDXMaT48j1DxkfD88enpMySOiW2qJcTxbMZE8Sj92Tu4wzDg8iuvpWuvUd7P0K2nWFvpemW1hZpst7WJYYl9FUYH6CrNFFNtt3ZKVlZFGy0mCw1HUb2F5Gk1CVJZQxGFKxqg28dMKOueavUUUhhXN+F/+Ri8Z/8AYaj/APTfZ10lc34X/wCRi8Z/9hqP/wBN9nQB0lFFFABRRRQAUUUUAFFFYPjbxCnhfwZqOrNJFG8MRWEzOFUyt8qAk8AbiKTdkNK7sb1FeTeGfGrab4Q8WWljr1v4kvPD8JurW8kuvtInR494Durc4cOuM5AA9q3dR8Za14ZtNXfXorG9ktNOW/gFjFJGAWcp5TZZy2Dj5xjIz8oqmrf18xLX+v67o7yivNx468RR6TqD/ZI7i4i+zfZ7mfR7zT4C0syxtGVm+ZiAc7lPf7oxzNfeJvF2lrrbXT6JNHoUSXU7x20qm5jZSxjVTIfLYBT85Lg8fKKLAehUVxd/r82n6r4geGaGB41tFha4NxOuXVj8sCMdzccLGFLdz3Gj4K8Q3HiLS7t71QJ7O7e2dxaS2vmYVWDeTL88fDDhienUiktb+X9fqK608/6/QS+/5KnoX/YF1L/0fY10lcV4u1m38PeMbLV71gsFl4e1SZs98S2Rx+J4rkfCfxA/sjTPEcU+vW/iW7tNMGtxmO+WZVYofOgDAnaquBgdg4xQtb+X9f5lWenn/X6o9jory6x8feIrjSvEGoW17oOr2un2kD2lxZWsqQyzSH5o2fznB2YAIHPzDp0ra8ReItd8P2MMc1/psl+Y3nkW30i7uSyjooiidmRexlZsZ/h7US93cmL5tjt6K8+l8Y+Ir83Nzoy6Xb2lrottqrpdwySSSGRZGMQKuoXiMfNg4/unPG5D4luZ9VuYFhiWGPRotQTIJbe5kypOcEYQdh3okuW9+n/B/wAmOPvJNf1t/mjpaK8quPF0+nX8/ieW2jmuX8K2c3kqSiGSSZgBk5IXc3XnArTvvHOt+HZdWsNZhsb++tba1uLeazjeCJzPKYQrqzORtYZyDyOwp8rvbrr+DsJNPVeX4pf52PQqK5K+1zXvDa6ZJ4hfTLi1uL9bW5ubWGSEIsi4jbazttxJtU/M2Q2eOlYsWt+Jte1Twzf2F/ZWFnf3F20cLWskglgUN5bNiZQSUAI44JB9qAbsj0eivPD471jf/ayw2R0X+2xo/wBl8t/tJPneT5vmb9v3udmzpzu7VLe+JdXFr4ki1aS3tJLayupbXTxazwyuiZ2yLdLKA4IwSIwrLvAJBHK6X/rZP8mi0ry5f63t+h31Fcfba7qkXiWysbuSCw02SKIW5ms5pmvCYwSBceZtjYNxtcMzYJGc8dhTasQncKKKKQzm/C//ACMXjP8A7DUf/pvs66Sub8L/APIxeM/+w1H/AOm+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLegDpKKKKACub8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OgDpKztb0S216xjtLx5UjjuYbkGIgHdFIsijkHjKjPt6Vo0UbO4HIaR4U8j4na94jmtWgSeGKC2zICJDtHmyhQflJ2xqc4J8v0xWpYeFbLT4dFjhluGXRkZLfeyncGXad3HPHpituijpYNziLzwPMuuaONKvtQsra1+3zSXkEsXmRyTyI+3aylWUkuMFSBgZ5wa2dL8H6bo8unyWj3BexS4CtI4YytOweR3OOWLLnjA5PHTGlqer6botn9r1nULXT7YEL511MsSZPQbmIFQ3/iPQ9Kgjm1TWdPsopU8yN7i6SNXXIG4FiMjLKM+49aYzLbwPaJDZCx1G/sp7J52iuYTEZNsz75EO9GXBOOQAwA4PXLrXwVaWDaO1hqN/bvpMTwI6tG5nidlZkk3ocglF5Xa3HWtW+17SNMtoLjUdUsrSG5YLBJPcJGspPICknDE+1Z0PikTeAZfEwtBiOzluhbiXO7YGON2O+3rjvSvbXsCV7RRXfwHZKLaSw1HUNPu7aS5eO8t2jMm2eQySIQ6MpUtjGVyMDnPNbNzpssujpY2mqXti6KqrdxGOSbA9TKjqSe5IJqpb+KtLvtMu7jTb6zvZ7ODzZ7a3uVdojt3bWxkqfqKbbeLtI/sbSb3Vr+y0uTVYI5IILm6RCzOoOxd2Nx5xwKeu39a3/4JPMnr6/1+Jzvij4fRX/hnS9CtIp7pP7VW5urySVFdVZmad2xtB3hmQqgA+foAK6PUPDK6nqdvPdanemztpI5Y9NVYVgDxnKtkR+ZwQDjfj2xxVzUNd0jSJYI9V1WysZLltkCXNwkZlb0UMRuP0qtr/ifSvDto7X9/ZxXJhklt7Wa5WN7jYpOFB5P4A0uayv53/L/Iqzk7FGXwPZyxXsLahfiC5uxfQxK0Y+x3G/f5kTbN2S3OHLDtjHFWT4Ya401bPVta1HU9l3DdpNcLAjq0Tq6r+7iQbcqM5GeTzWtY3P23T7e62bPPiWTbnO3IBxn8anp6xdu36f8ADE3Ute5iXfhWxvItYjlluANXkSSfay/KUVVG3jjhB1z3rboopDCub8B/8i7df9hrVf8A04XFdJXN+A/+Rduv+w1qv/pwuKAOkooooAKKKKACiiigAooooAKKKKACiiigAooooA5vwv8A8jF4z/7DUf8A6b7Oukrm/C//ACMXjP8A7DUf/pvs66SgAoorFTxdosmtf2Wl05uPNMO77PJ5JlHJj87b5e/j7m7d7UdbB5m1RWFaeNNAvdYGmW18WuGkeJGMEixSun30SUqEdlwchWJGDnoahl8aafLo99faXvmS0UN5t1b3EFvJlsZWbymDj3QN29c0Bsat/pEGoX+m3czyLJp07TxBCAGYxtGQ3HTDnpjnFUU8J2CXdvcCW4LQX82oKCy4MkqMjA8fdw5x36c1HeeONAsNVm027vJEubdkW4C2srpAXAKl5AhVAcjDMQO3WpNS8ZaDpGpGxv71o5lCmUrBI8cG7hfNkVSkee28jPajcH5/1/VyrpPge10a+tLiDUtRmjsI5IrO1laLy7dHABUbUBboMFix961dAj1GLQbVNbmaa+2kyuwQNkkkA7AFyBgEgAcVQv8Axz4e0zULizvb50mtWRbkrbSulvuAZWkdVKopBHzMQPfg1SXx7YWniTV9N1eYQpZzwxxSRW8rqqSRIwaV1BVAWYgM20cULX+v67h5s62iuS1/xdc6dHefY4rR3tdTsrI7ndztneMMWXaoUhZMjDMOme4q4PGFjBZy3GoHG27mto4rGKe6kfy22sdixB8jvhSo/vEc0dL/ANdP80Oz/r5/5HQ0VBZXttqVjDe2Myz206CSKROjKehqejYQVzfhf/kYvGf/AGGo/wD032ddJXN+F/8AkYvGf/Yaj/8ATfZ0AdJRRRQAUUUUAFFFFABVTUNKstUNt9vh84Ws63MILEBZFztYgHnGc4ORnB6gVbooAytS8M6Rq9zNPqFp5ss9m9jKwkdd8LHJQ7SO44PUc4IyamutC029mmkvLRJzPbfZJRJlleLJO0qeOpPbNX6KPIP6/r7jCt/BukW9rLbYv54JWjYx3Wp3NwqmNg6bRJI23BA+7jOMHird34f0y+j1FLq23rqkQhux5jDzUAIA4PHBPTFaVFAGTe+GNJ1A3JubZ99yYzJJHPJG4MYIRlZWBQjJ5Ug81No+h6foNvLBpcLxpNKZpS8zys7kAFizkkkhRk5569a0KKNhWRx/iHSrLWfiPoVpqUPnwf2VfS+WWIBZLmwZc4IyMgHB4PervjLwjB4p0m4RBHFqP2Wa2t7l92I1kADAgHkHA65wQCORVTxDqVro/wAQNL1HUZDFa22hanJK4RnKqJrHPyqCT9AM1saN4m0vXpp4dPlmFxbhTLb3VrLbSoG+6xjlVW2nBwcYOD6Ub6DvbU5/QPCGoKL2HxExGnXEKx/2f/bN1qALhs+Z50wV07DYvHGa6DV/DOla5NHLqMMzSIpj3Q3MsO9D1R/LYb1/2WyPataih6iStsZUHhnSLaGaKC02pPZx2Mg8xzugQMFTrxgO3PXnrUOpeD9E1YW4vrSRhbw/Z1EdzLGHi/55uFYeYvH3WyK26rf2hbDVBp3m/wClmEziPafuBtuc4x1PTrQ9Xr/X9aj2X9f12M8+EdCaB4ZNOjkiexXTmjkZmVrdc7UIJxxk89feo7XwXoFpp95ZLYtPFfII7lru4kuJJUX7qmSRmbAycDOB2xW7RRuByOv+Bre78C6l4e0hB/xMQscst/dSzttJALb3LsSqj5QTjIA4FbN14a0u8tbC3lhljXTiptWt7iSBosLtwGjZTjHBGcHuK1aR2CIzHOFGTgEn8h1ouFjEXwZoK62dVWxP2lpvtBXz5PJ83p5vk7vL8z/b27vej/hDtGM15LPFdXL3kUkEpur+efbHJ99U3ufLB9E29B6Cte0uUvLSK5hWVUlUMomhaJwD6o4DKfYgGpaNtAvrdGR/wi2lnVotQdbqSaHaYo5L6d4Yyq7QywlzGCB3C56nqal0PT7nTbGWK8uXuJHuZpQXleTYjSFlQM5JwFIGOg7cYrSooAKKKKAOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACub8L/8AIxeM/wDsNR/+m+zrpK5vwv8A8jF4z/7DUf8A6b7OgDpKKKKACiiigDlvGVrrU89hJo0E7onmLLLYpam6iJ27dpucoEODuwC33cCsnwt4U1Gxu/C8mq2KE6bpFzbSu7RuYpXki2gY9VVuVAGOOOld/RQtP68mv1B6/wBfM870zQtX0OPRJn0E6kIdNlsJLWOaEG3LyBgx3sFKFRg7SSMDCntpWWgajB8G5dCazji1A6ZNbraxyKVDsrBVDcDHIGePwrsqKTV48v8AXX/McXyyUl/X9WPOrXQdYv8AUYLh9A/sWPT9Dn04R+fEwuZH2bQmxiPLXYcFgpy3QVmnwp4gsbW4hOhf2p/afhu20v8A4+IgLKVEYMJNzDMZLg5QMcr06V6vRVN3un1/4P8AmyYrlaa6f8D/ACR5ff8AhPXLCbUII9L/ALej1LQINKSczxqLeSMOrGQSMD5bFw2UDNlenSrF94a1ixsdS09NFGvf2jo0Fity08SrG8UbKRL5h3bSW3AqG5zkDrXpFFEnzXv1/wCD/mONotW6f8D/ACRU0qGS20eygmXbJFbojrnOCFAIq3RRQ3d3ElZWCiiikMK5vwH/AMi7df8AYa1X/wBOFxXSVzfgP/kXbr/sNar/AOnC4oA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C/8AyMXjP/sNR/8Apvs66Sub8L/8jF4z/wCw1H/6b7OukoAK850v4d3Ol65iS3XUNP8A7Rkvkmk1+8iMRaUyD/RAphYqT1yM9SAa9GqrqWp2mkWLXmoy+TbqyIX2lsFmCqMAE8lgKOtweqscNpHgXWbRtE029l086VoN9LeW08Ujme53CQIjoVCpjzDlgzbsdBmpV8H63Pper2nl2Ol295Eqw2EGoTXUKuHDFwXjXyhgY2Iu3PPWu+op3B6qzOR1TwpfXtj4thiltw2tFDblmbCYhRDv445U9M8Vma54G1m9uPEllYy2B0zxN5Zupp5HE1qRGsbbECkSZVRjLLtOetdxY6ja6lFLJZS+asUzwOdpGHRirDkdiCM9Ks0J2DqeZXmj63rOp+NdD0saethfPDazz3MjiWAG1jDMqhSJPlPAJXB5yelbl74PvJtJ8U2dvNAP7WEa2xdm+ULAkfz8ccoemeK7GihNoHrocXq/g7UL99UMM1sv2zVrC+j3s3CQGHeD8v3j5bY7cjJFV7rwjr62nk2l1G8MmoXdxNbR6jPZb1ll3xt50S78qM5QYBz14ru3dY0Z3YKqjJYnAA9ajtLu3v7SK6sbiK5t5lDxTQuHR1PQhhwR70ulv66f5D5na39df8zlfC9rrWgHRfDjQxS2lpYSPfXe2QgybwI1jdjyT85YHJGBk8jPX0UU73EFc34X/wCRi8Z/9hqP/wBN9nXSVzfhf/kYvGf/AGGo/wD032dIDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPOviXbXN5qiW9jE81zJ4b1RYkSMuWbzrHGFHJ+gqbWfDuo2lhqWs6o0euajdQwWjRWtnJFDFAsm4nyUkaSXG4sybzvA2gDNbd9/yVPQv+wLqX/o+xrpKA6nkGj+H7q70GfTrvTHGnN4ktpYYINMlsIRb+XGWZIGYtGm7dkE9d2QMkVa1Hw/PYwalY2ukXA8OQeIIZZtOtbZiktmbZN6xxKPnTzTlkUHOGGCcivVaKq/6fhy//ACP4h/lb8/8AM8r8Ss3hvTNJ8ReDNIuLVA0umLYyxNAStwcRERtyiiYIdpAwrNwOlXbXwfpfh/xhofmaKtxLFpItYNRGnGcrcqy4d5FU+WcZO5iByRmu8v8ASrPU5LR76IymznFxCN7ALIAQGIBwcZPByM89QKt1P9fK3/BbE9f68/8AgL8TyHwjo15Fq3hx49IvrLWrVpz4jvprZ4xdgo4GZSAs+XKsu0ttA/h6VV8Haclzb+EpvDej3tjqcKu2o6jLauiSwmFwqmYjbKpcoVQE7cdFxivaDyOaradp9rpOmwWGnxeVbW6BIk3FtqjoMkkn8ad7/wBepXc8n8CaHqNpf2h1Mm21aO1lXUFi8OXUL3jlDkS3pdopsNhgR9BjkVp+FvCi6HaeFZrHSJLO5m0eSPU3WFld38pNqzHqSGyAG6cgY6V6dRSlqmu//B/zEtHf+un+R4fr+marJ4J0uzXQX+323h+H7JLLpFxeSidYzlYyrKtrIpA+duSSBg7cV7ZbljbRGTO/YN2eucVJRVylzX83cVtF5BRRRUDCiiigDm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v/AGGtK/8AThb10lc348/5F21/7DWlf+nC3oA6SiiigArm/C//ACMXjP8A7DUf/pvs66SuE0zwn4c17xb4wutc0DS9SuE1aKNZbyyjmdVFhaEKCwJxkk49zQB3dFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJXN+A/+Rduv+w1qv/pwuKP+FceCP+hN8P8A/grg/wDia5/wX4B8H3Wg3Ml14T0OZ11bUow0mmwsQqX06quSvQKoAHYADtQB6JRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQAeF/8AkYvGf/Yaj/8ATfZ10led+HPAPg+fXvFkc/hPQ5Et9WjjhV9NhIjX7DattUFeBuZjgd2J710H/CuPBH/Qm+H/APwVwf8AxNAHSVyvxJ/5Ea4/6+rT/wBKY6m/4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoGjhL7WNYPj6/gu9Y0/S7uPUo47CO/8AEEtpvt/k4S08sxzh8sNxYnccArgVpy+J/Ixo8urSjWP+EmVTbCZjKts1zlcgciIoQBn5Tnb7V1H/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E046cvl/wAD/L8RS95Nd/8Ag/5/gcd4Zvby38Y3MOqXMlvp8mpX40pIZCkdxc+dJvSYg8tt5Rfun5jyQMVvCOs3t3q3hxrfWL271m4af/hJLGW5d1tAEcjMJO2DDhVXAXcOfm613X/CuPBH/Qm+H/8AwVwf/E0f8K48Ef8AQm+H/wDwVwf/ABNJbW8rf1/XYcvebfdnn/hbW5Ln/hFm0TX9Q1TWpw41a0uLySULEIXILxMcR/OIwrgAtnq2af4E1nV72/tGvtZ0+PUXtZX1Swk8QSz3RfYTgWbxqICrY+4cY67uDXe/8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxND1TQN3dzlfCy3djaeFbo6vql3Lq2jyS3n2y9kmV3ESMrBWJCEEnlQM55yeaxta8R3CeCdDEl/cJqB0GK7jmuNakshNKYzymxGa5lBGTG2VwRnrXof/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E05O7duv4b/AOf4Cjpa/wDW3+RtaXO9zo9nPMcySwI7HHUlQTVqub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaG7u4oqysdJXN+F/+Ri8Z/8AYaj/APTfZ0f8K48Ef9Cb4f8A/BXB/wDE1z/hzwD4Pn17xZHP4T0ORLfVo44VfTYSI1+w2rbVBXgbmY4Hdie9IZ6JRXN/8K48Ef8AQm+H/wDwVwf/ABNH/CuPBH/Qm+H/APwVwf8AxNAHSUVzf/CufBH/AEJvh/8A8FcH/wATXL6DZ/DTU/C1vrWreFPCmjJPJOqpdW1sBiKRkY7mRc8Lk8cZoA9MoriJfDnwrg0ZNXm0fwfHpj42Xr2tqIWzwMPjafzp8/hf4X2ujrq1zofhGHTXAK3klpbLCwPQhyNvP1oA7SiuLk8L/DCLT4L6XQ/CKWdx/qbhrS2EcvBb5Wxg8AnjsDVeHRvhJcNaLb6d4Lla9JFqEgtGNwQcEJgfNg+maPIPM7yiuGu9A+FFheC0vtJ8G21yZBEIZra1R95AIXaRnJBBx15FSr4N8BLe38dz4V8IxxWaozsLWAugYE5kUxjyxxwcnIz0o8wO0orjtM8IfDXW7T7Vo3h7wpqFvkr51pZW0qZ9MqpFXf8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAC+/5KnoX/YF1L/0fY10led3ngHwevxJ0a1XwnoYt5NJv5HiGmw7GZZrMKxG3BIDsAe24+proP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaAOkorm/+FceCP+hN8P8A/grg/wDiaP8AhXHgj/oTfD//AIK4P/iaADwv/wAjF4z/AOw1H/6b7Oukrzvw54B8Hz694sjn8J6HIlvq0ccKvpsJEa/YbVtqgrwNzMcDuxPeug/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpK5vx5/yLtr/wBhrSv/AE4W9H/CuPBH/Qm+H/8AwVwf/E1h+LPBXhXSNLsb7SvDWj2N3FrWl+XcW1hFHImb+AHDKoIyCR9DQB6BRRRQAVzfhf8A5GLxn/2Go/8A032ddJXN+F/+Ri8Z/wDYaj/9N9nQB0lFFFABRUdzcwWdtJcXc0cEESl5JZXCqijqSTwBUgORkcigAooooAKKKKACiiigAooooAKKiuLqC0iEl3PHBGXVA8rhQWYhVGT3JIAHcmpaACiiigArm/Af/Iu3X/Ya1X/04XFdJXN+A/8AkXbr/sNar/6cLigDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/8jF4z/wCw1H/6b7Oukrm/C/8AyMXjP/sNR/8Apvs66SgAooooAKKKKACiiigAooooAKKKKACiiigArm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zoA6SiiqV7q9jp17Y2l5P5c+oSmG2TYx8xwhcjIGB8qk846UAXT0ryPwloF/GngUX+lXKfY77U5ZfOt2Hkbmk2M2R8ucjBPXPFeuVT1HVbLSltjqE3lC6uEtofkZt0jnCrwDjPqeKFoxPVHmX9imze9u7i313TpLXxHdXFldabYfaPKWRFBJh2sXR8tyqHBycjrTtOi1W2vNA13WtDY6dYz3q+Xp+lujgyFTHdtarudWPzggAsN+SBk49L0zVrLWIZpdOm85ILiS2kOxl2yI2115A6EYz0q5QtEvRflYb3d+7/ADf+Z5ImgX11qVheNpFwmnXXi4ahDbSWxBgh+zMvmOmP3e6QFsNggsM4JxT9Z8OXP/CPeOfsukTG4vNet5odluxaZF+znevGSAQ5yOmG969Sluo4bmGB1lLzlghSF2UYGTuYDC+24jPQVNTTtt/Xw/8AyIS953/rr/meX6roFzcWvxSb+yppJdQhVbU/ZyTc4tFACcfNh8jjPPvWRrfhzXL59Ukis9QCLJo88vlQqZJkiQ+ZsEilXZThtpB5GMZr2eqMesWM6xtazG5R7hrbfbRtKqyLkMGKghcFSCWwAeM5pLy8vwHLXfz/AB/4Y43w8+n6Re634ovLzxLPF9miW5vNW05bdWVCx+WGOGOQlcnLFMYIwSBx6ACGUEdDyKgvLO31CzktbyMSwSDDoSQGGehx2qenckKKKKQzm77/AJKnoX/YF1L/ANH2NdJXN33/ACVPQv8AsC6l/wCj7GukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACvFdQsLXUvjB4igvPCo8SgySeXAVgIhY2mnjfmVl2+mVyw7Cvaq5bwxbQHxb4xujDGbhdWSNZdg3hTYWZK564JAOPYUdU/X8mgd7WXl+aZiLF4j8L6VoKa1qt6NPs7aKK9uLDyZWM27B80zKXaPBVQY/nzkn1DbHxbrU/iMeGmn36lpt7czXzCJQZrNV3Q8YwN5kjXI/uPjvXbXXh/Rr3VYdTvdIsbjULcAQ3ctsjyxgZICuRkdT0Peq9h4fWz8Varrksyyz36QwoBFt8qKMHC5ydxLMxzx1A7U73vfz/wCB/XYP+B/wf67nA3OoalrHwd1HV9R19LiTVdCmuDpxhiC27befLKgPtXO1g5Y5xyvQ3PEN1qul6P4k0+/1IavGNBa9T7XZwlY3yylAgXaycDhwx9Sa7ePw3ocL3jw6Lp8bX4xdlbVAbkeknHz/AI5q1cabY3XmfarK3m82LyJPMiVt8f8AcORyvPTpTur7aD/r8V/kef6/4q1LTtdhbS7i+ks7fUbSwmijt7VLRDI0YZHLt5zPtfcDGNo4BBwarY1bRbX4galp+v3ZuI9Q2wpPDA0aO0MBD4EYYkA7cZxgcjPzV6BP4d0S61Iajc6Pp818qqoupLVGlAUgqN5GcAgEehFOl0DR576a9n0mxku54xFNcPbIZJEBBCsxGSMgHB44FCdl9/6f5fj5EtaWRx+s3N94c1uOZpjrV5a6DqF0ktxbQiV3VoSEVkRSq8kbR14zkgGt3wk95JZQ3F/4iGrPeWsdyIjFEvlbhk7PLA/d9hu3Hj7xrea1t3uluXgjadEaNZSgLKrEEqD1wSoyPYelVtN0TStH87+yNMs7D7Q/mTfZbdIvMb+820DJ9zST0t/W7/z/AAG/L+tv8vxPO7zQ/Db2njfW9XtbS3vba/l8rVNojuISLePbslHzA5PAB7+9WdIuPEV6b4wJBDrzaDpkjyNbxrKJGMvmAsV5OAdobKhu2Cc9m3hXw8+snV30HTG1MtuN6bOMzE4xnfjdnHHWrF9omlanHOmpaZZ3iXKok63FusglVSSoYEfMASSAehJoTtG3kvwVvxDrfzf4u/4HCp4h1G+1DQ9Atdb1Kxa6N39rvryG1N0ksO0+QNsZhz85OQp+VTg55qPR9e8ReJk8O241l9O+1DUBc3NpbxM1wsEqpG6eYrKu4c9CME+xHcTeGdBuNIj0q40TTpdOiIMdm9pG0KY9EI2j8qurY2iSQOlrCr26GOFhGAYlOMqvoDgcD0FF1/X9fgB5j4kvb/UrGS8udeMUMPiO2sV0sxRBGEd3GAc7fM8w43/extP3e9WbLxH4w1XxNeSWFjqT29pqxsmtx9iW0WBXCs7ln+0b9uXGBjoNp613c3h7RrjUjqM+kWEt8wVTdPbIZSFIZRvIzwQCPQgUy68MaDe6tHql7omnXGoRFTHeS2kbzIVOVw5GRg9OeKIuySf9bf5fiOWqaX9b6fj+BzFg3irU9N12+stcke4S+ubWzs/IgWOONJtudxQkybQwUsdvIyp5NdB4TvjfaJ+8ur+5nhmeGc6ikKzJIDyjeSojOM4yuR7mrtzomlXmnzWF5plncWc7mSa3lt1aORi24sykYJ3c5Pfmp7KxtNMs47TTbWG0tohiOCCMRog9Ao4FJaKwS1d13ZPXN+A/+Rduv+w1qv8A6cLiukrm/Af/ACLt1/2GtV/9OFxQI6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C//IxeM/8AsNR/+m+zrpK5vwv/AMjF4z/7DUf/AKb7OukoAK5Xx3Y2mpw6HZ6law3drNq8KyQTxiRHG1+Cp4NdVVPU9I03W7P7JrOn2uoWxYN5N3AsqZHQ7WBGaT6eq/MOj9H+R5hq2qHwPq/iWLwVboLG10+2Z7O3CmC0upJyhKoSEQ7DuK5UcAnGc1cutc8XaXody99NfafAbuxjt9R1hbFpP3k4SYFbdjHsCkYJ2n5jzxmvQ7PSNN07TvsGn6fa2tngj7NBAqR4PUbQMViXngDQW0z7Fo+l6dpMcl3b3M4tbGNBMIZQ4VguM5wRk5xnpVR0av5fn/Xy0B63/roc3f694g06HxHplrrZvJbCWwW31Ka3iLo08oV43VFVDgYPQHDjvzTdX1XxXbeKZfDul3Gt6g9lYR3a3VvFp4kuJHdxiUS+WvljaBiMBueWBxnvbTQNHsNO/s+x0mxtrLeJPs0NsiR7gQwbaBjOQDn1FJq3h7RdfSNdd0iw1NYjmMXlskwQ+24HFL+vwGnoc1qOo6/Z6npV9rU93pumSR26TRaeLeRUuXbDJN5is5QkooMRzySeMEZGt6lqtpoXim08Q3NxLff2bc3Fvaz29rLZPEpwGjATecblBWUnJJwCOa7pvDWhNqVvqLaLpxvrZBHBdG0TzYlAwFV8ZUAE8A96ba+F9AsYruOy0PTbeO9BF0kNpGguM9d4A+bqeuetVdXv6/1/X/BJWlvkcH4g8U63at4pu7DUxYr4aWAW2mrDGVvd8at85ZS2GJKLsK4Knr0q3rGseIY5vFGp2+tSW0GiNC0FgttEySZhjd1kZlLEEscbSpHqRwO3udB0i81KDULvSrKe9thiC5lt0aSL/dYjK/hU0mm2MyXKS2Vu63ePtCtEpE2AAN/HzcADnsKSYW0sWQcgGiiikMK5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zoA6SuD+IlkNR8S+CbV554Fk1WUM9vKY3x9llyAw5XPTIIPPBB5rvKhms7W5mgmuLaGWW2cvA8kYZomIKkqT0OCRkdiaa3Dozy6DVXgm1Hw5c32tXKp4h+wWEcN+UmkQ2yymOS5c7wo3Ochg/AAJ6VkWmoXk91Np1zcyzQab4xsYrdJb57xoVKhihmf5m5J4JODkZIFeu3fh7Rb+3ube+0ewuYbqUTXEc1qjrNIAAHYEYZsADJ54FJB4c0S2x9m0bT4cOkg8u1RcMgwjcDqo4B7dqadmn2t+HL/k/vFJXi0ut/wAb/wCf4Hmnhi+ntfEukwJdSQwXPiPWlljEhVZSC5UMOjYPIzUaeILzU9SjsV1i6Gl6h4uubKa4huWVhEkO5IUkBygLrj5SD6HmvT7rw5ol7YyWV5o2n3FpJKZ3t5bVGjaQnJcqRgsTznrmlPh/Rjps2nnSLA2Vwxaa2+zJ5chPUsuME8Dr6VK0tftb8v8AIctW2urb++/+f4HHTTjTvFPhvTdK8Q3mo2wuL6OcSXvnMpWHcInYctsOCN+WHc1geHJ9QsvD/wAP9bfWtVubrVbkW98Lm9kljmjaKVseWxKggouGA3cck5r0exj8MJqCaTpqaQt5paFksrcRCS0VhgkIOUBBx0Gc1eTSNNjt7SCPT7VIbJg9rGsChYGAIBQYwpwSMj1NNPr6frf7wWzT8/8AgHks2uTC88K6xpV5qyRazq6W5l1DWGY3ULFgQLVcxpwM5ARl4zySKb4eSbQ9M0ddNub5DceMbyGaN72VxIim4whDMeDhSfU8nJ5r0ufw/wCE9Nma+udI0W0lnuY2a4ktokaSfd8h3EcvuPHfJ45q6vh/RkvXvE0mxW6kmFw84tkDtKAVDlsZLAEjPXBNC0X9eWn4fiN7v+ukl+q+48zsdSvY/Cnh7xPFrN/ca5qWpQQXVo94zQtvl2ywCAnYnlru5VQw2ZJPOYHm1GHwzqPiNda1U31n4ne3hVr6QwiE3gjMRizsZdrHqCRxgjAr1OLw/o1vrEmrQaTYxalKMSXiWyCZx7uBuPQd6kOj6Y1q9qdOtDbyTee8RgXY0m7dvIxgtuG7PXPNNNJ3/rpp+D+8Hqrf11/zX3Fyis3TNGh0zUNUu4ypfUrgTyBYwuMRqgHHU/LnJ559q0qkRzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/wDkYvGf/Yaj/wDTfZ10lc34X/5GLxn/ANhqP/032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc348/wCRdtf+w1pX/pwt66Sub8ef8i7a/wDYa0r/ANOFvQB0lFFFABXN+F/+Ri8Z/wDYaj/9N9nXSVzfhf8A5GLxn/2Go/8A032dAHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+A/+Rduv+w1qv/pwuK6Sub8B/wDIu3X/AGGtV/8AThcUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf/kYvGf8A2Go//TfZ10lc34X/AORi8Z/9hqP/ANN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc34X/5GLxn/wBhqP8A9N9nXSVzfhf/AJGLxn/2Go//AE32dAHSUUUUAFcJ4T1DxB4ktn8RNrRgt0vrmE6ULSN4jDFI0YAbiQSHbnduK842V3dYI8E+Hxq/9pCwPn+f9pEfnyeT53/PXyd3l+Z/t7d3vQHQ4+08S+II/C+ieMLjVmnj1a8t4pNI+zxiGKOaUIAjBfM3rkElmIJDcDjFW08SeJk0G08Rz67JOreIW017A20KxNAbxoAchN+8DBBDY4GQeSe6tvBPh+01Rb+CxZZUlM8cRuJWgikPV0hLeWjHJ+ZVB5PqalHhHRBpKaYLL/Q0vPtyx+a/E/m+bvznP3+cZx2xjirTjdXXX8NNPz+8Utb2/rf/AIB5xos+qeH5tRkttZup/tfjNbOZZ4oMMjbdx+WMEFhgH0wMAc56HVNb8UXGs+LLDw663Eun/YfIhVY98aOCZthbCl9oyoc7c47V0tx4Q0O6sLyznsd0N5dfbJsTOrefx+8Vg25GGBgqRjtVaLwB4aht76FdPdv7QMbXMkl1K8kjx/cfzGYsHH98ENnnNQvhSfS35RX6P7w+25ev5t/qjkZ/F+pWWjtBFrV/JqMOrafFLDqenRQ3UMM8yqyttURuCN4DoBjBGSRmny+JvEB8J33jSPVSkVrfSQro/wBnjMLRR3BiKs23zPNIGchsAkfKa6+PwPoEds0LWcs2+4iuXluLuaaV5Im3RlpXcuwUjgE47YxSyeCfD8uqNqElixlaYTtF9ok8hpQciQwbvLL553Fc571V1+P+X+T/AKbB3/r5/wDAOJv/ABD4mh0nxLr8WuOsei6w0EFh9mh8qWENHlJG2b84Y4KsuO+a9UByAayJfCujT6bqFhLZ7rbUpzcXcfmuPMkOCWznI+6OBgcVr9KlfCl6fkr/AIhrdv1/PQKKKKBnN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFc34X/5GLxn/ANhqP/032ddJXCaZ4s8OaD4t8YWuua/pem3D6tFIsV5exwuymwtAGAYg4yCM+xoA7uiub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Sub8B/8i7df9hrVf/ThcUf8LH8Ef9Dl4f8A/BpB/wDFVz/gvx94PtdBuY7rxZocLtq2pSBZNShUlXvp2VsFuhVgQe4IPegD0Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoA6Siub/4WP4I/6HLw/wD+DSD/AOKo/wCFj+CP+hy8P/8Ag0g/+KoAPC//ACMXjP8A7DUf/pvs66SvO/Dnj7wfBr3iySfxZocaXGrRyQs+pQgSL9htV3KS3I3KwyO6kdq6D/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Sub8L/wDIxeM/+w1H/wCm+zo/4WP4I/6HLw//AODSD/4quf8ADnj7wfBr3iySfxZocaXGrRyQs+pQgSL9htV3KS3I3KwyO6kdqAPRKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgAvv+Sp6F/2BdS/9H2NdJXnd54+8Ht8SdGul8WaGbePSb+N5RqUOxWaazKqTuwCQjEDvtPoa6D/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgDpKK5v/hY/gj/ocvD/AP4NIP8A4qj/AIWP4I/6HLw//wCDSD/4qgA8L/8AIxeM/wDsNR/+m+zrpK878OePvB8GveLJJ/FmhxpcatHJCz6lCBIv2G1XcpLcjcrDI7qR2roP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Siub/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8AiqAOkorm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqgDpKK5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKoA6Sub8ef8i7a/8AYa0r/wBOFvR/wsfwR/0OXh//AMGkH/xVYfizxr4V1fS7Gx0rxLo99dy61pfl29tfxSSPi/gJwqsScAE/QUAegUUUUAFc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc34D/AORduv8AsNar/wCnC4rpK5vwH/yLt1/2GtV/9OFxQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/wDkYvGf/Yaj/wDTfZ10lc34X/5GLxn/ANhqP/032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV59Z+J/wCxvG3ifT7fR9Q1W6u9UMyR2RhG1I7CxDEmWRB1deBk16DXlh8JyeJPid4glke9t7OC7nie5sr17Z45HsdO2cowZhhWODleOR0o6/12KjbqdtB4z8PyeHrXWrrVLbT7K6JWN7+ZYPmBIK/MQNwIIx7Vdvdf0fTZrWLUdWsbSS8IW2Se5RDOTjAQE/N1HT1rzZfCvie1XQbz7LfW8mn2E2nTQaL9gDk+YMTKtwDGFkVckAhhkDB5rWTRNS0hdGXw1pmsw3kNpFbvc3UtmYfKDk+VcAPnK5Ygwr1IAOMiqsr/AD/z/r5kdDSu/iZoS2WvNpdzb315ojFZrRbpA0mNmWGCx2gvtJI+8CK6K413SbTUrfTrzVLK3vrkfuLWW4RZZf8AdQnJ/AVxms6HrVxYeM9Mt9Kml/tWUXVpcrNEI3/dwp5Zy4YNlGPK7cd88VQ1XwfrLeJtb87+3rnTdYuYpR/ZT6eFRVRFxIbgCRSrKSPLJ45GD1Stp6f5f18gd7s9Cj17SJdYk0mLVbJ9RiTfJZrcIZkXjkpncByOcd6gh8V+Hbi3mnt9e0yWGCQRTSJeRssbnorEHAPHQ81g2VhqUHiDUIbXSdRh0Sfz3uoLqW2KXEjZ+aAo5kBckkiQqBkYCnNZttoOt32n2theabcjSrTUbSS2tdUa2eeKKNiXBMTFGRRs25Jfg5zxSWtvl+ev3f1YJO17ef5f1/wTtovEGjT6M2rwatYyaYoJa9S5QwgDqS4O3j60yTxLoUWirrEutacmmOQFvWu0EJycDD529feuI8QeD9bvJtVuLBZoQNeg1KJLZ4PMuI0tkQ7RKGjDBwSBIAMrnjg06PQLuHRXu/7L8WTaq+pG7jkebTBcQSeSI/MAVxBsK5Uggkkkkd6elr+n6f5v7vupqzt/XX+vmdrL4m0KCWyjm1rTo5NQANmj3aA3IOMGMZ+fORjGetadcJJaeJU1fTL2DT7mPWJYLeLU7yKS3+wSorEsjKz+aCoZypRRywySM46bw/rTa9a3V0LXyII7uWC3k37hcIh2+YOBgEhsdemckGiwjVooopAFFFFAHN33/JU9C/7Aupf+j7Gukrm77/kqehf9gXUv/R9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/8AkYvGf/Yaj/8ATfZ10lc34X/5GLxn/wBhqP8A9N9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP+Rdtf+w1pX/pwt66Sub8ef8i7a/8AYa0r/wBOFvQB0lFFFABXN+F/+Ri8Z/8AYaj/APTfZ10lc34X/wCRi8Z/9hqP/wBN9nQB0lFFFAHJ2vxG0W8svEVxEl0G8PNKLuF4wHdY9wLxjOGUlGAORypBxW3d+INH0+S0i1LVLOylvMC3iubhI3lJ7KCfmPI6V5x4g8B69N4M1CbRbdV1xp9RiFu0yqt1a3M0h2sc4BAZXXJGCMHGTVnxH4S1mTxHqNyq6zc2GqafDaSRaQbDcoQMGR/tY+6d2QUbqTkdDVaWRUkk2l3f5q36+p3l/wCJtB0q5+z6prenWU+M+VcXccbYwTnDEHoCfoKtvqNlHJHG95bq8sTTRqZVBeNcbnAzyo3DJ6DI9awNJ8O+T4h1q4u7TMF5Z21skspVpJERGDKxHueexJ4riYPAfijUPCuuWWqpEt1b2i6VpPmThhc20cm/c5XO3zFCIQefkyetL+v6/D8exC1Sf9f1v+Hc9Ls/Eeiajp8t9p+safdWcLbZLiC6R40PoWBwDVifU7C1M4ub23hNtEJpxJKq+VGc4dsnhflbk8cH0rgLjw1rOuTeIdTGkHSGvdMt7OCxnmiLySROz7mMbMgHIUHJOOoHSrE2nanrGpa3qWr+F9QitrqwtIYLSK7tjctJFNI+7PmeWpUsrDLkED1ytDQ1re/l+n5fodna61pl/pLanp2oW17YqrN9ptZVlQhfvYZSQcYNZuj+MLXVbMXk9jeaXZSoklvdX4jSO4RyAhVldtpJYYV9rc9KfoJ1weGZP7Zhaa9Bk8mK7eNZHT+ATGIGMMe5QEegrkrPwheX39qadFpt34d8PXenyQSWNzdRyqtwSNssCo7iNVAPGVycHaOtLRN/1/X9eqN0vU7661fTbH7R9t1C1t/ssQmn82dU8qMkgO2T8qkg8njg1jSfEPwomrabYLrunyPqcbvbSx3kRjfawUDO7ksxIGM5KsO1cn4Ysb7XvAV1ruvaddX+o6pPC6RabNEJEW3IWJ0aVlQjcjS8nHz9D32LW28TJqHh3VNV06e9mgW6t51jeBZokkZPLeQb1jJCp8/lk8n5QRVWs7f1sC1R1Q13SW1g6QuqWR1ILvNkLhPOC+uzO7HvioD4s8Oi5ltzr+lieFHkki+2R7kVCQzEZyACCCexBrhNI8H6xY68ttqh165tV1iTUY57V9P+yjdIzqXLAXOQp2sBnjgHHFaFp4NuBp+jR3OlQF7fxHc6hcBhGcIzzlJDzycPH7jj04SV0n/X9f5fcPdrt/wf8l9/391ZX9pqdnHd6bdQ3dtKMxzwSCRHHqGHBqesTw1p1zp39rLcxeUk+pSzwAMCCjBeeOmTuOOtbdLomLuFc34D/wCRduv+w1qv/pwuK6Sub8B/8i7df9hrVf8A04XFAzpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/wDIxeM/+w1H/wCm+zrpK5vwv/yMXjP/ALDUf/pvs66SgAooooAKKKKACiiigAooooAKKKKACiiigArm/C//ACMXjP8A7DUf/pvs66SuCsPEaaT4w8V2UOnX2pXc2rLN5NkqFo41sLIM7F2UYyQMAlj2BoA72iuI8OeLb+9sNGM6y3lxeaZPetbrbKkspSRFADNIiofnA2lcHuy45nj+ISS+Hr/WF8O6uIdPuJILlGktFKbBl3DGfYyg/KcMTkEY4NGyv/W9g3/r5nYUVyL+OI4IbrUbq3uobO20WPVHs3tALhAxfgt5hG7CY2bRg/xHoLEfjqwSC/l1Wx1DSRY2wu2W8iXdLCSQHUIzdSMbThs4yozTs0H9fl/mjpqK5c+OrWCzvJdT0vUtOntY45fslykXmSpI2xCpSRk5bj5mBX+LA5qSfxfJbyWNs3h3VW1G9WSRLAPa+YkaEBnZjN5ePmXgOTz04OC39f1/SA6SigdPSikAUUUUAFFFFABRRRQBzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/+Ri8Z/8AYaj/APTfZ10lc34X/wCRi8Z/9hqP/wBN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP+Rdtf8AsNaV/wCnC3rpK5vx5/yLtr/2GtK/9OFvQB0lFFFABXN+F/8AkYvGf/Yaj/8ATfZ10lc34X/5GLxn/wBhqP8A9N9nQB0lFFFABRRRQAUVz3jW6vrbR7VdMvpbCa51C2tmuIUjZ0R5QrYEisucHuDXOaxr+seFbjVtLvdUuNTRNFm1K1vDHDFcxmNgrISI/LP3lwfL4wcg04rm2/qyv+Qdben4u35nolFcxbeKp5vFs2jNb2kUVqgZ5Lq9KXMy7AxkjgEeHTLBS28YIbjgZo6R8QZdRutHe50gW2ma8zrplyLnfI+1GceZHsGzcqkjDN74oEdrSOiyRskih0YYZWGQR6GuL0/xxq174es9Ufw/bwtqkkcOm251ElpXYMSZD5WI1AUnI3kj+EHisiPx7c+Hl8QXXiNIbe5bWYrK2trjUQLaJmtYm/1zDCR/ebO0Hn7uTii173/rb/Muz/r+vI9ItraCztYra0hjgghQJHFEgVUUDAAA4AHpUlcDa/Ex9TtbRNE0+x1O+n1JtOcW2qB7VXEBm3rOIzuTaAD8oI54yMHYh8UXsnjBdClstPt2WNXlM2oMssmVBYwR+V+9RSQpYsvOeB3LO+v9dSP6/Q6aiiikMKKKKACub8B/8i7df9hrVf8A04XFdJXN+A/+Rduv+w1qv/pwuKAOkooooAKK534hf8k18R4/6Blx/wCi2rnJrnX5PGXg7+2tM061iVrgxNZ6jJcM5+zNwVaCMDj3NHQJaRT/AK6f5notFeXeFvFPizU1tdbvLXUU02fznvftC2f2WzjVXIMYjf7QzBlUEODnJ4XimweNdc09tXeZr+6RNEl1S2OoxWqAlSNpjWBiwjIbOJfm46nnDtrb+uv+Qbf152/U9PNzALpbUzRi4ZDIsW8byoIBbHXAJAz7ipK8ze7m0TxjJd6h4n/tDyfDs1z58ttGzW4MkZzsiC7kOPlB54PzHtUbxt4h0u18Rwzm9M1nBZzQyaslr5kHnytGzkW7bfLUAMA2G4OeMUW0X9dWhJ3b+X4pf5nqUtzBBLDFNPHHJOxSJHcAyMAWIUdzgE4HYGpa871yx1A6r4asF8UyXdyNVfF41vAZ4VNnMSCFUJnGSpKcAjIbvW1LxV4gstGsrGGW6vbqfXJtLa9to7dbgxorsrASbYfMO0DJAXrhc4FHl/XT/Mfn/XX/ACPTaK5zwxqWox6ckHivfZ3kt08Nmt9JbrcXSBdwJWFihfAbITsucDpXR0NWFcKKKKQzm/C//IxeM/8AsNR/+m+zrpK5vwv/AMjF4z/7DUf/AKb7OukoAKKKKACiiigAooooAKKKKACiiigAooooAK8+07Qr668eeK9V0fU47C6TU1tpfOtfPSSJrGybgblKuCODkjk5U16DXN+F/wDkYvGf/Yaj/wDTfZ0AUYPAt3ZWFnHYa4Yruz0q40+K6e1DHdK6MJSoYDI2fd6HPbpVaTwJrj+EtP0Jdc0qOGxuIpAq6RL5c6R8hJFNyWbLgMTuGcYIOTXd0U7/ANfO/wCbD+v0OU1Lwdc6xBqf2/U4ftOpaSunSPBaFUUhnPmBTITj9593d2681Nr/AIKtvETX6X1wwgvdNFg8aoMrhy4fJyDzjgjtXS0Ut/6/ruF/6+7/ACRxmjeB7jQ7G/isI/CltPdRrGslp4c8hWUHkSqs/wC8BHYFQDzz0qCb4e3cnhuHRU1DS0thI8r50libdiePso84C3287fv4PPtXarcwPdSWyTxtPGqu8QcFkVs7SR1AO04PfB9Klp63uBj6PHq66pqj6lIRYiSOKwhbYW2Kg3SFl5+ZieCTjHbOK2KKKQbBRRRQAUUUUAFFFFAHN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFc34X/5GLxn/ANhqP/032ddJXN+F/wDkYvGf/Yaj/wDTfZ0AdJRRRQAUUUUAZfiDQ08Qaalo95c2TRzx3Ec9rs3o8bBlI3qynkdwazG8CWM9nqUepX+oahd6namznv7h080RHPyoFRY0HPZBnjOa6eihabAYc3hdbrXYNRvtVvrqK1kMttYyCEQwvsKbgVjEh4ZuGcjnp0xS0jwBpuj3lpLHeX1xb6eXOn2dxIhist4IbZhQx4JA3s2AcDFdTRQBgHwhZDwzYaNDc3cA04o1pdxuvnQuoIDglSpOCRgqQQSCKqr4BsBa3KvqGoyXdxeJf/b3lQzRXCxiMOvybR8q/d2leSMY4rqaKP6/r7kO5hw+Gj5unzalrGoanPp9y1zDLcrApy0bR7SIo0BXDk9M5744p134c+365Df3uq300FvKs8OnkQiGORRgMCIxIepOC5HPTtW1RTuIKKKKQBRRRQAVzfgP/kXbr/sNar/6cLiukrm/Af8AyLt1/wBhrVf/AE4XFAHSUUUUAR3FvDd20lvdwxzwSqUkilUMrqRggg8EH0pr2dtJNBLJbxPJbkmF2QExZGDtPbI447VNRQBlp4Y0CPWTq8eh6aupsSTeraRiY5GD8+N3Tjr0p+n+HdF0mSSTS9HsLJ5N29ra1SMvuwWyVAznAz64FR6b4htNUt7aaCK6UXMs0KZt2YAxMytuZQVQEqcFiM8DrxWrRsG5nWXh3RNNV107R7C0DhlcQWqJuDEFgcDnJAz64pLDw5oel28kGmaNp9nDKmySO3tUjV1yTggAAjLHj3PrVt7uNL6O0KzeZIjOrCBzGACAcuBtB54BIJ5wDg1PR0Az7Hw/o2mQQQ6bpNjZxW8hkhjt7ZI1icggsoA4JBIyOxNSXGj6Zd2U9ndadaT2twxeaCSBWSVj1LKRgk+pq5RRvuBiW3g/RLK+sJ9PsYbKLTzI1vaWsKRQrJIAGk2qo+fbkZ9GNbdFFABRRRQBzfhf/kYvGf8A2Go//TfZ10lc34X/AORi8Z/9hqP/ANN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeWRXmoSfFnXtFtNebR7e6u5ZnaKKFpHeOy07btMisBgM2eDxnjoR6nXnmn+EdO1/4g+Kb7WLe1vraC/NubO6tllRy9lp7BvmyOPL9O/Xihbq/n+T/UfT+u5nN4x1vUPCdlPBeX329YLieQ6Xb2oEsccjIkztcsEEbbQSqfMc8ECtnS9U1vxD4g09l1aWws/wCxLTUZra2giPnSyM+V3OrEKQuCBg9MEc56u88P6NqKWyahpFjdLaEG3We2RxCfVMj5fwqxBYWdq6vbWkELLEsKtHGFIjXO1OP4Rk4HQZp9/wCu/wDmvuJ/r8V/k/vPOPCXiHxrr72epLZ3/wBmvTKJ1uhZLaWoCvs8vy3M5YOFUhwc5Y4Wq+tSape+Dr3T9X1vV7fVrW9sJLlJI7PaoedQDGUiIMZILDd842jdxkH0FvCfh1tUk1NtA0s38oYSXZs4/NcMNpy+MnIODz04p9r4Z0Kx0qbTLLRdOt7C4z51pDaIkUmRg7kAwc+4o/r8SvtXOI1K11e08VeIp7DxBdQS6fodrK0rW8DvdOpuCPMym0KcHIRVPPBFQ6n4o8Wal4guLPQbbUd1rp1tdRR2C2RSaSVWP777Q6t5eRt/d4P3vmzivQ7fRtLtIGhtdNtIYmhW3aOOBVUxLnbGQB90bmwOgyfWoNT8MaBrSQprGh6bqC242wi6tI5RGPRdwOPwob1/rzF/X5f5fiYU19rVp4us5Nauby0066McVtDaLbvAZSnMcxZTLu3bsFCFwBkjvgxazeQeE9MtdJmu7a5kW7uGg0azs0bYkxBcmcrEqgkbhjcxbORya72Pw7okOsHVotH09NSKhTeLaoJiuMY343YwAOvQUt14d0S9t4IL3R7C4htpPNgjltUdYnzncoIwpyTyKT1X9f1/VvMOt/6/r/h/IpeEfEK674Z0a5vJ7ddRvdOivJLdHAbDAZYLnO3Jxnp71vVl2Xh6w0/V5NRtY9kjW0drFGoCxwRISQkagDaCTk+uB6CtSqk03dC2CiiipGFFFFAHN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFc34X/5GLxn/ANhqP/032ddJXN+F/wDkYvGf/Yaj/wDTfZ0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc34D/5F26/7DWq/+nC4rpK5vwH/AMi7df8AYa1X/wBOFxQB0lFFFABXGeM7OC48QaVJrmlT6roaQTrJBFaNdKtwTH5bNGoJ6CQBsYUnkjrXZ0UdQPNPD+mXFlpHhj7TpF6kFrJqTTW0sLSOiN5m1WHOSQQByd2epzWDYWWk2vw/1u5t/Bch1HVLiNpNNfwxOILXJKxfujCBII1yzFA2Wz6ivaaKHq35iiuVHmen6Hb2UemW/h2wvhp1v4ev7dWmsZYGMjSRHDI6qVZiGIGBnnHFQ2/hS70eHTl8Kac+nXt14auY551jK7roLD5XnMergl8bjkfN716lRTbvfz/+2/8AkvwHH3Wn2/4H+R434e0BUs72O8lutPVtMeG+g07wpe2zzSFk/ePIWkFxICCMrksGY5Iq3PptpN4MtYrnQYbaK2vXa1tIfC072t8Ng+eWzVS0WSSAXIwV3cjivWaKG7/153Elb+vIqaS0raLZG4s1sZTAm+1QgiA7RlBjjA6celW6KKG7u4JWVgooopDOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAK5vwv/AMjF4z/7DUf/AKb7Oukrx7V7OCXx14iu1006xewaunkWFzpEt3byE2NmciULsgkyOHY8DPHehbpA9mz2GivH9R0W+n17Ud2j3zeJ312Gex1UWzlIrIPGSBcY2ogQOpj3Akknac1e1LwbDdf2lqD6PM2oy+JIilyqOJRbNJEsmxhysZTfu24BGc04rmt5/wDA/wA/wYpO39ev+WnqepUV5jqPhfytP1jRbDSJYdKOvafJBa20LJGIt0DSsgXGFyHJI4B3H1pmueHbrTtL1+w8P6VNBpQ1GxmaxsYiiy2/yG4WJRwcgHKr15HU0aWv/XT/AD/Aq2tj0DW9bttBsY7u8SV45LmG2AiAJ3SyLGp5I4ywz7etaNeRHRJzp2qNoGj3lnok2t6ZLYWP2N4NgSaMzyLAVDRpkZOVH3S2MHJbo+h6pH42EusyC21P+1pJRdx+HLmaWa38xikZvlcxLGUwNrKAvcZ5ppKy9f0X+bE9I3/rr/kev0V5jo/hRbFdM1WHSJIdWbxDcme58lhN9naafhj1ERBU4+7yD1Oai0XS549M1WGPSL6Hxqy3obVZLZ0R2Yv5RM5+WRMFAqgtt44XFS9E32/yHb3rf1u1+h6nRXkXhAJ4UF1rN7vtUsNMka+s7bw1c2JuZAVO555ZGjnlBBAIOW3k5xXrUEvn28cux4/MUNscYZcjOCPWqasSmPoooqRhRRRQBzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/wDkYvGf/Yaj/wDTfZ10lc34X/5GLxn/ANhqP/032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc348/wCRdtf+w1pX/pwt66Sub8ef8i7a/wDYa0r/ANOFvQB0lFFFABXN+F/+Ri8Z/wDYaj/9N9nXSVzfhf8A5GLxn/2Go/8A032dAHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+A/+Rduv+w1qv/pwuK6Sub8B/wDIu3X/AGGtV/8AThcUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf/kYvGf8A2Go//TfZ10lc34X/AORi8Z/9hqP/ANN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc34X/5GLxn/wBhqP8A9N9nXSV51pvi+20f4n+INDntLyVtQ1QSCaC0mlVNtjYgAlEI53HJJG0AE8MKN3YD0Wiufh8c+Hp472SO9k8mwZ0uJ2tJliR1fYUEhTaz7uNoJJ4wMEUp8b6AmkTanPeS29tBMkEwubSaKSN3ICBo3UOMlhgkYwc9KAN+iuZh+IfhqeZYUvZ1l8wRSRyWM6NAzY2iUMgMW7I2l9obPGatXvjPQdO1b+zby+KXAdI5GEEjRQu/3FklClIy2RgMwJyMdaANyisi38UaVd+ILjRbWaaa+tW2TqlrKUhO0OA0m3YuVYEZPPQZINa9ABRRRQBFcWsF5D5V3BHPHuVtkqBhlSCDg9wQCPcVLRRQAUUUUAFFFFAHN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFc34X/5GLxn/ANhqP/032ddJXCaZ4ZsdZ8W+MLi8n1SN11aJALPVrq1TH2C0PKRSKpPPUjPQZ4FAHd0Vzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSUVzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSUVzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSUVzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSUVzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSUVzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSUVzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSUVzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9AHSVzfgP/AJF26/7DWq/+nC4o/wCED0j/AJ/PEH/hR6h/8frn/BfgrS7nQbl5LrXARq2pIBHr98gwt9Oo4WYDOAMnqTkkkkmgD0Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gDpKK5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6AOkorm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gDpKK5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6AOkorm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gA8L/8jF4z/wCw1H/6b7Oukrzvw54K0ubXvFiPda4BDq0aKU1++UkfYbVvmImBY5Y8tk4wM4AA6D/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6SvPLDTNSl+I+t6tpaWs32PWGhniuJmi/dyafYZdSqNlhs+6QAc/eFb//AAgekf8AP54g/wDCj1D/AOP1z/hzwVpc2veLEe61wCHVo0Upr98pI+w2rfMRMCxyx5bJxgZwAAdbgXL3wHc3/gCbQpbmOK5/tN7+OSKR0U/6WZ1UsuGXIIBK8g8jOKhtfBV8dPkEllb2V5Jf2VxJI+uXWpGWOCYPgvOgZSBuwo4yeSK2v+ED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH6abTv8AP8v8geu/9XK2peFb68tvFEcUtuDq80MkG5m+UJHGp3cccoeme1ZWp+BdZup9e062lsDo+vX0d5PcSu4uLfAjDoqBSr58sYYuu3J4OK3v+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfpLR3/AK6f5IHqW9D0efTNR1y4naNl1C+FzFsJJC+THHhsjrlD0zxitmub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6dwOkorm/+ED0j/n88Qf8AhR6h/wDH6P8AhA9I/wCfzxB/4Ueof/H6QHSUVzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9AHSUVzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9AHSUVzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9ABff8lT0L/sC6l/6Psa6SvO7zwVpa/EnRrcXWubJNJv3JOv3xcFZrMDD+duA+Y5AODwSDtGOg/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gDpKK5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6AOkorm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gDpKK5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6AOkorm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gA8L/8jF4z/wCw1H/6b7Oukrzvw54K0ubXvFiPda4BDq0aKU1++UkfYbVvmImBY5Y8tk4wM4AA6D/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkrm/Hn/ACLtr/2GtK/9OFvR/wAIHpH/AD+eIP8Awo9Q/wDj9Yfizwlp2maXY3dtc6w8setaXtW51u8uIzm/gHMckrKevcHB56igD0CiiigArm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vwH/yLt1/2GtV/wDThcV0lc34D/5F26/7DWq/+nC4oA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACub8L/wDIxeM/+w1H/wCm+zrpK5vwv/yMXjP/ALDUf/pvs6AOkooooAKKKKACiiigAooooAKKKKACiiigAooooA5u+/5KnoX/AGBdS/8AR9jXSVzd9/yVPQv+wLqX/o+xrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C/8AyMXjP/sNR/8Apvs66Sub8L/8jF4z/wCw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8AIu2v/Ya0r/04W9dJXN+PP+Rdtf8AsNaV/wCnC3oA6SiiigAryq21l/DPxb8T3+oXTpo19dGB1eQ+XFPFp9rKpC9AWTzAT32KOwr1WuHt/DekeKtQ8Y6f4gskvbVdegmETswG9bCzIOQQfw79DRr0/r+vzHp1K2g3esRTaA+pedPf6laX2oNDJdSgRsTGyQ7d2zCq4X5lOMZGMnM+neLtVNrb/wBoTWbX0moW9tPZ/wBnzWz2iyEgg75G8zodsgwpwSAa6650mzu7uG6mibz4IpIYpEkZCiSY3AbSME7V56jHGKzF8E6Gun3Nm8FzMtyyNLNPfzyzkocoRMzmRdp5GGGCTjFPS/8AXf8Ay0Jd3Hz1My+8XXkDa7EstlbPZajHZ2zyW8s7MGt0lOIYzvlfLNhV28DrxziJr9x4iuvBt1eIFnh8QXFu5FtJbhyltON3lSfOmRg7WyR6nrXWR+BfD8VhLaRWc0azTi5eVLyYTecFCeYJg/mBtowWDZPOc5NWLXwlolktoLazK/Y7p7yAtNIxWZ1ZWcksSxIZuueuetOLSf3fp/wSpNNaef5P/gFbWdT1hvENvo+gtYwyG1e7mmvYnlUqGChFVWXBJJ+bJxj7pzXK+FNRv7fT/D8FvbCe6OhXlwsC3Mio8qSxgLjcEIJYjcykjsRyD3Gr+HNL1yaCbUYJGltwRHLDcSQvtONyFkYFkOBlTlTgZFRweFNGtILeGztGtktrSSzg8ieSMxROQWVSrAjlVwRyMcEVK8/P9bfmvuDr936f8E4y+1vxJqOk6cbXXLG3v11eCG4iOj3EDRBuiPG04ZhnJzna4xj1rd1XxRqOm2Pip9lrLNomnpcQt5bBZHMTMdw3fdyvQHOO561oDwVon9mS2LQ3TpNKkzzSX873BdPut55fzARjjDcdKbqvgfQNbfdqlpNPugFvIpvJlWaMA4EgDgSYySC+SCcg5pr9f0X+Ql8Sk/61ZRGra7qPiPUrKJ9Pg0yytYZJN0DvNKZEYlQd4VcYHJDemO9YHg/Xta0XQfB9vqp02TTtT04JD5SvG9sY7fzA0jsxDKVU5IVdpx97rXoMOlWUFxczxQ7ZLpESZt7HcqghR14wCelZOleAvDeiuhsNPYCOA28Uc1zLMkUZGGVEdiqbgOdoG7vmi9k7df8Ag/5iV7K/9bHNW3xB1P8A4nCSfZrprfSZ9RtpF0y5tYwY+Nm6U/v1OQfMTaD6DIqzdeNNb8PWd5ceIYrC72aNJqsSWMbxbChUGJizNuzvHzgL3+Wt638DeH7YXAS1nk+0Wz2khnvZ5T5L4zGpdztXgYC4x2xWhNoOmXMokuLRJSLRrLDklTC2NyEE4IO0deaNP6+f/A+773r+P+X/ANt9/wB3Ka34p8R+GtFtZdUGn3NzqVzFb2sllY3EggLqzNvhRmeTaF4KkbieiYzUa+LvEk/h554bBo5IL7yJr+XRLpVMPl7/ADls2ZZiNxCEBjg5OSBW/F4G0CHT5bIWkzxSlDulvZpJI9mdmyRnLx7cnaFIxk4xUjeENNbTRYNcawYRKZd39t3nmEkYwZPN3lf9knb3xmjTX+u3/BDt/Xc0tLuhe6Ta3K3UN2Jolf7RbqVjlyPvKCSQD6ZOPU1aqGzs7fT7KG0soVht4EEccaDAVQMACpqHa+glsFc34D/5F26/7DWq/wDpwuK6Sub8B/8AIu3X/Ya1X/04XFIZ0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/+Ri8Z/wDYaj/9N9nXSVzfhf8A5GLxn/2Go/8A032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5bBqM3h74ta5qVzdyJpF7qf2G4RpD5cco0+0kifbnAJCyKT3yo7CvUq4i38O6V4quvG+la/ZreWUmuQs8TMy5K2NmQcqQeo9aNegadSlomoarJHoN/eedNc6zNeXsdu9zKixoYy0MW0NtxsCZDAgEkgA81YtfGGrJo3nX01m+o/2hZ281kdPmtmtVmmVGBDyEydW2yLhTtyARXX3Gj2N09s8sJDWqusDRyMhjDLtOCpHbjPbtWfH4M0NNOu7J7e4njvNvnyXN7PNM205T967lxtPIwwweRg07pS8tPwf+RNn1/r+mUNT8U3VpNrkKyWcBspYIrd5YZZSxkQMf3ceWlbrhFwT0z3rnj4huPEUPh971QJ7PxOts7i0ltfMxA7BvJl+ePhhwxPTqRXXReB9Ahsri2jtJgLmRJpZvtcxmaRRhZPN37w4HG4Nn3qW18IaJZRQpBaPiG8F8rPcSOxn2bPMLMxLHb1yTnqeeaUdHr5fmv+CU72svP8U1/kQa5qmqLr1jouhPZwXNzbzXTz3kLSoqRsi7QiuhyTIOc8YPBrkfDGoaha2Gixw2yz3jQ6vN5EdzIkbypPwuMhSCWIy6kjqMc573V/D+m640DahDIZLckxSwTyQSID94B42VtpwMrnBxyDVe38I6JaWtvb2dm1tHaxTQweRPJGYllIMgUqwIyQMEcjtijpb+uv/ABW5k2cbq2ueIr/AMKwPba3Z22ox6xZw3EY0m4t2hDzIPLZGn3EZPLZ2uuQOu6t3UfE+qaZpvihpBaTXGiaclxG6wsiSyGJmOV3khcrwM5A7nrWkvgzRBpVxp7wXEsVy6SSyzXs8k7OhBRvOZzICpAwQ3GOMVHqXgTw/rGBqVrPcD7OLaQNez4njAIAlAf96RkkF9xBOQc81V1a3n+i/wAgjpJN/wBalIatruo+I9Sson0+DTLK1hkk3QO80pkRiVB3hVxgckN6Y71geD9e1rRdB8H2+qnTZNO1PTgkPlK8b2xjt/MDSOzEMpVTkhV2nH3utegw6VZQXFzPFDtkukRJm3sdyqCFHXjAJ6Vk6V4C8N6K6Gw09gI4DbxRzXMsyRRkYZUR2KpuA52gbu+aV7J26/8AB/zEr2V/62OatviDqf8AxOEk+zXTW+kz6jbSLplzaxgx8bN0p/fqcg+Ym0H0GRV8eLda0Zbl/EaWNyq6PLqsa2ETxmMR7d0RLM2/O4YYBe/y1sW/gbw/bC4CWs8n2i2e0kM97PKfJfGY1Ludq8DAXGO2K0m0XT3ukuHtleRLVrQFmJHlMQSpGcHO0deaT20/re36fd979e/+X/233/dyGpeLPEeg+FIdU1RNPuJNQkt47RbO0nb7O0p6Oilml2jnKbSx42r1pIfFviSfw/dSw2LNNb3axNfPol3ErQlNxlW0ciVyp+UqrHPUHtW7B4F8PW+nzWSWUj28wUbZbuaQxBTlRGWcmIKeQEKgHpipR4Q00aabH7TrPkmXzSx1u88zOMY8zzd+3/ZzjPOM03bX+u3/AAQV9LmVa3f2/wAd+GLn7XBeGTQtRJnt4jGkh86xyQhZivPYkkV2Ncn9httN+Ivh2zsYhDbw6JqKog7Dz7L16/U11lD3EtgooopDCiiigAooooAKKKKACiiigAooooAKKKKAOb8L/wDIxeM/+w1H/wCm+zrpK5vwv/yMXjP/ALDUf/pvs66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACub8L/8jF4z/wCw1H/6b7OukrhNM8WeHNB8W+MLXXNf0vTbh9WikWK8vY4XZTYWgDAMQcZBGfY0Ad3RXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJXN+A/+Rduv+w1qv8A6cLij/hY/gj/AKHLw/8A+DSD/wCKrn/Bfj7wfa6Dcx3XizQ4XbVtSkCyalCpKvfTsrYLdCrAg9wQe9AHolFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQAeF/+Ri8Z/wDYaj/9N9nXSV534c8feD4Ne8WST+LNDjS41aOSFn1KECRfsNqu5SW5G5WGR3UjtXQf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSVzfhf/AJGLxn/2Go//AE32dH/Cx/BH/Q5eH/8AwaQf/FVz/hzx94Pg17xZJP4s0ONLjVo5IWfUoQJF+w2q7lJbkblYZHdSO1AHolFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQAX3/JU9C/7Aupf+j7Gukrzu88feD2+JOjXS+LNDNvHpN/G8o1KHYrNNZlVJ3YBIRiB32n0NdB/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQAeF/+Ri8Z/wDYaj/9N9nXSV534c8feD4Ne8WST+LNDjS41aOSFn1KECRfsNqu5SW5G5WGR3UjtXQf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lc348/wCRdtf+w1pX/pwt6P8AhY/gj/ocvD//AINIP/iqw/FnjXwrq+l2NjpXiXR767l1rS/Lt7a/ikkfF/AThVYk4AJ+goA9AooooAK5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vwH/AMi7df8AYa1X/wBOFxXSVzfgP/kXbr/sNar/AOnC4oA6SiiigApk8y29vJNJnbGhdsdcAZp9V7+J5tNuYohueSF1UZxkkECpk2otocbNq5z+j/EHR9c8M2Wt2SXQgu7qO08mSMLLDI7BQHXPH3geCeCCM1tR63pUurvpUWp2b6jGu97NbhDMq+pTO4D3xXnkngfXLI+F5tKgXaxsF1u2aVQI2t9pEy84LDaUOM5G30qeLQvE03jjS7m5tLiKzstUnuJBF9jSz8t45VV4wo89nO5d28gZJIBHI2ajey7v9P8AgmcXJq77J/np+SPQV1KxdIGS9t2W5cxwESqRK4BJVeeSArcD0PpVeDxDot1eXVpbavYTXNkN11DHcozwD1dQcr+NcZp+ka+l74e06XRZI7XR9UmuJb9rmLZLGyThSihi/wDy0XIYLg9Nw5FTUfDHiHVdE1jRNKtr7StLlXzIYNQktmPmecrlYjGX/dsA+RLnlhxjIrMvt/XU76z8Q6NqOmyajp+r2F1YxZ8y6guUeJMdcsDgYqfTtTsNYskvNJvba+tXJCz20qyI2ODhlJBrz+30PXDp+rXqWWuS6lcC1QrrI0xiyRuTmFYP3fmKCcGXAzt7CpPD82s+FVvX1Oyu7q71zW4RaxXs9us7I0MavI3kL5YKBHJAHO3qc5NJJu39dP8AP8A6XPRqKKKkAooooA5vwv8A8jF4z/7DUf8A6b7Oukrm/C//ACMXjP8A7DUf/pvs66SgAooooAKKKKACiiigAooooAKKKKACiiigArm/C/8AyMXjP/sNR/8Apvs66Sub8L/8jF4z/wCw1H/6b7OgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObvv+Sp6F/wBgXUv/AEfY10lc3ff8lT0L/sC6l/6Psa6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/ACLtr/2GtK/9OFvXSVzfjz/kXbX/ALDWlf8Apwt6AOkooooAK5vwv/yMXjP/ALDUf/pvs66Sub8L/wDIxeM/+w1H/wCm+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vwH/yLt1/2GtV/9OFxXSVzfgP/AJF26/7DWq/+nC4oA6SiiigAoormPEV7fS+J9M0Sz1V9IjuLa4unuYo42djGYwEHmKy4+ck8ZwvBHWgDo7e5gu4fNtZo54ySu+Nwy5BIIyPQgg+4qSvK/CV6lvb+HJ5prWdVt9Xna8Fsr/dnB3oeWCkEnCtyMdcCoZvGPiG0tdcC3eobv7Cm1Kzn1CC0Xa6kBWiSIkiMhs7ZRu46nmna7sv63/yEvhTfX/O36nrVRw3MFx5n2eaOXynMcmxg2xh1U46HkcVxd5D4hj1zQtHTxVeL9shubi6uRa23mHZ5W1UBj2qAWPUMcE5JOCMlJ9X0eXVtVtNXkEC+JY7c2PkRmOVZXhjYuxXfu+YkbSoHcGiKvLl/rdL9Q6Jrr/k/8j06ivND4i8Xaj4t1VdJtNRkh03UktFt4hZC1aLCFmlMjifcVZiCgA+7w3NSxeLNTPjrS0hub+50zUb+ezzLBbR2v7tJD+7AY3G9WjwWb5DzgDIoir28x9/I9GoqG1vLW/hM1jcw3MQdkLwyB13KSrDI7gggjsRU1IAooooA5vwv/wAjF4z/AOw1H/6b7Oukrm/C/wDyMXjP/sNR/wDpvs66SgAooooAKKKKACiiigAooooAKKKKACiiigArm/C//IxeM/8AsNR/+m+zrpK5vwv/AMjF4z/7DUf/AKb7OgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObvv+Sp6F/2BdS/9H2NdJXN33/JU9C/7Aupf+j7GukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/8jF4z/wCw1H/6b7Oukrm/C/8AyMXjP/sNR/8Apvs66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/ANhrSv8A04W9dJXN+PP+Rdtf+w1pX/pwt6AOkooooAK5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vwH/AMi7df8AYa1X/wBOFxXSVzfgP/kXbr/sNar/AOnC4oA6Siq1/efYLJ7j7PcXJXAENtHvdyTgAD8epIA6kgVyeq+NpP7LhuLOzv7S5g1iCyvbF4o5JxuwdnysynKspyrdD1GDRu7f1q7fqD0VztaqajpOnaxAsOr6fa38SOJFjuoVlVWHRgGBwfesKPx5ZvaXJk03UYdRtrpLR9KdIzcGV13IoIcxkMvO7ftwDkjBrN03x40S69dazbX0Yg1SKxstOaFBcb3hiIiGDtYl2Y7ixXHO7AppX/r0/wA0M7CLTLCBojBY20ZhDiMpCo2Bzl8YHG48n171Ut/C3h+zjnS00LTIEuVZZ1is41EobG4Ngcg4Gc9cCsk/EGwXT5ppNO1JLq3vo7CfT/KRriOZ8FQQrlSCGB3KxGD7GmQ/EO1knMc+iaxaiG6WzvJJootlnK5UIrkSHdu3pzHvA3DJFCu3p/X9XX3oX9f19x1LWsD3EVw0EbTQqyxyFBuQNjIB6gHAz9BUbabYvG8b2VuySTCd1MSkNICCHIxywKg565A9K5y48app1zex3FvdX7Jqq6dbwWVqA+8wCUAlpMMMH73yAdxgFquQeLEutLkubbR9Uluorg2sunrHGZo5QNxVm3+WBgg7i+3kc5OKXn/XR/qg20f9b/5MuX3hnQdT1KLUNS0TTru9hIMVzcWkckkeDkYYjIweeKcPDmipqUmpQ6TYxahK29rxLWMTFsFQ2/GScEjJ9TWF/wAJXJqWr+GG01pbe2v7m6gu7eaNd6tFG+Ubrgq6n7pwcdSK0dY8UppOrJpkGk6lqd5JbNcrHZJHjYrBTlndVB56E89snijbQL7l/RdHtdB0iDTrHeYoskvIQXkYkszsQBlmYkk+pq/XMy+ObP8AsO21jTtN1PUrGa3+0vNbQqBBEM5Zt7LkjByq7m46U2+8ZW+m3GrTzmS4stPsLe88u3tcyMJWcAq2/wCfOz7u1cerZwG76hsdRRWNoviSPWL66sZNPvdOvLVElaC8VAzRuWCOCjMMEowwSGGOQK2aWwHN+F/+Ri8Z/wDYaj/9N9nXSVzfhf8A5GLxn/2Go/8A032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfhf/kYvGf/AGGo/wD032ddJXN+F/8AkYvGf/Yaj/8ATfZ0AdJRRRQAVl6v4k0vQ5Ior+eQ3EwLR21tbyXEzqCAWEUas5AyMkDAzWpXF6e32b4r+IFvHSK8vbK2/s15VyHhQNvVeRu2yNlgDn5l9qOodDYXxloLaLdar9u22tmwW53wyLJAxxhXiK71PzDgqDzW51rxrxPql9caZ4506/fRryS0tbIyX+mWLW7O7SHMUhMsmSoCkDPAfpzV7U7+5n0fxnrl1rd9ZanodxNHZW8N40cUCpGDFuhBCSeZnPzhvvYGMU9Pwv8Al/mCve3yPV6K8m1W+1Syu77xFrF7eXNjamCRzpGr+XJpvypvhktD+7kySxy25yGAA6VNq13e6Xrt7ruo399e6bDqESx3Gk6vg2ikqvkS2bfu25PJ+aQhhgAgYLapf10/z9O3S6vpf+v6/E9GOsWKzJFNMYJJLg20SzxtEZZAu7CbgN4wCcrkcHnip7a6ju0dollUJI0Z82F4ySpwcBgMj0YcHqCa8fu4X1nxVprajd38gt/Gdzbxbb2aMRx/ZWYKNrDHI49iw6MQZrRtd1qV0j1WW9ii1XUlk0tdZksbmRFnwjxyIdxWMZGwlV+YZPAoWqT7q/4J/r/W5T6+tvxkv0PYKKwvBWqw6z4Qsru3kvZVw0TNflDMWRijbinytypG5eD1rdoas7ErUKKKKQzm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C//IxeM/8AsNR/+m+zrpK5vwv/AMjF4z/7DUf/AKb7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/wDYa0r/ANOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACub8L/wDIxeM/+w1H/wCm+zrpK5vwv/yMXjP/ALDUf/pvs6AOkooooAKK88m8Q32oR6nq0+t6lo+m2OoS2UMOl6X9sdzFwzzDypGCkq33dgAxlskVa8Q/EWLw1o9lfyvptzbTWi3Jnub9bN7pcZPkQsGZ3xzsO3qBuzQtfw/HYdtbev4aM7miuYfxXdS+LW0Wzs7FQsQkVr2/aCWcFN2YoxE29ASFZtwwc8cDOPpPjDxHD4Js9R1XSbW9vbu/FpAlvfY8zdKybmJiULtx2ByBnrxR/X6E3S/r5nf0VxmpeNtUsbm7tLfQYLu60uxS91RUvyqRK27CRMYv3r4Rjhgg6cjNQ3fjprd7+/sbe5v4FsdPnt7VpY41f7TKyDHyblbgZ3MQeOF5Jdh/1+X+aO5orgte8X+IYPDutpBptpZazpqwyEC9MkXlyE4YOYeW+UgqUx7mn+IPiOPDl/a6XqKaLbam1r9quEvNaFvCibioWOR48yMSDgbVHHJHGV/X6gtdv66HdUVx1v49/tLVNHg0y0tVttTtYruObUL027SK+TthURsJXUDJXK4yvPORnR+JfEg0zXJtVjht4rXV0tLeaxu1eVQ0sS7Nr2+3bh85OSckccNTs+bl/rdL9Rf19+p6FRXGy+OL+G/uWfQkGlWuqJpsl39t/eMzsiq6xbMEbpADlgR1G6n6p49j0nxhbaNdR6eq3E8duinU0+2MX4VxbBSTHnjduB6nbgUlra3X/gf5ob0Tb6HX0VzHw/u7m98N3Mt5cS3Ei6pfRh5XLEKt1Iqrk9gAAB2Arp6bVg6tBXN+A/8AkXbr/sNar/6cLiukrm/Af/Iu3X/Ya1X/ANOFxSAv+JdFbxBoUunpci3Lsrbnj8yN9rA7HTI3ocYZcjIJGa5ax+GkmnaRcW2n6nZ2E0uqQ6kpsdLWGCJkRFKLDvICnZnrnk9TzXfUULTb+tn+gbqxxo8D3rrPf3GtRvrst7HerdrZ7YI2jjMaoIS5JTaWyN+SWJyOMRy+ALq4tbyS41wNqk2pw6pDdraBUhmjjRAvl7vmQhSMbs4bG7PNdNba/o96bsWerWNwbIkXXlXKN5BHUPg/L074ptt4j0O90ttSs9Z0+4sVYI11FdI0QYnAG8HGckDGepoTtt/W3+SDy+X/AAPxMS18ESI0l1e6ms+oXOqQ6jdTR2/lxsY1CrGibiVXao6sx69anuvB/wBpttYi+3bf7T1KC/z5OfL8vyfk+9znyevGN3TjnVtfEOjXumzajZavYXFjBnzbqK5R4o8ddzA4GO+ayrj4ieE7e602E6/psi6mXFvNHexGM7evzbu5+UYzzxTTa2/rb/JfcG3vP+t/82B8H51hr77d97WBqmzyfS3EPl53e27d+GO9VNW8BNqMF4q3ts/2nUjfmC9svtFs4MSx+XLFvXzANu4cjBxwcc7Z8S6bDHcyajcwadFb3DweZdXUKq5VdxIIc4wMnDYYAEkAc1JJ4j0SHRl1eXWNPTTHxtvWukEJycDD529fel0+79Lfkger/rz/AM2YGheAE0OPRY4r2MppV3d3KpFaiJGE+/5FUHCBd/GM9O1Lrema5dePobjQ71dPC6U8bTz2RuImJlX5eGXDAcj5vqCK0dS8ceHdJ1DTLS+1azibVAWtna5jVGUDIbJYZB6AjOTxVv8A4SHT4bW+utRni0+1spzDJPdXMSx5AHO4Odo56Ntb26UPV3fS/wDl+otHdd/+H/Q5DUvhPBe6Vaacl7bT28Fl9kI1PTxdlWyxM0QLKscpLHLYboOBite58D/aIdQj/tDb9t0+1ss+RnZ5DOd33ud2/p2x1NbUviPRINNh1GfWNPjsZwTFdPdIIpAAWJVycHgE8dgTVuzvbXUbOO70+5huraVd0c0EgdHHqGHBFPVXB67/ANf1Y53XtF1eO71XVfDlzt1K/s7exg+RMWxWRyZiXOGAEpO3H8PfPHUKCEAY7iBycdaWii+g3q7nN+F/+Ri8Z/8AYaj/APTfZ10lc34X/wCRi8Z/9hqP/wBN9nXSUgCiiigAooooAKKKKACiiigAooooAKKKKACub8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OgDpKKKKACqmp6TputWhtdY0+11C3JBMN1CsqEjvtYEV5vd+JvGmq6trzeHLLUpDpd69paQW62P2aUqqnE5mkE3JPVNuAR96rviLWvE+matc3up3GoaPpEMUUsNxZWUN5bKMDzRcrzNwc8oVUKM54NC1SfceqbO4j0TSotJ/suLTLNNPxj7Itugix1xsxjsO1NudA0e81OHUrzSbG4vrcYhupbZGlj/AN1yMj8DXGT63res/wDCT6lpeuf2db6C7R21slvHJHc7YEl3zFlL7TuwAjJxzk1U0/XPEfifUtXuLXXJNIt7PTbO9gtUtYX/AHksJdlcupJTI6Aq3owobsuZ+v37C0vbv/wP8ztptI8Nah4j+0XGn6Vda1aIj+a8Eb3MKnO05I3KDhsH2NTS+HNDn1lNXn0bT5NSjxsvXtUMy49HI3Dr615hot3q/ibxVqet2epz6FNN4a068kSCGKQl2EzBT5qt8o5yAATxyO+nH4r1PxFoWnXFprGoWt9Lo0N/LZ6PYQyMjupILyThkCsei/KflJLY6VKLhe/T/g/5MSfM/X/gf5nfXGgaPd20tvd6TYzwTTfaJIpbZGV5f+ehBGC3A568VFeeFvD+oWv2a/0LTbq385p/Kns43TzG5Z8EY3HJyeprh/DvifXvGkfh+0XU20eS50X+0rq5tYI2eZy+wIgkV1CjktxnlcEVm2fjXxTdafommCW6vb6+u9SWe702G1SYpbzFFEazssQ4IznccA8E8gcWtP600/Qa7/1qr/16npV14ftLjUdIuVSOFdJd3gjSIDG6MpgH+EYY8Drx6VfuLy2sxGbu4igEsgij81wu9z0UZ6k9hXAxaz4kTS7ew8QXV/o97PfPFaNHZ29xe3kCoG3bYy8MbAk7mKlcDgLuFYK69qesWcFtrEk80ml+Mra0jluY4kmdMK4Mgi+Td856AcYyAc0JNyS9PxaX6il7sW+yf4Jv9D2KiiipGc3ff8lT0L/sC6l/6Psa6Subvv8Akqehf9gXUv8A0fY10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf/kYvGf/AGGo/wD032ddJXN+F/8AkYvGf/Yaj/8ATfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/ALDWlf8Apwt66Sub8ef8i7a/9hrSv/Thb0AdJRRRQAVzfhf/AJGLxn/2Go//AE32ddJXN+F/+Ri8Z/8AYaj/APTfZ0AdJRRRQBzN/wCCILm8vZ9P1fU9JXUSTewWTxGO4JUKWIkjfaSBglNpPfnmoNQ+HWnXts9tBqGo2FtNp66dcRWrx/v4VUqgZnRmBAY8qVz3zXW0ULTYOtzDn8MC61e2u7vVr+a2tZFlgsGEIhjdVwGyIxIT1OC5GT07VDaeDra1tY7U6hfTW0F8t7bwyGPEDBi2xSEBK5Y/eJPvXRVnz69pVrcXUF3fQ272ixNOZ28tU8wkJ8zYHJBAGev1FAml+hla34Hsta1Se++36hYSXlsLS9SzkRVu4QSQj7lYj7zDchVsE81Jc+C9LuHnIaeFJorSHy4mUKi20hkjC5B7nB68dMda6GimnYfn/X9aGJqPhSx1NtWaeW4U6rbxwTFGA8sR7trJxwcsTzkcDioLnwi081veQ6/qlrqcUH2eTUIVt/NuI8lgrq0Rj4JJBCAj8TXRVWs9QttQWY2cnmCCZoJPlI2upww5Hb16Uuobf1/XYyb/AMLNqktoNR1zUp7W3MTvaFbdY55I2DLI5WIODuAJCsq8dMZFMm8GWs8moBtQvhbX9zHdvagx+XHKjo25Ts38mMZBYjrgCuiop9bgYc/hOxuLK5tnluAlzqKai5DLkSI6OAOPu5jHHXGeaqz+B7SbVDdDUtQjga9S/NkjRiEzqwbeTs3nO3oWx6AHmumopLS1un/A/wAl9wPVWZnaJoltoFhJaWbyvHJczXJMpBO6WRpGHAHGWOPb1rRoooAK5vwH/wAi7df9hrVf/ThcV0lc34D/AORduv8AsNar/wCnC4oA6Sq2pW0l5pV3awyeVJNC8aSD+AlSAfwzVmilJKSsxp2dzzCXw1rWo/DiHQV8NR2F5p1tbw75biEpeCKRGaJChJEbhD9/byRle9SXnhbVtcfX9Rm0ZrJNUbTo10y4lhZmWCbdI77GaPlTjG4khR9K9Loq+Zt3fqSlZJI4zVNAkfUvEU02kXN5Z3kFkIYrGWJJZJImc5Xe6qCvyH5iAcd+lQRW/iYNoGo6lp91fy2d1OrxeZbLcrC6FUeTDrEWH8Ww/QGu6oqQtpY8x1qxvtM1vSpZNI+3vL4muLqC2EkYaRPskmGUsdobgkBivI6jrT00LxJa2c97badPayX2rTXzW1kbSS7s1ZFVdjTEwgkqS+CfvHGetejS20E8sMs0EckkDF4ndATGxBUlT2OCRkdialo2SXlb8v8AJB1/H8/8zzzRtD1zRdJ8LvPplxezafc3QuYYpoPMVJS+18lkQgAgkLjrwvam6j4b1qLUrfVINOa+Sy8QzX5sUmjV54nh8tXXcwXcrHIDEdD7V6LRTv73N/W6f6CUUlb+tmv1POdJ8H6ilxpVze6dHHGfEFzqslqXRxZpJDIqDrgtuKk7c4LHBOM1qabc3XhvUItLOniSXV9ZupURZQPKt+XM2ADxnaMHHLjvXZUUX1Xpb8v8inr/AF6/5hRRRSA5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACub8L/8AIxeM/wDsNR/+m+zrpK5vwv8A8jF4z/7DUf8A6b7OgDpKKKKAMDUPBHh/VNQmvLyycyXOPtKR3MscVzgYHmxqwSXjj5weKNQ8EaBql5Jc3dnJumCieKK6liiuABgCWJGCScAD5weOOlU7fxfqWp6xeRaJoP27TrC9+w3Nyb1Y5fMGN5SNlwyruGSXU8HAPenr/j+78OXkTalpNnDYSXqWY36qn2ti7bVdYApUqchseYG25JUYxQuluuwPr/X9bGzqPgnw/qt41ze2LF5ECTJHcSRR3CjgCWNGCSgDgBweKyW+HllfeMtZ1XVohJa3kVvFDFBcyxZWNSGSVUKq6EkfKdwPcVW1L4i39i3iG5i8Pxzab4duRDe3BvtsjJ5aOWjj8shiA/ILL04JzgV/GnjPU5vDPir/AIRrTzJb6XayxXF+t4YZYpTCHzEgQ7toZSSWXHbJFGqV/mNRvK3yO0j0DTIdQur2K1VJ7u3jtZmVmAaJN21QucDG9ugHX6Vln4feGvLtUSwliS1tUs0WG8mjEkC/djkCuPNUZPD7up9TWFb+N106S6gFlcXeobNOt4Ve9YrdTTxkqNrZEQGCWYAkgEkEisq78U6tZa94yl8QWc0aWGnWDLYWuqSCPLSSAvHKFVlzxk7QTtweKqzu1/X9a/iQpXjf+un9fI3tZ8DtDa6VZ+GtK0+Sz06J4oY5tTurKeAMei3EW9ih6GMjB454xVnRPhzpVj4PsdF1GPz2tJ5LmOa2ke3aCSR2Y+U6MHQDcV4OSOtQ+LfHt54Shu7670mzGmWe3e9xqqRXEynHMUQRg3XADOhJB46ZU+P5rjxZc6NpmmW07WjxrLHPqKwXUiuFPmRQsuHQbgNxdeQQASOUrtf1/XUp6Go/gXw89hFaizljEMxnSeK8mjuPMIwzmdXEhYjgktkjrRZ+BPDdhGyWmneWrXyaiw8+Q5uFAAk5brwM9ieTk1z198Q4NEutXUWIR01oaf59/qbJaqxt0k3vIysIEwdoVVILe7Guy0S/u9S0tLi/skspixUxx3Kzo2DjcjrjKntkKfUCjXf0/Rr9AfZ/1uv8zQooopAc3ff8lT0L/sC6l/6Psa6SuD8ca+nhjxdpuqvCZ2h0TUFihBx5kjXFgqLntlmAz2rXbVdY8Paddap4wu9MbT4YTK5sreWOSJsjCYLP5uc4yNhzj5eeADpaK4TXPHkh8M64LO1vdF1rT7VLgQX0cRcI7YVxtZ0IOGGM5BHIFP8AEHjXUtIe9FhYPqbW+qWdl5UUKIY1l8stlnmAcnfhThQCRkEAtTs72Ffc7iiuWn8YjT5NSl1CCcLaraKlksCCZZZ+Ahk80oxLEDPyqv8AeI5HQafdS3ljHPcWNxYSPnNvctGXTnuY2Zffhj1osMs0VjX/AIjW01+HR7bTb3ULp4xNJ9nMSrBGW2h2Mki5GQeF3HjpyM42nePJBZ6/e+IdKutMstIuZIxcN5TB1XbhQqSOxc59ADkY54pLX+vkD0Oyorkz8QrGCz1OTUdL1OwudMt0uZrGaONpmickK6bHZWyQRjdkEYIFRTfEaC2e7juPDuuRSWMaz3SNDF+5tznExIkwV+VvlBMnyn5KdgOxorB1PxXDpdxGJdN1CWzZo1k1CONPIh3kBc7mDMCWHKKwHfFZP/Caal9r8WRT6PcWlvoqM0N4yRSJhYVf5kE4ZickgDaNuASppDinLY7SiuKg8Z6m/iLU9Nk0iYW1npsN0t+qRbAzLISzJ5+4qSgCqBnIbJAw1aFj4u+03Wn6fDp93qN1NZwXVzNbJFFHAkuQHZZJd2Mq3CeYRjvxl2d7f11/yJuv6+X+Z0tFFFIZzfhf/kYvGf8A2Go//TfZ10lc34X/AORi8Z/9hqP/ANN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP+Rdtf+w1pX/pwt66Sub8ef8AIu2v/Ya0r/04W9AHSUUUUAFc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ0AdJRRRQAUUUUAc945urmz8Kyy2ss0C+fAlxPDnfFA0qiVwRyMIWOR069q4KK7tLe48ST+GdZu7y18zSViuzePOSpuCGVJmJZ1wSM7m6kZ4wPXqKa0/r0/r5g9WvI81j1Z4PFeuRaXqS67qhguXtxbatJKtoyjKwzWgby48EBQ/3mOcgHOcnw9rEs01q2h69qGpiTQbibWvPunl+y3YVNuQxIgk3GQeWu3gfd4zXsFFTb3beVvz/AM/wQ7+9fz/y/wAvxPM5I4tJ8L+GTrGvapDp2obJdU1G41SZCW8jKAy7h5Kl8fdKAkAd+cGXUbux8O240++kOjza/eC8vb3UZbDKYJj8y5RC8ak4+bA3YUbvm59qoqpO8m/66f5ExVopdv8AJ/5nmGni81m38MWdz4hNxaXF3d7pdG1mSZZYVRikbXKhHcr0LcNx1zknQ02/trf4nS2P9q/2vNIzIkdvrErtYKqfcntQ2wDjiU/MWYAjvXf0UX1uFtP6/r+vJBRRRSGFFFFABXN+A/8AkXbr/sNar/6cLiukrm/Af/Iu3X/Ya1X/ANOFxQB0lFFFABXn/jHxbqXhrXrrTo7jdLrFmq6GrRqQl3vEbL0yw/eRvg54V+wr0Cq9xp9nd3FvPd2kE81q5e3kliDNCxGCVJGVOOMijrqM801XxTr9v/b99FrHlvoGoW9lHppgi23odYss5K7wzmQ7dhUDHQ81d1/VPEkd14ovdP15rWLR5oFtrP7JE8b7oo2YSEjeRlzwrKR644HbzaFpFxq0Wq3GlWUuowjEV49ujTIPQORkdexqaTTbGVbhZbO3cXRBnDRKfOIAALcfNgADn0FPov67f18xd7Hn+t3mo2kes6Pqd6usJbyaZPHLeWkJx51ztZNgQKQNmVJBYZ6kgGqVxa3Njo3xMvH1Se9WOabFpd29tJCW+ywsGK+VlsD5cElSByCck+mzabY3Ekkk9lbyvKEEjPEpLhG3Jkkc7SSR6E5FQTaBo9xe3F5PpNjLc3MPkTzvbIXli/uMxGWXjoeKcWk/68v8v1H/AJnEavqmv2z+J7+z1p7e10Iwm3sEtYTHIPJjdldipbadxxtKkepGAKmpa74n1bxte6boupapaiz1S3thHZ6bG9sbYojzO88kTKJBvPyhgeB8pzmvSX02xljuUksrd0usfaFaJSJsAAbuPm4AHPYCuJv/AIXx33ia71Q3ViPtd0ly1w+mhr+EqFASK63jYmEAxsPBbnmlFrmV/wCtv+CS0+V2O5gvLW6knjtrmGZ7d/LmWOQMYnwDtYDocEHB7EVNWfpOjW2jLdfZzJJJeXL3M8spBaR29SAOAAFHoFFaFIYUUUUAc34X/wCRi8Z/9hqP/wBN9nXSVzfhf/kYvGf/AGGo/wD032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfhf/kYvGf8A2Go//TfZ10lc34X/AORi8Z/9hqP/ANN9nQB0lFFIzBEZj0UZNGwHKQeENT03Vr2TQtfFhp+oXv225gNksswkON4jkZtqq20ZDIxGTgjjGLefC27uLS6sYddt4bObURqAY6aGuWfzhLskl8z51yMDCqQAvJxzraH8SNO1yPTbhdL1SysdUfyrO9u4o1jlkwTs+VyynggFlCkjgnIzYufHMFjewpfaLq9tZT3a2ceozQIkRlZtijYX80AtwGKYOQc4OaaTTSX9bafkEut/63/4JXvfAX2zRPF+n/2ls/4SWVpPM8jP2bMKR4xu+f7me3XHvVbV/h9fXVprVlo2vJp1lrsZF7HJZecwkMQjLxtvULkKNwIbOOCp5qcfEvTjJI7aVqqWMOotps2oNFGIYphJ5Yz+83lS2BuCkDIzjnF0+NrV9YnsrLS9UvobW5Fpc31pbiSGCU4+UjdvOMjJVGVc8kYODVpLyt8tP+B+A7uL9H+P9J/iZ03w5WW4urkao0dy5spLWVIBm3ltlKhsE/MGyQRxwSM96r3Xw51DVD4gm1fxBFNc61a21uWhsPLjgELsw2qZGJB3dC2Qc8noL0XxI051v5n0zVIrKxuXs3vHijKSTrII/KRQ5dmZiMfLjnqCCKvWnjK3mkvLe90rVNPvrS3Fy1jNAss0kRJAZBCzh+RjAOQeoGRRd799f6+X4E8qXu/L8f8AP8Tntc+F9zq1vr9pa63b2ltrjNJLI2miW5RioG0SmQZjwuNu3IBIDCr/AIh8C3/iOF7G/wBZtZNMkCfJJpitcW5UD/UTBxs5GQWV2BJ56Yj1f4iSWWn6pENA1Ky1a202W/tba8EBE6JgFgUlIwpKkqWVsdATWbqvxDvrHwpJqMdlfrq6+HjqQspEtzAMMB5jEPu6nO0P93tu4pJ20XT/AIP+TK/X/gf5o3U8HahZSavNpOtxwyalqAvGS5sRPEV8lIzG67wzD5N2VZDn1HVmkeH73wfawwaU0FxJqOq+ffCOzMcEaMvz+UiviIfKDyWySc5LZEJ8e2enyyTa0NStJI9Mt7qSzeOFkUyytGu0oSS7MAMbtoGOnNdFo2tSat56XGkajpU0BG6K+jT5gehV42dG98MSO4FVqn+H3dPwJ0a/rqv+CalFFFSM4jxhoVt4l8aabpN80iRXOh6iPMiOGjYXFiVZfcEA/hVu+8J6vruhXmleI/EEdxDNFsiazsBAyMGDLIxZ33MCoPG1evHTFi+/5KnoX/YF1L/0fY10lAHE3HgG71O11eTWtajuNS1OzjsjcQWXlRRRIxYYjMjEkliSS3pgCrupeDZL1dVeDUVhnvb22voWe33rC8Aj2hl3AuCY+cFTzjPeupop3YHNy+G9QYanMl9p8l3qUUEcoutOaW3+RSG/deaCQ2TgFuP9qq/h/QtZ0LULDToroHR7W3mecrEiRyzSSApHEmWaNIwGwM4wyjJxx1lFCdmHSxzfiXwzdeIb60Y3djBa27rIrNYF7uNwckxT+YBHkcfcPGfXite+CJNQsdf0251NRp2rS/aI1jtsT203ynd5hcqwBQEDYPcmutopf1/X3BucY/gW7vk1S41rWY7nUtQtYrQzwWfkxRRRuXGIy7EkljklvTAFaWpeFf7Qudel+2eX/bGmpYY8rPk7RL8/X5v9b04+71546Gih6qwLR3X9WOB1r4YrrGpC5lvbN1BgZHutNE89u0e3iGUuPKRtmSApOSTmte98J3V1deIRFqcMdlrtsY5YmtS0kUvlCIOr7wNu0D5Suc/xDpXT0Ubji3F3X9WOZl8KXQ1a4ubXUoY4LzTUsLqGS1Ls2wSBHRg4C8yHIIbOOCOtV7vwXdXj6LE1/Yra6UkISUaeftgaPGdk/m4RWwARsPBIzzx11FO7vf8Arr/mTZf18v8AJBRRRSGc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFc34X/5GLxn/ANhqP/032ddJXN+F/wDkYvGf/Yaj/wDTfZ0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc34D/5F26/7DWq/+nC4rpK5vwH/AMi7df8AYa1X/wBOFxQB0lcb4g1nWP8AhYej6HYRajBZSW8l1PcWgtSJNrxrtbzWLBBuO7au45XaeuOyrLn0bzvFNrrPn7fs9nNa+Ts+95jxtu3Z4x5eMY5z7Udfv/J2/EOjOe0LxhejwHpGpX2najrF1cWxmuHs4YwEUE5Y7mRf+Arlj2BqzY+MrrUPG39mWukXM2lyafDeRX6mILiTf8xBl3bSFAACbsg5GMGsu6+Fy3OhaXpkt9Y3cVjbG2ZdR00XMZySfMjjLgRyc43Hdx2rZ0vwndaPqWm3FnqULRW+mxaddRy2pJnWLO1kYOPLOWOch+MdOtPu/wCuv/AHLy/rVf8ABLdp4rsb210WeGK4VdaDfZtyrlMRs/z88cKemeawvD/jidvC2h/arS91rWb60a5eGySJW2K2DI25kQDJAxnJ7A81Y0vwTfWF9pPna3HNp+jNJ9jtUstjbGRkAkkLncVDcEBRgcgnkZtx8J7WSw0ZfM0u9u9LtGtN2raSt3BIhbdnyi6lWB6EN0JyD2T30/rf/gB3Neb4g2XmRJpulapqfmWK35a1hQCOElhlvMdcMChyv3vQHnE83jix+0wQabZahqryWsd7J9iiVvIgkztdgzKTnBwqhmOPu0un+ExZTSSiW1iEmlx6f5FnZ+RDHtZzuRNx2j9593Jxjqao2vge+0q5tbjQtbjtJhp1vp128tl5vmpDna6DeNj/ADN13jkZBxVK19f63/4H9bJ76f1t/wAH7l87s/jeyg1Oe3Wxv5bS1uEtbrUY0TyLeVtuEbLhz95clVIGeSMHHS1wk3wytR4quNYtoNBn+1XS3U39p6It1cI/GfLmEiFB8uRkNgkn2rpfD66ubS6k15sSzXcrwQfITBBnCISvBOBknn72MnFT9nz/AOG/4PyDr/X9f8E5248bz33iDw9Bpllf29hfag8RvJYozDeRrDKxCkMWX5kUgsFJxxkZq5a/EGzuYIbt9K1O20+a8FlHezpEsZkLtGOPML7dwA3bcHcMZ5xFY+B760utHR9cSTTNEuDNZ2osgshUxugWSTed2BJwQq9OQTzRrfhxLP4U6lo7faL5o7eaSI2sBMpk3GRCiDJ3BiuPpTbSVyt5JL+tX/wDodL1m31ae/jtY5Qtjcm1eRwAsjhVLbcHkAttOccg1oVieD9Gk0HwnY2Ny5luwnm3cpHMk7kvI34uzGtuiSs7EJ3Vzm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zrpKQwooooAKKKKACiiigAooooAKKKKACiiigArm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zoA6SmT/8AHvJ/un+VYlx4y0e18b23haa6iTULi1a5VWmQdCAExnO4gkgY6KT2q3p/iTQ9WvJrTSta0++uYM+bDbXSSPHg4+ZVJI59aTXNH1HezPO/h7outa54C8Ix6l/Z8WlWDR3scsMjtPMV3bEKFQqYJBLBmzjoM06/+HPiO/FnHcnSbmay1eK//tO5uppJ50WbeVCFNsJ2/L8pYEDGFBrvh4s8POL7ydc02VtPRnu0ju42a3A6lxn5eh64qlpPj/w5qnhG08RyarZWNhcgfPdXUaCNz/Ax3YDDuM1fN73Mu9/8vyE9d/T+vvZizeBdTk8F6jpAntPtF1rh1FGLtsEZu1mwTtzu2jGMYz371b0/w/4k8P6tqcehvpUmnanqLX7z3byebb78eYgiUYkzjht64zyDjnsIZoriFJreRJYpFDI6MGVge4I6is+LxLoU+sNpMGtadJqSfesku0My/VAdw/KktHb+un+SG3zK773+ev8Amzkrn4dXGoeCNT0W8ms2muNZl1ODehlhIM/mokikDII+Vhz1PWi38D36aPq0em6R4a8KXt1beTDLokZ8zOcktMI4yFOMYC5HUNmrNt8UdIOoWdjqXlWNxe6pdadCr3KY/csy7znB+YqAAAeWAzXTjX9HOsf2QNWsTqW3d9i+0p52PXZndj8KXTTr/l/kEvid97/r/mcAnw41W78QzahdW2kabDcaHc6XJHaXEtxLukK7XMjopccHggY98mrE3gHWtVsHh1GSwtXk8NSaMfIneUCQsNr5KL8uBk9wTjnrXZp4o0CS8mtI9c01rm3VnmhW7jLxqp2sWXOQAeCT0NZ+oeP/AA1Z+FdR8QW2sWOoWWnoWlazu45MtjhAQ2Nx4ABPJIovp/Xn/wDJMLO6X9dP8kY48Ja5cX93f3lvojSXOjQae9nOz3MDskrswbKJlWVgM44P8JxzFpek6r4JsNZ1gWdpBALeNbXQLPUJZYFdMjcrvGNjMCqhVQD5R1zkdTpviOz1WRZLS806W0ezS6WSK9DybSSCSgGAny/f3HJBGBipLTxPoN/p1xf2Ot6bc2dtnz7mG7jeOLHXcwOF/Gq1u/66k7pfL8lb8LGmCSoJGDjkelLWfp+v6Pq0txHperWN7JanE621ykhhPowUnb0PWjTNf0fWnmXR9WsdQa3bbMLW5SUxn0baTg/WpGZd9/yVPQv+wLqX/o+xrpK5u+/5KnoX/YF1L/0fY10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf/AJGLxn/2Go//AE32ddJXN+F/+Ri8Z/8AYaj/APTfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/Iu2v/AGGtK/8AThb0AdJRRRQAVzfhf/kYvGf/AGGo/wD032ddJXN+F/8AkYvGf/Yaj/8ATfZ0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc34D/5F26/7DWq/wDpwuK6Sub8B/8AIu3X/Ya1X/04XFAG7eXtrp9v59/cw2sO4L5k0gRck4AyeMkkAVnweLfDl19l+zeINLm+2OY7by72NvPYdVTB+Yj0FVvGekTa3olvaQWy3IGoWkssb7cGNJ0Zyd3BwoJx3rD1PwndSr4wltdOi+0alcW72silA0gjjjGc54wytjOPUU1td/1t/n+AM62713SLDULewvtUsra8uf8AUW01wiSS/wC6pOW/CppNSsYUuXlvLdFtMfaGaVQIcgEb+fl4IPPY1514k8K65d3Xi2wttL+2J4k8n7PqXnxqtkEjVcOGYP8AKQWXYrct261a8R6Nr4i8TafpmjyagutpG0V0LmKNIisSxsrhm3bvkyMKQc4JXrQrNIHpc2r74h6FbXOuWNteW1xqWj2rXD2f2lA0u1C5VQCW4xg/LxkVs6Rr2ma3G39m39pcyxBfPiguFkaFiM7WAPB+uK5nWtK1aW88VW1tpc1xFrGliO3uUliCLIsTrsYM4YElhghSOeSK0LDQprLxVpdzBZxwWdvozWjmPaoV98ZVMDtgN0GPzpR1dn/W/wDkkJu0U/66f5tmxqOu6RpEsEWrapZWMly2yBLm4SMyt6KGIyfYUXOvaRZ6hFYXmq2UF5MVWK3luEWSQtnaApOTnacY64PpXF+KNA1h/EevT2mi/wBsW+uaRHYRP50ai0dTJnzA7A+Wd4bKBjlenStbw14audI8TTXV5GsoTR7KxjvCQWkaMy+YP7w6oeeufamkmrv+v6/UctNv62/zf3GhfeM9C03xXaeHb7UbeDULuEyxRyToufmVVXBbO5i3ygDna3pTNA8Y6Zrjm2N1aW+oia4jFh9qVpisUrx79vDYOzPTjOM1HqtrfxeO9I1S20+a8tVtJ7OYwyRgwGR4mDsHZcqBG2duW6cGsjT/AAre2ul6Yn9nxx3EPiKe/mKlMiNpZiHJB5JR198HHamrcqv/AFr/AJag+tv60/z0Oph8R6JcXM9vb6xp8s9sjPPEl0jNEqsVLMAcgAggk9xinWfiDRtQ0x9RsNWsbqxjzvuoLlHiXHXLg4GPrXGXPg3UpfhlqGlW9pFHfTapLetAzqFul+2GUKzDj54wBz64NRy6J4gurnxBrlvoxsZNQWzjj06c28s2IWYvKBuaHzMMNm5iPkXOOlL+v6/roHU6XVPH3hnSdDttXm1mylsLq5S2iuIbqNkZmYKSG3AELyWweACe1b1vcQ3dtFcWk0c8EyB45YmDK6kZBBHBBHevNLTw34jTQNYlubO9ubmbXLTUoYbqa1FxNHH5BYHytsQf92wxkDgcnrXpdvK81tFLJBJbu6BmhlKloyR907SRkexI9zTsrf12X63Dqc/4X/5GLxn/ANhqP/032ddJXN+F/wDkYvGf/Yaj/wDTfZ10lSAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfhf/kYvGf8A2Go//TfZ10lc34X/AORi8Z/9hqP/ANN9nQBjeLIr628dw6ha6TJqSS6Fd2kUXkNJFJOXR1jkIBCKwUjLYHbNc7ZJqWqeNfCNxJY6pJa2trcwXIGitYQWzNDxGoZQwBPAO4pwADmvX6KFtb+uv+bB66/10/y/rp5V4ZtLyz1PS9M0ey1C5061gmgYa3o/kTaXGU+VI7kKqyAsoUhd+QcluBnG0fS9Us4fCl5d/wDCRaZBpujvps8lhpfnTW9wGUt+6kgkZkYDHmIpHy9cGvbqKd3v/XX/ADYdLf10/wAjm/A+lx6P4TS3tU1II000ypqixpNl3LfdjAVFJOQuAQDyAeK86m/trUf+EWifSL+1lsdcilu7Cz0RoLayUu2SJCp8wc8tG2Dks2BxXtNFF/eUvT8BPWLXe/4nkunabqGn6lo99c6dfLBb+KNTkl2WkjsscolWOTaqk7CWHzYxg5zjmqejeGrlLWHRNdm8WG8h1c3Rt7Swt/szN55dZxdGDoRgkGXfjK4PSvZqKE7W8rfhYctW33/W/wDmeXW2n6hpfgPXpIfD63N1L4huJzHc2Bmbyjcg+esXBkKqAygddoxWTeaZrGuap43lgtdVuV1Lw0ILWa7042omkBkGxVKqQeRw/wA3J/hxXs9FLp/XaxXNq353/G54/rmk6n4hvL6403TL54JdDsFaKe1eA3AiumaWDEgXDFARtOMhh2NHjW0u/FMGs6h4e0bUYrZfDlxZSJNp8tvJcysyGONY2UO+0BuQMfNgE817BRVc2t/X8b/5krT8Pwt/ked61oHneMLJf7JupdOfwxd2dwtomzdlotsQbIUMRv2gkd/ek8F/2hH4mtoIIby+02DT2ha+1bRjZXVqQw2QiTaglUjrtXA2A7jmvRaKOb9fxbf6itpb+un+Rzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jXSVIwooooAKKKKACiiigAooooAKKKKACiiigAooooA5vwv/yMXjP/ALDUf/pvs66Sub8L/wDIxeM/+w1H/wCm+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v8A2GtK/wDThb10lc348/5F21/7DWlf+nC3oA6SiiigArm/C/8AyMXjP/sNR/8Apvs66Sub8L/8jF4z/wCw1H/6b7OgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Af8AyLt1/wBhrVf/AE4XFdJXN+A/+Rduv+w1qv8A6cLigDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/wDIxeM/+w1H/wCm+zrpK5vwv/yMXjP/ALDUf/pvs66SgAooooAKKKKACiiigAooooAKKKKACiiigArm/C//ACMXjP8A7DUf/pvs66Sub8L/APIxeM/+w1H/AOm+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C//ACMXjP8A7DUf/pvs66Sub8L/APIxeM/+w1H/AOm+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLegDpKKKKACub8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Af/Iu3X/Ya1X/ANOFxXSVzfgP/kXbr/sNar/6cLigDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAK5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm77/kqehf8AYF1L/wBH2NdJXN33/JU9C/7Aupf+j7GukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/wDIxeM/+w1H/wCm+zrpK5vwv/yMXjP/ALDUf/pvs66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACub8L/8jF4z/wCw1H/6b7OukrhNM8WeHNB8W+MLXXNf0vTbh9WikWK8vY4XZTYWgDAMQcZBGfY0Ad3RXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJRXN/8LH8Ef9Dl4f8A/BpB/wDFUf8ACx/BH/Q5eH//AAaQf/FUAdJXN+A/+Rduv+w1qv8A6cLij/hY/gj/AKHLw/8A+DSD/wCKrn/Bfj7wfa6Dcx3XizQ4XbVtSkCyalCpKvfTsrYLdCrAg9wQe9AHolFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQAeF/+Ri8Z/wDYaj/9N9nXSV534c8feD4Ne8WST+LNDjS41aOSFn1KECRfsNqu5SW5G5WGR3UjtXQf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSVzfhf/AJGLxn/2Go//AE32dH/Cx/BH/Q5eH/8AwaQf/FVz/hzx94Pg17xZJP4s0ONLjVo5IWfUoQJF+w2q7lJbkblYZHdSO1AHolFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQAX3/JU9C/7Aupf+j7Gukrzu88feD2+JOjXS+LNDNvHpN/G8o1KHYrNNZlVJ3YBIRiB32n0NdB/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQB0lFc3/wsfwR/0OXh/wD8GkH/AMVR/wALH8Ef9Dl4f/8ABpB/8VQAeF/+Ri8Z/wDYaj/9N9nXSV534c8feD4Ne8WST+LNDjS41aOSFn1KECRfsNqu5SW5G5WGR3UjtXQf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lFc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFUAdJRXN/wDCx/BH/Q5eH/8AwaQf/FUf8LH8Ef8AQ5eH/wDwaQf/ABVAHSUVzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVQB0lc348/wCRdtf+w1pX/pwt6P8AhY/gj/ocvD//AINIP/iqw/FnjXwrq+l2NjpXiXR767l1rS/Lt7a/ikkfF/AThVYk4AJ+goA9AooooAK5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vwH/AMi7df8AYa1X/wBOFxXSVzfgP/kXbr/sNar/AOnC4oA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C/8AyMXjP/sNR/8Apvs66Sub8L/8jF4z/wCw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAK5vwv/wAjF4z/AOw1H/6b7Oukrm/C/wDyMXjP/sNR/wDpvs6AOkooooAKKKKACiiigAooooAKKKKACiiigAooooA5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6Psa6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5vwv/wAjF4z/AOw1H/6b7Oukrm/C/wDyMXjP/sNR/wDpvs66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/2GtK/9OFvXSVzfjz/AJF21/7DWlf+nC3oA6SiiigArm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5XwJd266TcWjTxC5fVtWkWEuN7INRnBYL1IBIGfcV1VeLLPLbXOoz20rwzR6b4meOSNirIw1JiCCOhB70dfv8AwTf6DSvp6fi0j2mivOCNU0G4mh0W+1C/urnw7NeKl7dPcb7lCgRlDEhc7z8q4XpxWcb2xuvB0I0DxZqlzd3F3p8d/ImoSSNBI9wiyDJz5THJBjGAB/CKpRbdv63a/T8iFJNX/rZP9fzPWKK8j8YXN7o3if8AsttTj0/SYNPjawudU8TXFgGnLvvJl2yGdlwvyO2AOxB4j8SeJb2DUbUDUV/tS2FnuK6zJCk+7y97wWqIVuIjuYF5CMc4IxSWuxT03/rb/M9gorz6DU44fiTd20OprrF5L5gihttWkY2OI87JrQN5arkYEh+YlgMd6xfh1q+rX+uad/aGsaeuoSQu2qWEviCWe5ZtucCyeNVgKtj7hxjOd3BpR1E9D1RL21kvpLKO5ha6iRZJIBIDIitkKxXqAcHB74NT1554uv7+O88XQ22oXVsItKsmhaGUqYWaWYMydgxAHPfAzWt4ehk0vx1q2kR3t7c2a2FtdKt5dPOyyO8yuQzkkAhF+UfKOwFOw+/l/wAD/M218RaQ1xcwtfwxyWt0lnKJj5eJ2VWWMFsBiQ64xnrjrWlXmUdxNB4h14W80kPm+LbSNzG5XcptoMqcdj6VBpGra7da9P4bgmvJbrwsLqWeR5XP2vcp+xq7H7+Vck5J5jBNLTlv5X/8lTf5jfxW/rdr9D1SivHPB2salcxSSSa7Ym7/ALKmk1C0/wCEilu7vztoIb7M8a/ZirZBCEAZxg4Br0TwVp/2LwpYSyXl9e3F1bRTTzXt08zM5QZIDEhR7KAPanbfy/4P+RN9vP8A4H+Zv0UUUhnN+F/+Ri8Z/wDYaj/9N9nXSVzfhf8A5GLxn/2Go/8A032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfhf/kYvGf/AGGo/wD032ddJXN+F/8AkYvGf/Yaj/8ATfZ0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/+Ri8Z/8AYaj/APTfZ10lc34X/wCRi8Z/9hqP/wBN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP+Rdtf8AsNaV/wCnC3rpK5vx5/yLtr/2GtK/9OFvQB0lFFFABXN+F/8AkYvGf/Yaj/8ATfZ10leV2es6hpvxk8SQ2Wm6jqsUkzM9rZSwqAwtNPAciWRFPBIyCTzQtXb+tribsr/1vY9Uoryy28dalpnh/fJDdLfal4hu7OJbq3kvWs1Uu+DFAzM+0JgKjY9wBmtW18WeJNRXTLS1tra1urq6uLd7m/064gV0jj3rMkDlXAOcbWbscN3ItVf+un+Y5e67P+t/8jvqK8//AOE31V9FKSS2FrqkN7cWcrR2Fxe+cYWALxW0J8wqcjOW+TPJaorTXPEHiDXvCF9ZX1tYW1/p88txaSWsrhmVo93/AC0Tnn5dy5XnIOcBrX+vK47dP60PRaK88PjvWN/9rLDZHRf7bGj/AGXy3+0k+d5Pm+Zv2/e52bOnO7tVTT9a1vw9Z3moKNPl0k+JJrWS3Mb/AGhhLdGPeH3BQQzfd2nIHUdKIpu3n/wP80D0T8v+D/kz06ivM5bp7zWPDjybsp4qvohmaSThYblRguzEcDoMKOwFMbxvf6Z4I0u5sZrfz/7OF5Lbva3uoyuPmOCVZmiU4IEsjMOoxxS2Vx8rvb+t2j0+iuPi13xBq3iiWy0htNtbKHTra8Zrm3klkdpfM+QbZFAHyD5ue/BzxH4W8bXXibUNNtooII2FjJNqq8k28yyeUI154y6S9c8JT5Xe39df8iL6X/r+tTtKKKKQwooooAKKKKACub8B/wDIu3X/AGGtV/8AThcV0lcb4W1zSdF8NStrOp2enrNrmqpEbu4SISN/aFxwNxGT7CgDsqKzdQ8R6JpMiR6rrGn2LuFKrc3SRlgxIXAYjOSDj1wabe+KNA03UYdP1HXNNtL2cKYrae7jSSQMcLtUnJyeBjrQBqUVVXVNPeCGZL62aK4k8qGQTKVkfn5VOeTweB6GqA8Y+GSJyPEWkkW8YlmIvov3SHozfNwORyeKANmis678Q6LYaXHqV9q9hbWEuDHdTXKJE+emHJwc/Wi+8Q6Lpkds+pavYWaXZAt2uLlIxMT0CEn5uvagDRooooAKKKKACiiigAooooA5vwv/AMjF4z/7DUf/AKb7Oukrm/C//IxeM/8AsNR/+m+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACub8L/8AIxeM/wDsNR/+m+zrpK8ri1jUNM+MOrx2NjqGpxS3c5ks7KWJckWWm4ciWRFOMkdc/Nx3oWrt/W1xpXPVKK8qj8eanptre+ZbXkN5qHiKWzgiu4HvWslECyEeVbsxcDacKjY+bORzWvF4v8RXlppMFtawW95e6lLYtcX+n3FujosDyCZIXKyD7oG0nsRu6NTSbWnZP77f5k37+f4X/wAjvqK4E+NNVXTLu3uJrC31Oz1F7F5o7C4uhPtRX3xW0TGRuHGRv+Xkkmq0Gv8AiHxFdeEL7T76109Lt7pLmCWymYSNGGUkqZUIB28KwypPOcYpf196uDaX9fI9HorzO7vteuP7MOi6lDYF/E11bSC4Se5EgXzguczqduE5QELnBG0DB0Zdb1m1XxA+mQiSW21ZIJJTFPdiGL7PG7SC3Em5uWxsjK9c4JzkWqv/AF0/zLkrO39df8ju6KpaPd/b9Htbn7XBeGSMEz28RjSQ9yELMV57Ekiub1HXZdN17xCyywwm3trPymuZJ3TdI0g4iUkFuBhUUM5wCehA9CLnY0VwWj+OdRvbMrPHE88Otw6bJK1hPaeYkiI+4QynfGcPjkkcZ6Gp9S8WaylzqVrpsVj51vrVtp0BuFfbskijdmbBySC5xjA4A96dn/Xnb/5JD7+Sv+f+R21FcMvivXES40qX+z31ePVk0yO7WB1tzugE3mGLeW4Ukbd/JHUZ4yLa61GxbxE2pNDJdt4msIZHtHmgRg6Wq7gFcMODnaWYdjuHVxjzO3p+Nv8AMbTS1/rf/I9QorhrTxhrE+kap4laGy/sSwe8Q2gjf7SRbl13+Zu2ksyfc2jAOdxxgr4N8X6vrmqRwajaSPBcWhuROmjXdnHbNlcRF5xiUkMSGXbnaflFJK7t/X9aCem5qX3/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJSAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACuR8M6dat448X6k0WbuPU1gWTceEaxsmIxnHVRzjPFddXM+GWCeIPGjHousxk/8AgvtKL21C19C7N4T0WexltJLRhFJdPeFknkSRJmJLSI4YMjcnlSMZ4rL1HwHaXtzo0YkupLKwmmldrjUrl7gM8ZUFJi5cEE9mGO1bOjeIbTXLKxubSK6Rb60W7i8y3YAIccM4BQNz93dnv05rUptW0B6vUwD4J0D+z7WzitJYI7QuYnt7uaKT5zl90iMHbceW3E7jyc1KPCOirb6bBDbSwJpZJtPs91LE0YPVdysCynAyrEg4GRxW1VLWdVg0PRbrU7tJHhtYzI6xAFiB6ZIH60a3AoL4M0FdbOqrYn7S032gr58nk+b083yd3l+Z/t7d3vUUfgXw7Fqp1FLF/PNybsqbqUxNOTnzTEW2F8nhtuR2xXQg5GaKW2wbmUPDOkrLbyC0+e2vJL6I+Y/yzSBg7dech24PAzwOlUp/Afh24tYLZ7KVYYLf7KEiu5ow8XOEk2uPMUZOA+cZPrXRUUDuylaaPY2N491aweXNJBFbs29jmOPdsXBOON7c9Tnmsnwr4Y/sK/16/njt0utY1Brl/s5JAQAKgJIHOBuPbLHrXR0U7u9/6/rQVtLBRRRSAKKKKACiiigArxuz8Pa1Nfz6zpzatNayXOq2Tw6V9iMqH+07lmJF2Nu1gQDtIPyjII6eyVzfgP8A5F26/wCw1qv/AKcLila/9fId9Lf13MrTPCUlreM32GV4E8OQ6dA980TzBgZN0bFTjOCmSPlPYnFUo7DXku/C1hqXh2+vNM0qxgeQ29xbFTeBQuZA8qkrGASMBskgj7or0air5ne/9df8yWr/AHW/Jfp+Z5pomi3Q+KmoaafLfR9IlfVbYA5Kz3SkbMdtuJm/7airuheDprO08FLc6Vbo+kpM1zxGfJkaMjcMdSW7jPrXcQ2dtbzzzW9vFFLcMHmdECtKwAALEdTgAZPYVNS6JDetzyqbwh4jtJdJv7UajGLGXUUNtpj2ZmVZrjfGyi4BixsGCMhgCAO4q+dC1TSdN0j/AIRrTNcTU4YHjW5upbEoitJuMVyofG3PP7lcgAAHtXo1FF/6/r1E1cBnAz174ooopDCiiigAooooAKKKKAOb8L/8jF4z/wCw1H/6b7Oukrm/C/8AyMXjP/sNR/8Apvs66SgAooooAKKKKACiiigAooooAKKKKACiiigArkfDem2kvjfxXqUkWbu31UQxSbj8qPYWJYYzg5KL1Hauurm/C/8AyMXjP/sNR/8Apvs6ALlz4T0W6t7iGa0bFxdG8d0nkSRZtoXzEdWDI2BjKkfrWVq/gS2v10S1jkuZLKwvXuZjdajcST8wyINkrMXBDMpHzDGDiutooWgGD/whWhDTIbGO1mhjhkaVJIbyaObe33mMyuJCW7ksc980/wD4Q7RBp9lZxW0sENhM01t9nupYnjZiS2HVg2DuOVJwc4xW3RQFjHufCmj3entZyW8qRG6a8DQ3MsUiTMxZnWRGDKSWPQjgkdOKLjwrpdxDcR/6bB9puBczPa6hcQPJIECZLxurY2qoxnBxnGea2KKP6/r7h3e5haZ4VtNL19tStyFSOySytbdUwIYwxdsnJLFmIJJ9Pck1I/C8mpatrlz4iht/IvjBHBFa3Em5UhLFJN4CMkmWz8v3cDDHrXUUUf1+pNl/X3GDH4K0GLS7uwW1lMN5Ms87NdzNK8qhQsnml94cbF+YNnIznNPsvB2h6dCY7WzZQ10l4zPPI7POoAEjMzEscKM5Jz1Oa26Kd2MyLvwvo97HepcWhP26dbmZ0mdH81VVVdWUgowCqAVI6VHa+DtCs7SS2gsiI5bqO8kLTyO0k0e0rIzFiSfkXOTzjnOTW3RQm1sD13MSPwfocWqTaglk3mzM7vGZ5DCXcEO/klvLDEEgsFycnnmpNI8L6bodw0umm+QFNghl1G4mhRc5wkTuUTGONoGBwOK16KW2wb7nN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NdJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34X/AORi8Z/9hqP/ANN9nXSVzfhf/kYvGf8A2Go//TfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFeQz2Fpc/EzxdJr+iXWr6ebyKOyWC0e4EN19itSzfKD5TFdmJDtAwfmHf16ub8L/APIxeM/+w1H/AOm+zpNXHc5LRNFuI/Dum2+qW+p2MK+EhazyW9vI00L5XKgKpYyAZ+UAnjpVD+zn/sbS428MgeG7bV2a+t7DRJLb7dEYCFleyKmQgSFQwwd20NjHFewUVbldt/1vcXf+uljyfT/Cj39rodpqOkTtop8QXU9vY3ELbbe0MEojWRD9xCx4RsYDBSO1R+LtAt3XxHbXHhq7vNQfYNFmtLFnWG3WKMbEkUbYwGD5jyCw6Bs4r1yijm1X9f09N/UTV7/11b/X8jyDxfoepXPjPVJtRcRRTJENKvV8OXWpy2gCAMYpIXHkOHyeV545IGBuQ+FbGW58Z6jq9lcx3M87Rw6hDau9wsRtYlZoAFLcncPkByRjnFeh0Uk7K39dP8h9Ucl8PIVttFuYINHttNtkuSIXt9MbThdDauZDbuNyNn5ST125HBFdbRRQ3cS0CiiikMKKKKACiiigAooooAK5vwH/AMi7df8AYa1X/wBOFxXSVzfgP/kXbr/sNar/AOnC4oA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C/8AyMXjP/sNR/8Apvs66Sub8L/8jF4z/wCw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAK5vwv/wAjF4z/AOw1H/6b7Oukrm/C/wDyMXjP/sNR/wDpvs6AOkooooAKKKKACiiigAooooAKKKKACiiigAooooA5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6Psa6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5vwv/wAjF4z/AOw1H/6b7Oukrm/C/wDyMXjP/sNR/wDpvs66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/2GtK/9OFvXSVzfjz/AJF21/7DWlf+nC3oA6SiiigArm/C/wDyMXjP/sNR/wDpvs66SsTUPBXhXV7+S+1Xw1o99dy48y4ubCKSR8AAZZlJOAAPoKANuiub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkrm/Af/ACLt1/2GtV/9OFxR/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AHhf/AJGLxn/2Go//AE32ddJXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lc34X/5GLxn/ANhqP/032dH/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQB0lFc3/wAK48Ef9Cb4f/8ABXB/8TR/wrjwR/0Jvh//AMFcH/xNAHSUVzf/AArjwR/0Jvh//wAFcH/xNH/CuPBH/Qm+H/8AwVwf/E0AdJRXN/8ACuPBH/Qm+H//AAVwf/E0f8K48Ef9Cb4f/wDBXB/8TQAX3/JU9C/7Aupf+j7Gukrm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoAPC/wDyMXjP/sNR/wDpvs66Sub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpK5vx5/yLtr/wBhrSv/AE4W9H/CuPBH/Qm+H/8AwVwf/E1JbeAfB9ndRXVn4T0OC4hcSRSxabCrxsDkMpC5BBGQRQB0FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf//Z" alt="" width="792" height="629" vspace="0" hspace="0" border="0" style="width:792px;height:629px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/4RESRXhpZgAATU0AKgAAAAgABAE7AAIAAAAYAAAISodpAAQAAAABAAAIYpydAAEAAAAwAAAQ2uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAE11aGFtbWVkLCBVc21hbiAvU0EvRVhUAAAFkAMAAgAAABQAABCwkAQAAgAAABQAABDEkpEAAgAAAAM1MQAAkpIAAgAAAAM1MQAA6hwABwAACAwAAAikAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMDowMToyMyAxMzozMTo0NgAyMDIwOjAxOjIzIDEzOjMxOjQ2AAAATQB1AGgAYQBtAG0AZQBkACwAIABVAHMAbQBhAG4AIAAvAFMAQQAvAEUAWABUAAAA/+ELKmh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjAtMDEtMjNUMTM6MzE6NDYuNTA3PC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPk11aGFtbWVkLCBVc21hbiAvU0EvRVhUPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAvcDEQMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiivP/BWi63qfgHw/fz+OvEAlutMtpnHl2T4LRKx+Z7dmPXqxJPck80AegUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUVzf/CL6v8A9D34g/78af8A/ItH/CL6v/0PfiD/AL8af/8AItAHSUV5/wCNdF1vTPAPiC/g8deIDLa6ZczIPLskyViZh8yW6sOnVSCOxB5rc/4RfV/+h78Qf9+NP/8AkWgDpKK5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRaAOkorm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoA6Siub/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWgDpKK5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRaAOkorm/+EX1f/oe/EH/AH40/wD+RaP+EX1f/oe/EH/fjT//AJFoA6Siub/4RfV/+h78Qf8AfjT/AP5Fo/4RfV/+h78Qf9+NP/8AkWgDpKK5v/hF9X/6HvxB/wB+NP8A/kWj/hF9X/6HvxB/340//wCRaAOkorz/AMFaLrep+AfD9/P468QCW60y2mceXZPgtErH5nt2Y9erEk9yTzW5/wAIvq//AEPfiD/vxp//AMi0AdJRXN/8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItAHSUVzf/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLQB0lFc3/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi0AdJRXN/8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItAHSUVzf/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLQB0lFc3/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi0AdJRXN/8Ivq//Q9+IP8Avxp//wAi1h+CtF1vU/APh+/n8deIBLdaZbTOPLsnwWiVj8z27MevViSe5J5oA9Aorm/+EX1f/oe/EH/fjT//AJFo/wCEX1f/AKHvxB/340//AORaAOkorm/+EX1f/oe/EH/fjT//AJFqJ9A1CO5jt3+IOuLPKrNHEYtODOFxuIH2XJAyM+mRQB1NFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUV5/oOi63d614mhk8deIAtnqaQp+7smyDZ20nRrcheZDwoUd8bixO5/wAIvq//AEPfiD/vxp//AMi0AdJRXN/8Ivq//Q9+IP8Avxp//wAi0f8ACL6v/wBD34g/78af/wDItAHSUVzf/CL6v/0PfiD/AL8af/8AItH/AAi+r/8AQ9+IP+/Gn/8AyLQB0lFc3/wi+r/9D34g/wC/Gn//ACLR/wAIvq//AEPfiD/vxp//AMi0AdJRXLW+gaheW0dxafEHXJ4JF3JLFFpzKw9QRa4IqX/hF9X/AOh78Qf9+NP/APkWgDpKK5v/AIRfV/8Aoe/EH/fjT/8A5Fo/4RfV/wDoe/EH/fjT/wD5FoA6Siub/wCEX1f/AKHvxB/340//AORaP+EX1f8A6HvxB/340/8A+RaAOkorm/8AhF9X/wCh78Qf9+NP/wDkWj/hF9X/AOh78Qf9+NP/APkWgDpKK8/8FaLrep+AfD9/P468QCW60y2mceXZPgtErH5nt2Y9erEk9yTzW5/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItH/CL6v8A9D34g/78af8A/ItAHSUVzf8Awi+r/wDQ9+IP+/Gn/wDyLR/wi+r/APQ9+IP+/Gn/APyLQB0lFc3/AMIvq/8A0PfiD/vxp/8A8i0f8Ivq/wD0PfiD/vxp/wD8i0AdJRXN/wDCL6v/AND34g/78af/APItUbS01LSviTplrdeJNU1W3uNJvpDFeCBEVkmtAGAhijBOHYZbOMnGMnIB2VFFFABXN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFfPvgvQZNd8NrHpnh7fqwg0v7P4gLQp9gAsbYkB93ndM/KqlTuwTya+gq5b4Z2sEHwx8NSQQRxyT6RZvM6IAZGFvGuWI6nAAyewFOOjv/W6HfRo5yx8ReMNU8SXclhZalJb2mrGyaAfYltBArhWdyz/aN+3LjAx0G09aqSX2reE/D/ifUrHUr7UZn10WqxSx22IvMeJTIPkQbgG/iYLwM45Neh3XhjQb3Vo9UvdE0641CIqY7yW0jeZCpyuHIyMHpzxUx0PSTeXV2dLsjc3iCO5n+zpvnQdFdsZYexpLS3p/l/l8ridm/nf8/wDP52ODuNd8W6Xorx363tmlxqNpaW+o6qLMzxpK22Rituxi+XgKSBywyDjmzf2Goz+MtBsovFEsk8UN8r30dvAZ1X9x8hG3yw/IOdmMfw966u08KeHtP0+5sbDQdMtbO6/4+LeGzjSObt8ygYb8as2ejaXp0dumn6bZ2qWyskCwQKgiVsbguB8oOBnHXAp/1+Fv69QV1/Xr/XyOI07XJ7m+8P3urPbvNFaaoJbprVSw8mRE3jA3LkDJVSAfwGM0eONe0tNZlcahfLHokuqWo1CK1TcVI2mNYGLCMhs4l+bjqecemRaZYQtG0NlbxtFvEZSJQU3nL4443Hk+p61Bp/h3RdJkkk0vR7CyeTdva2tUjL7iC2SoGc4GfXApdfv/AF/zX3B0S/rf+kcv4V1jXoWmu/EpvYdG+xi4a/1d7GNY3yOENu5HllSTl+Rj7xzx3AIZQVIIIyCO9c9ceAvDUtpdW9ro9npy3pX7W9jbRwtcIGDFHYLkqxGCO4JrogAAABgDoBTbTQkmgooopDCiiigAooooA8p1TQjrninxD5S6ZqD2mtGZtG1R8Q3if2dZgseDhkOCGKsAT2yCJtHkXXfGHhbVNIv9R06zbRblo7H9y4ASaEGMsyMxVvUN0VdpHOd3TNC0nXtc8Xw65pdlqUUetxsiXlukyqf7PtOQGBwa6a50XS71rQ3mm2dwbJw9qZYFb7Ow6MmR8pGByMU46f15NfqD1X9ep574T17xn4jazvjb6nFaX5mW4aUWItrIbXCGIK5mLhgoIkBzk8L0qk3xH1ybQby5smWS78P6ZKNWjMS4a9EnlLnpgDZJJgEcFc4Br0iPwxoMWtHWItE05NUJJN8tpGJySMH95jd0469KtwabY2z3LW1lbwtdv5lwY4lUzNjG58D5jgYyaP6/r7/yH1ueetq/jGx8Ma1cTnUoES0jks77VY7FpFmLYYKtsxVkwQRuAPXk9tmx1PWdI8Q6tplzJe+JPs9pbXcSJHbxTZkeRWUcxptHlgjcd3XluK27Lwn4c01LhNO0DS7RboATrBZRoJsHI3YHzYPPNaS2tut290sEYuJEWN5gg3sqkkKT1IBY4HufWi4l1uclq13JN408IzSWkttO0V7IbWZkMifuhwdjMvXA4JHPWsLw54q1y7m8K39zqn21PEbTi407yY1SxCRu3yFVD/KVCNvLZJ7dK9Ci0XS4NXm1WHTbOPUZ1CS3iQKJpFGMBnxkjgcE9hTbTQtIsNQuL6x0qytry6/19xDbokkv+8wGW/Gl0/rzF0OB8ET6tpWleDlk1Z7q01SF4mtGgjVIQsTSKUIG/d8uDuYg54Aqx4Z1bxEYvC95qOuPqH9upIstvJbRRxxERNIrLsUNn5cHJIOeAtd5HptjElskVlbotpn7OqxKBDkYOzj5eCRx2NIul6esNvEtjbCO2BECCFcRAgqQox8uQSOOxpvW/wDXcb1uedXXijXvD3hrVRql9dNr0P2XzRdxW5trZJpfLM8RiUExj5jiQ7vkGfUuvtf8Q6YfEOkW+tteSWLaebfU57eIujXE2143VFVGwoyMAHDfjXd6f4b0PSbKaz0vRtPsrW4/10FtapGknGPmVQAeOOadaaBo1hpo0+x0mxtrIOJBbQ2yJHuBDBtoGM5AOfUU7oOpleHLjUYPEWr6NqOpS6mtpHbzRXE8UaSfvA+VPlqqkApxxnnknrXS1GltBHcyXCQxrPKFWSUIAzhc7QT1OMnHpk1JUiQUUUUDOb+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACubvv8Akqehf9gXUv8A0fY10lc3ff8AJU9C/wCwLqX/AKPsaAOkooooAK5v4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISgDon3eW3l4L4O3PTNeYW3iDVx4a12HXdbvbfX49JuJpNNntUgELqp/eWsiKC8YzjO5z93JU8H0+RBLE8bFgGUqSrFSM+hHIPvXLv4Ctbp531XV9U1OSSzmsoXunizbRSgBwmyNckgD5n3Hjr1yu5cWk033M2LxnNqfg99T0+OeKxSe2tob5JkEtw5mSOQhHjYBQSRk8thsBeGq1L44v4b+5Z9CQaVa6ommyXf2394zOyKrrFswRukAOWBHUbqut4G03bdxxT3cMF28EstvG6iPzYnVhIAV4ZtqhuxA6A81Zn8J2NxZXNs8twEudRTUXIZciRHRwBx93MY464zzV3Tld7f8N/wTNK0Uv6tb/hiXxBrU2krZQ2Nol5fahcfZ7aGSbykLBGclnCsVAVGPCk+1cppGv6qbx11I3NrNP4lNo0CXKSrGgtg+wMyHMZK5wuw/NnI5B6/W9Dh1uG33XNxZ3FrL51tdWrKJIX2lcjcrKcqzAhlI56Vn2XgqxszE32y+uJE1E6kZJ5VZnmMRjOfl+7g5wMYPTA4pR0d3/Wq/wAmOWqVv60f+aMwfEPydN1rUb6xto7fTCU+yw3pe8L79irJCY1Ee4kEHe2QQaS48fX2mQaxDq+hJFqem2cd6ttbXvmxzxuxUASFFwwZSCCuOnJq/deA7LVDenXtR1DVjdW7WoNwYozBGzBiE8qNOdyqQWyRtHPXJH4Dsja363+o6jqN1qEMcE17cvH5vlxksiAIioACSfu5OeSaS21/r+v67id9bf1/WoTeItejurXT49Bs5NTlhe5lhGpERxQqwUfvPKyZCW+7tC8H5u55ey+JQ0Xw3oFrfS2P9pXtm9zI+tastpGqq+3BlKuWfJwAARwckCu31fw5HqmoQX0OoX2m3cMbQmazdAZImIJjYOrDGQDkAMOxGTVBPAdpa2unppOqalptzp8DW0V5A8byvEzbij+ajq3IByVz78nJ/X5/8D8R/wBfl/wfwK9n43utavNIi8P6RHcxajY/bnnuLzylhTeFI+VH3Hk4xwcdQOaveG/E8+v6hfxPbWVtHaOY/KF6XukIYgebD5YEeQMj5myCKv2uiJBqcOoTXlzdXcVp9kMs2weYu4MWYIqjdkdgB7VBp3hsWetvqt5qt9qd2Ymhia6EKiGNmDFVEUaZGVHLbjx1609Pz/PT8LE6/l/wf1MnXvH0Xh/xLa6bdx6esc88MAWTU0W7cyMFDx2+CWQFuSWU8EgHHLZfHF/Df3LPoUY0q11RNNku/tv7xmdkVXWLZgjdIAcsCOo3Vbv/AAJZ3+pT3J1LUIILi6hvJrOFoxFJNEyFXJKF/wDlmoK7tvtnmrc/hOxuLK5tnluAlzqKai5DLkSI6OAOPu5jHHXGeaI205v62/4P4FPy/rf/AIBzPijxTq9zasdKsfJ02HWbWye/S+KTFhdRrIPKC/6s8oTvyeflxzXoVcvd+A7K7upGOpalDaSXiXxsIpUEPnrIJN/3N/LLyu7byTgHmuooXwJdf+Av+CN76HN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD10lIQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Dj/klnhT/sC2f/AKISukr528J2FtqHgOSCz0W9uPELw2A0zUIrV3W2f7Da/MJgCsOOrZK7hx83SnFXdv63S/UHtc+iaK8y1oXtqfEulDStSubnUtTt7q3e3s3eJogsCsxkxsBBjbKk7vQGnal4ctUs/iHrV5pi/bWE4tbqaL5hH9ijU+Wx6AncCV64welJ7N+V/wAtPx/AqKvJR7ux6XRXkNroY1Jpx4U0S90yKXw7c21+bm2eAXVy6oItxYfvmGH/AHgLDB+8c1e1GS615bxrLR9WjSPwtdWmbixkh3znZ+7UMAWPHYYP8JPOG1b8f1/y/FEx1S87fp/n+B6hRXmmv+HLHS9A0nTbDw3aG0mUvcyS6TNqCedtQAy28RUyO3P7xz8u3k81teC9WlsdH8OaBqtvdjVJ7CSV98ePKWJlX5wzFlzuUDr06+pbVpCWyZ0aatA+vzaQEk+0Q2yXLMQNhVmZQAc5zlD29KvVw2veF7XXPGupT6ppX22FNFjS3aWItH5vmSn5e28fKQfvDPGM1yHi6z1i+8NWUb6NLLqcehxNb3M+lXF7MbgISwjZWVbWVSAd7csSODtxRHVf15/5FNe/yr+tF/mewx3cct5NbKswkgCli0Dqh3Zxtcja3TnaTjviq+uavBoGgX2r3iSPb2MDzyLEAXKqMkAEgZ49RXD+I9HvNSh8RRSWV1Kl4+lj5I2BkCyL5mCOeBkkjpW34w0KC0+FOu6R4d0xIkbT50gs7KADLMp4VFHJJPYZJNAQtKzfU6qNxLEki5wyhhn3p1eO+JtFvbrUNfS40e+utbuEgHhy/jtXdbQCNQcSgbYCHDFtxXcCPvdK6C9soYviRHdx6dJqV4+xJ5rjR5ibNRHgvb3ZXYox1jXJLMcYORQ/6/r8+xK21/r+uh6FRXmfhW9sfB2l6pcR6PKbCLyFW/GjvY3l9IzlAkiyhWmkBYHzOAxcjGc16ZQ1YfU5vwv/AMjF4z/7DUf/AKb7OukryTX7G0u9e8RvcWb6jNDrYaGxm0eXULacnT7LiRUUiNuyuxAXJPIyKmu7HUD48h8NfYzDpuuvBrM6K422/kBfOi47M6wdODuaiOrt/X9Wu/l5hLRX/r+tv6R6rVHVdWg0iG3luUkZbi5itl8sA4aRgqk5I4yea8/g8Krb/wDE3h0iRNYPidn+1CFvOFu10Q2D1ERQkkD5SDn3qnNoyvqdubnw9fS+Io/EKzzaitm+37N9pJQmf7roI9o2ZO0jJUYzRFX5b9Wv0/zFU93mS6X/AF/y/E9aory+48JXCeDPFd7pOlvH4gu727CThNlzJAZ8lI3PKhkBxggEnPvVGTRPO0fxj/wiuh3unaJd6IsMFibGS2M11iTeUgZQ2dpQFtvzHucZoSuU1Z287fjb/g+h69RXml38P9IXXNWjh0Bfsf8AY6SwosTeW13ulzIB0M+Anz/f6c81ha9o2r3uqpca8rCKXSrVLO4l8PXWpyWswQ+aU8h1MEoYg7iuTxz8uKX9fn/kLrb+un+f4HtFVrTUbW+nu4bWXzJLKbyJxtI2PtV8cjn5XU5HHNUtG1iK9vLzTE8+WfTFhjuLh0CrI7oGwOchsEEggY3CuBuPDpsv+E/g8OaIbHX70SS2N5BYGLzY2hiyqXAXaCZA527s7vmx3p9X6f5AtUj1SoLq7js1jMqzMJJFiXyYHlwScAnaDtHqxwB3IrymDR7J49ak0jwvqVvoU2jLBPp4spLZ7q93fKyoyg7wMZlxjodx25FjQdG1y10+GDX7W5utdj1y1lvL8Rs6XEQHyOrYwFVflI7EEn72SW1+787f8H0sS3aLf9bX/wCB6nqtFee+BbC3tNSYapot+viUXFybvU3tZFWVC7FCZz8sibSoVAW28fKuK9CpdCuoUUUUAc38OP8AklnhT/sC2f8A6ISukrm/hx/ySzwp/wBgWz/9EJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/JU9C/7Aupf+j7Gukrm77/kqehf9gXUv/R9jQB0lFFFABXN/Dj/klnhT/sC2f/ohK6Sub+HH/JLPCn/YFs//AEQlAHSUjuscbO5wqgkn0Fefw6jEnxIvLRNV/ta6n8xY47TV5C2ngR52TWgby1GRxIfm3MBjvVLQPFCanH4WsItWkuryLSp11SMSs5WZYkBWb0kDbuG+bqaTfucy7f5/lYa+Kz7no1hf22qabbX9jJ5ttdRLNDJtK7kYZBwcEcHvVivFvB+pmPT/AAxH4P1m71LUDpT/ANp2Mty8qQhbfMWYidsJ8wIFwF3Ak/N1rQ0/VrZ/AZvtN8S6le6skVrPqyNeSSfZ2E0Zm3Kf9QQN4Ma7Rtz8p61pKKUmv66/5Ep3t5/1+p6rcXMFpbtPdTRwQpy0kjBVX6k1JXlHiXU7LxXp3jFrPU57zTLa0s5YpLS7kWIENIXZWQgMuByQSPl5+7w3xtr1laabbwaDq0rxpp7XFjcyeI5oUnbLYMTqJHu5ARyjErjbnrWb03HH3noes0V5lqAu9Xv9ZuptW1SA2Xh61vIIrS9khjWciclyqkBvujg5U45BwKyPEuu6u2vFb7VrLSojpltLp1xfa/JpcZmZSXcKsbLOQ2Mo5wBj5fmzVNWdv66/5AtUn3/4H+Z7JRXjviXWtQS/19brWrm28QW0dv8A8I/ZWt06R3hMalmWIECcGQsDuDbQB93rWp4n8Tto9v4vs73VZLXUZkik02BZmEhUwoGaJRztDh8kcDknHWiwr6XPTqje5gjuY7d5o1nlVmjiLgM4XG4gdSBkZ9MiuFutRt7f4owxS6suozSukaafbavIktj8nV7RDtkQ8sXflcjgjGH+LbXS4/iR4ZvtXvp7KNoriGOT+0pbaNpd0ZjjwrqpZvm+X+PGCDgYS1t5leXkdpaXtrfwmawuYbmJXaMvDIHUMpwy5HcEEEdiKnryG/1jytDs7zVteLCO91Ef2WdZlsrm823TKnlNGweRlUbVi+6dwGRgVvXOp28XxMgR9U+3TTlEj02DVpI57DMfWS0VtsiHli78rkdRjD/r+v6/ET0uegUV5hovimS6XwjpkGqSXOrw+emo2/nMzCRYJMLN6HcAQG5OMjpmqfw61fVr/XNO/tDWNPXUJIXbVLCXxBLPcs23OBZPGqwFWx9w4xnO7g0W1sJux2/xH/5JZ4r/AOwLef8Aoh6t2+r3E3ja/wBHZIxb21jb3KMAd5aR5VIJzjGIxjj1qp8R/wDklniv/sC3n/oh6l1TQdRk1s6v4f1K3sLySBbacXdmbmORFZmX5VkQhgXbndjnkHjAitLP+uq/QzLXx26WcH2rTLq+vLvUryytoNOjX5hBI4BYyOAvypySQM+lVpPHepp/wlf2jRbmwh0VC8V1LHDMoxEr4dFuAzE7iQBtGMAkGtmw8Ix6fLpLxXbubCa4nlLoM3Ek+4u3BAX5mJxg+lVtV8HXWoSeIootUhhstet9ksbWheSKXyxGHV/MAK7VHylc5/iHSjS400235/qW38WwrrTaXb6ff6hJb+WLy4tIlMdqXGV3AvuOQc4QNgcnA5p8PimN9dj0240vUbQTl1trq4jRY7hkGWCjcXHAJ+ZVBA4zVceF7+z8SXWpaPq8dpBqDRPfQSWfmu7RqFBjfeAmVAByr9OMHmsvTPhsun+LLbW3u7KSS2llcTLpwW7nDoy4muC5L43DHCjAxjoQiNbfcWbXxydX02xv7DTr6wtLu8ghinvraNhcB2IIVVmDLjH3mGOhAcVqQeKI5Nej0yfTNRtBcM62t1cRosdwyDLBRuLjgE/MqggcZqvbeEvs/hrRNI+27v7Jmhl83yseb5ZzjGflz9TisrS/huuneLrbXHu7KWS1llcSrpwW7nDoy4muC5L43DHCjAxjoQ1a/wB/5L9bhK99PL83+ljua5/V/F0el6xJpkOkanqVzFarduLOOMqsZZlzud1GRtPHU9gecWpl1iTxda+S3k6PDayGfIQ+fMzAIB/ENoDEngHcOvOMDVdI128+IV3Po1+NNifSYYXnmsTPG582XIU7lw6ggjkjnlTxUu+lvP8AUvSzv5fmv0L1v46stQ1KwtNG0/UNTF9ZxXyz26RrHHBIxUO5kdcYxyoBb0BwcW4PFljPb6TMkVwF1a6e1gBVcq6rIxLc8DETdM9R+EXh/wAIweHbuF7O4d4INMg05I3X5sRM53ls8k7+mO1Z9p4Iv7fUtNMmuRvpulXsl3a2i2W1/nWQFXk3ndjzTghV4HOeov3b6ef5/wCRP+X42/zFHjr7dpa3thp99Z2zX0Nol1eWyOkzNOIWCoJlbr/ERjuA3So7Lx3dC48SNq+h3lvZ6PdeUk6mEh12RkKQJSSxMhYHAG3GcNkVfHhDHhey0f7d/wAet9Hd+d5P3tlx523bu4zjbnPvjtUV14OnuZPEEJ1ONbDWj5pj+zEywTBEQMJN+CuIwdpTOf4u1KNktfP9P+CJ3a0/rf8A4Bc1Xxfp+j3N/BcxXDPY20Nw/lqpDiWRo0VSSOdyd8AZBz1xqabeTX1ik9zp9zp0jE5t7po2deepMbuvPXhjXOW/hXW0u9T1C71vT7vUL+0htf3ulH7Mixu5/wBV525siQjBfrz0+Wk0jw/rGgzaRp2n3Ma6fHLNcXzQwJFDgrhLeKIlmjXcdwweAhGecUaXHLy/rT/MtfDj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJXSUgCiiigAooooAKKKKACiiigAooooAKKKKACuR+FunWtj8M/D81rF5cl7pdnPOdxO9/s0aZ5PHyoowOOK66vNvAHjeyg+H/hu2FjfS2trptja3Woxon2e3laGPCNlw5+8uSqkDPJGDgW9l/X9aB0PSagvbODUdPuLK8j8y3uY2ilTJG5WGCMjkcHtXMv8QrSNb64fSNVXT9PujaXF+yRCJXEojJAMm8qM7iwXAAPcYqLxP47l0ozQ6LpVzqU9rqFpaXBTygg85lyoLSJ821hjsC654zgSvbz/X/hx6xfp+h2EUawwpFGMIihVGegFOrhpvHVxpeu6x/aWl6nJY2dtbXEgiiiIsUZGMhdt43YxyELnjgEVrar40tNMvpraKwv9Q+yQLc3stmiFbSJskM+51J4UnagZsDp0y9dyV5HR1ELWBbtrpYIxcOgjaYIN7KCSFJ64BJOPc1y+ofESwsLq9X+y9VubXTzF9qvbaBHiiWRFZW+/ufhxwisR6YwTdtPF0VzHfK+kapBd2QjZrKSJGmkWQkIyhHYYJB6kYwd23FIZ0FFZeha7FrkVzi0ubG5s5vIubW6CeZE+0MASjMpyrKQQxHNalABRRRQAUUUUARzW0Fz5f2iGOXy3EieYgbYw6MM9CPWpKKKAOb8L/8AIxeM/wDsNR/+m+zrZXSrNdafVhEftrwC3MpdjiMMW2hc4HJySBk8Z6CuPsvEMWi+KPFFslndajfXmtqLezswnmSBdOsyzZdlUAAjJLDqB1IFaLePrN2s4tP0rVNQuryKeRba3jjDxmGRY5Ecu6qrBmxycHBwTxkQHVUVy1r42sb+7sp7a48vT5tPubuQS2x3p5Lojgtv+UqWIK7Gzj7wxznx+OZpvFlktzZ32kaV/Zd1eym+ijAlVGh2yBlZiAFZvlJVueV6U7fr+F/8mNK+39f1c7miuWi8e2Ztbie80zUrBY7GTUIVuUjDXUCAFmQK5weV+V9rfMMgVGfHoxYqvhnXGn1FZHtLcRwB5UQIS5zLhAQ4xvKngggHGV/X9fcxbnW0VzGj+O7LWbuyjj07UraG/wB6W1zdQqkckiAl48bt24BW5K7TtOCamj8VrPqL2EmmajYPJDJLaT3USKlwEA3bQGLKRkcOqk9s0PRXYLV2N2G2gtvM+zwxxea5kk2IF3serHHUn1qSsLwPqV1rHgLQ9R1GXzru6sIZppNoXe7ICTgAAc+grdqpRcZOL6CWquFFFFSMKKKKACiiigDm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf8AYF1L/wBH2NdJXN33/JU9C/7Aupf+j7GgDpKKKKACub+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/iP8A8ks8V/8AYFvP/RD10lc38R/+SWeK/wDsC3n/AKIeukoAKKKKACiiigAopCcKT7VwWn+KfEL+CbbXNUu9Ht5NRCfZYYrG4laPIYnCI5ediACEUJjn5jjNA7HfUV5/F4z1298KwX1tDFC6Xs1reXjaVcyLEqEgSfZNyyqG4yCfkyScgZqtdajrEXizXNV0G60uaOHQrO6lkmhd1uADcMBGFcbAwz8xLY44ajo2/wCuolq7L+tbHpNFQWNz9s0+3utuzzolk25zjIzj9anptNOzEmmroKKKKQwooooA5v4cf8ks8Kf9gWz/APRCV0lc38OP+SWeFP8AsC2f/ohK6SgAooooAKKKKACiiigAooooAKKKKACiiigAryD4f/DO0Hhfw5rFtBoE32uwsrub+09EW6nR/Ijz5cwkUoPlyMhsEk+1ev1zfw4/5JZ4U/7Atn/6IShaO6DdWHP4btrbwnrWnX5e+tr57ueVI4juKyszFAoJJIzgY6ntWD4b8GX8nwvsbO/vHg1ueaHUp7m5g3n7QrrIokQFcgBFUgEcDqK9AooWm3l+H9fgD138/wATmLzwjNqGn6/Dd6jH5+t2KWskkVsVWJhGyFwpckgls7c8dMnrWZrvwztdU159Whi0Oe4mgjhmXWtGW/X92CA0f7xChIPPJBwOBXdUUB0scxc+DRcWOuW63iRDVniYbIMLB5caJgDdyPkz2xnHam654MbWLvVLhNQEJv4LaLy3g3x/uXdsONw3o2/DLleAeeeOpooA5rwZ4QTwhb6hHE9ni+uRcmKxshaQxHy0QqkYZsD5M9c885610tFFNtvcAooopAFFFFABRRRQB5lc+CLXxb4o8SXUqWD3VhrQ8pdSsBeW7K+n2W4NEWXJ+UYIYEH8qtHwvrOneJNDg0GXTdMNrpt4rzWmjFLIF5oSF8kSfKSMniTJKk8jIrf8L/8AIxeM/wDsNR/+m+zrpKa0/rya/UHqcfa/Dy1t7e3t5L2WaFdOu7KfKAPM1zIrySZBwpyG4x/F7cs/4QS8v7hT4j1pL+3TTbjTVhgshBmKXYCzHe2XwnJGFOeFHfs6KL3/AK73/wA2NNp3X9bf5HA6X8Mo9N07UbKNfD0C3dhJZJdWOgi2uQGGN0kglIf1ICrk88V050HOs6Tf/af+Qbay2/l+X/rN/l85zxjy+nPX2rXoou3/AF6/5iWn9f12OatfB/2a30KL7du/si7muciLHm+Ysq4+98uPNznn7vvxk6L8NF0nXotTe8spZYoZofOj00R3NwsgA3TzbyZXGOuFHsK7uik9QWhmeGtG/wCEd8LaZo3n/aPsFrHb+ds2eZtUDO3JxnHTJrTooptuTuw2CiiikAUUUUAFFFFAHN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jQB0lFFFABXN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9dJQAUUUUAFFFFAAeRzWRL4W0ibQ7XSTbyR2lnt+z+TcSRyQkAgFZFYOpwSMhs4JHeteigd2YB8FaKNNWwiS9t7cSvMVt9SuYTI7/eLskgL57hiR19auJ4c0mNblYrNY1ubRLKVUZlUwoGCoADgAB26YPPsK06KOlhdbjIIY7a3jghXbHEgRFznAAwBT6KKNw2CiiigAooooA5v4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAK8b8G+LPFFt8NtOuLFNIax0uDTbFYJo5RLP5lvbcmQNhMGXP3GyBjA6n2SuI+Hvh3S5vhPoEclruW90+wu7geY3zypBDtbrxjy04GBx7mmrX1/rVfpcYsvinW9NF1aal9guLy21CxgM0EDxxvFcSKp+QuxDAFudxHQ47VS8b6rPeQ3tjKsYisdb0lYioO4754mOefX0xXX3vhzStRW+W8td/28Ri4IkdS3l/cIIIKkHkFcHPNVYPBGgW9rLAlk7LNcQ3UrSXMrvLLEwZHZ2YsxBVeSecc5pxdmm+jT/L/ACf3i/4P6nIyX3iC3tPHE+oanDdWtrfCOGCOOeB48xwEbZVnyqgNyFAy2TkA7ar3N5e+HfEXjPxTeppuoy6c0VtaKbNkmQPHHsQTGRtqZf5gF5OW46V3c/hPR7m7vria3mLagoF1Gt1KscpG3DGMNs3YRRuA3YGM4qxN4f0u5i1KO5s0mj1TH2xJCWWbCBOQTgfKoHGOlT29LfkNbu5x194x8R6Kuu6ffppl5qWn6fDfW08EMkML+Y7JsdC7MMFTyG5B6DpWnf6j4sttU0jR4LrRjeX0VzLNcvZS+XEI/L2hYxLlj8+DlhnrxjB0rXwXoNpYXVpHaSSR3iqtw9xdSzSyKv3VMjsXwOwzgc4rUl061m1K3v5Yt1zbI8cUm4jar7dwxnBztXr6U3YS3OL0nxhrzDR7zWotOFnqbz24gtI5DJG8SSNv3s2CG8pvl25XI+Zqi8GePtV8S32nSS2MrWOpxNKoTR7uAWY27l3XEg8uYEcZTbyRjcOa6+Lw7pcEdikVrhdPlea2HmMfLdwwY9eciRuDkc/SqcHg+w03zpNDkurGZonSFDe3ElrCWGMi2Mnl4B5wAPwov1FbSxv0Vn6Do1v4e8P2OkWRYwWUKwozdWwOp9z1rQodr6DCiiikAUUUUAecx6nrFt441vTtCNjHJqGulZJr2J5BGqaXaNkKrLuOe2R9RTLr4i6nHZaXaLDHFqV3c3kE1xDptzexoLaQozLBCfMO44wC2Fyck453PD2n21z4w8U3c0W6e01pTC+4jZu060VuM4PHrWlceD9EuLJbZrWSNUuJLlJILqWGWOSRizssiMHXJY5AIHOOnFA9P6/r0OcsPF/iLXLzT9MsLO30y+ktZrq4l1KzmVWWOXyl2wko67/vZY5UEcNWkut68/ibUoJP7Og07SraGa4VYpJZpWZGZkRtyhQNvDFTn071eufBWi3cFpHcx3kjWYZYbg6jceeFY5ZWm8zeynjKsxHA44FaVppFjYzTS2lusbTxxxyYJwVQbVGOgwDjiiW2m/8AX/AJ6+RxGk+Mtbvv7Ek1WKway8S2MtxbR2qOslptj8wK7FyJMqeoCYPY5rH8N+Nrrw54D0uxkggd28OWtxpIOR9omO2Ixtzz87xdMcN7V3uleCtA0W5M+nWLRv5bRRh7iSRYEY5ZIlZiIlPcIFHA9KoXvga1m1TwolrbW8el+HWeSJHdmkVhHsjVc5yozkknOVXrV3jqujt/7d/mvUetv68v8gh1zWU8YDTdXltLG1YBLdDYysb0+UGYpceZsQht37sqWwhOecjIsvE2rW3hnw5crJDYafc2olur+6tri/VGJHyM3mhoxgk+ZIzAYwa64+GdNbXBq0q3U10rbkE17NJFE23buSFnMaHGRlVB5Pqary+C9EmtLS0eG6FpZxiKO1S/nWFkHZ4w+2Qf74apXS/9b/1/wNAezX9f1/XmUPHs++LQdMJ/danrEEE2OjIoaUqfY+WB9DVnw9c3lxN4mUTmSSHU3jtxMxZYx5MRC4zwuSTgY6mrPijRJtZsbP7E8Ud3Y3sN5A0uQuUb5lJAJGULLn3oj8JaVDrkurQm/iuppvPlWPU7lYXfAXJhEnlngDqvaktnfrf/ANt/yYpatNdP/tv80cknxRnbRf7QFlE50/SJ77VoFzuimjcxiJeeMukvJzwtZut+KNW1jwTr1rqdtI8R08Trcro13YJG29QYj5/+sPOQy4zg/KO/ZeHfB8Omy+I5tRtrR316+kmnjjBZGi2hFVsgZJAJI6ZY9asx+CdFjsbqzK301rdR+XJb3Gp3M0YXOcKryEJ0/hxxx0qrq93/AF/w36BJaNL+tv8Ag/ec9Doa6/4o8UWzyiIQ6rpt2CU358qOKTbjI67cZ7ZzzWx4c1zU7/W72z1uW3tZo9zRacLGWORUDYDiZnKTKQV5RRgtg81u2ul2dnfXl5bQ7J75le4fcTvKqFXgnAwABxiqum+G9N0u/lvbYXUt1KpUy3d7Ncsqk5Kp5rtsUkDhcDgegpLTTp+tkv0G9UatFFFIDm/hx/ySzwp/2BbP/wBEJXSVzfw4/wCSWeFP+wLZ/wDohK6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6PsaAOkooooAK5v4cf8AJLPCn/YFs/8A0QldJXN/Dj/klnhT/sC2f/ohKAOkooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPXSVzfxH/AOSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/ySzwp/2BbP/wBEJXSVzfw4/wCSWeFP+wLZ/wDohK6SgAooooAKKKKACiiigAooooAKKKKACiiigArm/hx/ySzwp/2BbP8A9EJXSV87eE7C21DwHJBZ6Le3HiF4bAaZqEVq7rbP9htfmEwBWHHVsldw4+bpTiru39bpfqD2ue96dq8GpXWo28CSK+n3P2aUuAAzeWj5XB6Ycdcc5q9XmOoeFRLN4n1Y6TJJqy6xbyWN15TGRVEduGaI9QDhwSvXBBzis7xDo17da9ryy6RfT+IZtRgk0PU0tnZLa3AjztnA2xAESblLAtno2aEk2l5L9P8AP8A6Nnq1tqNrd3l3a28u+azdY512kbGZQ4GSMH5WB49as15Zqnh02t/46Hh/RPsuv6hbmXT763sCnmAwoHC3AXarGQN8pYEn5sd6TSdHs3utYk0fTNW0DQJtFEF2sVhLBK90ScukWze8gXguqncSOWxSW3y/r/L1G1b+vT/O/wAj1SivF7vSL6bQLCGx0GztdDttSdrlE8NzCO8Qw4SWTTwyyth/lI5yVDYxjG1p3haHUbfwzaajbvqmmxXV5I0UulT2cMKFG2xmCUlljBOFViQeMcYp2JbsenVn3muWNgZ/tjzQrA0SPI1tJsJkYKgVtuG5IB2k4zzivNLzRo4vC1nb3+mT3L2WoX62OmXWiT31rJF57CNWRVxGNm0RuxAUHIyMirfifw++r2euyaj4f+0IDpk6W5tfPA2HMojGDvKoWXCgkg4xzigpq0uVnpKXcb30loFmEkaK7MYHEZBzjDkbWPHIBJHGQMii6u47NYzKszCSRYl8mB5cEnAJ2g7R6scAdyK88v8Aw7/aja6ND057OH+ybCXSd9m1ukc0LzOihCqlSp2ZXAIB6DNM02z1TWbG38R6jpN3a3mqa1aytZzQkSWtvF8qh16qM7256b6La29Pxdv8/uJk7Jv+trnoljqNrqUUsllL5qxTPA52kYdGKsOR2IIz0qzXkY8NWuk+G9fk0XQl03WtI1OTU4pI9OMCzxJKzoiy7QrgxFlwGO3dg4rs/h/FLN4ek1u7iaK61ydtQdGHzIj4ESn3ESoD75oWqv6fj/T+4qWkrLu/w/pfedTRRRSEc34X/wCRi8Z/9hqP/wBN9nXSV5Jr9jaXeveI3uLN9Rmh1sNDYzaPLqFtOTp9lxIqKRG3ZXYgLknkZFTXdjqB8eQ+GvsZh03XXg1mdFcbbfyAvnRcdmdYOnB3NTjq7f1/Vrv5eYS0V/6/rb+keq1R1XVoNIht5blJGW4uYrZfLAOGkYKpOSOMnmvP4PCq2/8AxN4dIkTWD4nZ/tQhbzhbtdENg9REUJJA+Ug596pzaMr6nbm58PX0viKPxCs82orZvt+zfaSUJn+66CPaNmTtIyVGM0RV+W/Vr9P8xVPd5kul/wBf8vxPWqK8vuPCVwngzxXe6Tpbx+ILu9uwk4TZcyQGfJSNzyoZAcYIBJz71Rk0TztH8Y/8Irod7p2iXeiLDBYmxktjNdYk3lIGUNnaUBbb8x7nGaErlNWdvO342/4PoevUV5pd/D/SF1zVo4dAX7H/AGOksKLE3ltd7pcyAdDPgJ8/3+nPNYWvaNq97qqXGvKwil0q1SzuJfD11qclrMEPmlPIdTBKGIO4rk8c/Lil/X5/5C62/rp/n+B6zaaxb3ms3+lqskdzYiNpFcAB0cEq64PIyGHODlTV+uN01T/wtaYB2leLw/brcSldu9jM+0kdjw5x712VPp/XewutvT8Un+oUUUUhhRRRQAUUUUAc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/JU9C/7Aupf+j7Gukrm77/AJKnoX/YF1L/ANH2NAHSUUUUAFc38OP+SWeFP+wLZ/8AohK6Sub+HH/JLPCn/YFs/wD0QlAHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfw4/5JZ4U/wCwLZ/+iErpK5v4cf8AJLPCn/YFs/8A0QldJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyPwt061sfhn4fmtYvLkvdLs55zuJ3v8AZo0zyePlRRgccV11c38OP+SWeFP+wLZ/+iEoA6SiiigAooooAKKKKACiiigAooooAq6lp1rq+l3Gn6hGZbW6jMUyB2TcpGCMqQR+BqxHGsUaxxqFRAFVR0AHanUUAFFFFAHN+F/+Ri8Z/wDYaj/9N9nWyulWa60+rCI/bXgFuZS7HEYYttC5wOTkkDJ4z0FY3hf/AJGLxn/2Go//AE32ddJQAUUUUAFFFFABRRRQBVttMtLS+u7yCLbcXjK08hYkvtXao5PAA7DA5J6k1aoooAKKKKACiiigAooooA5v4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACubvv+Sp6F/2BdS/9H2NdJXN33/JU9C/7Aupf+j7GgDpKKKKACub+HH/ACSzwp/2BbP/ANEJXSVzfw4/5JZ4U/7Atn/6ISgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAK5v4cf8ks8Kf9gWz/APRCV0lc38OP+SWeFP8AsC2f/ohKAOkooooAKKKKACiiigAooooAKKKKACiiigAooooA5vwv/wAjF4z/AOw1H/6b7Oukrm/C/wDyMXjP/sNR/wDpvs66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4cf8ks8Kf9gWz/APRCV0lc38OP+SWeFP8AsC2f/ohK6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5u+/5KnoX/AGBdS/8AR9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigArzvwD4+8H2fw28NWt54s0OC4h0m1jlil1KFXjYQqCrAtkEEYINeiVzfw4/5JZ4U/wCwLZ/+iEoAP+Fj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqukrLuPEmk2niS00C4vVj1S8haa3tyrZkRfvEHGPwzmjyAz/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrRm8R6Tb+Jrbw9LeKuq3UDXEVttYlo1OC2QMD8TzzjpWnQBzf8AwsfwR/0OXh//AMGkH/xVH/Cx/BH/AEOXh/8A8GkH/wAVXSUUAc3/AMLH8Ef9Dl4f/wDBpB/8VR/wsfwR/wBDl4f/APBpB/8AFVqXus29hq2m6fMkrS6i8iRMoG1SiFzu544HbNaFAHN/8LH8Ef8AQ5eH/wDwaQf/ABVH/Cx/BH/Q5eH/APwaQf8AxVa2r6vBo1rFcXSSOktzDbKIwCQ0siop5I4ywz7etXqOlwOb/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qtS91m3sNW03T5klaXUXkSJlA2qUQud3PHA7ZrQoA5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKKAPO/H3j7wfefDbxLa2fizQ57ibSbqOKKLUoWeRjCwCqA2SSTgAV0H/Cx/BH/AEOXh/8A8GkH/wAVR8R/+SWeK/8AsC3n/oh66SgDm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrpKKAOb/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qukooA5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq6SigDm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrpKKAOb/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qukooA5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq6SigDm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrpKKAPO/APj7wfZ/Dbw1a3nizQ4LiHSbWOWKXUoVeNhCoKsC2QQRgg10H/Cx/BH/Q5eH/8AwaQf/FVmeD/Eek6F8M/A0OrXi20moabZW9spVj5khgTA4Bx2GTgZIGeRXb0Ac3/wsfwR/wBDl4f/APBpB/8AFUf8LH8Ef9Dl4f8A/BpB/wDFVcn8UabFpceoRNJcW8l6tiDGmCJTN5J4bHAfOT6DIzWxTt1A5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKz7XWbe71y/wBKjSUT2CRPKzAbSJAxXBzn+E5yBSAy/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqt25vI7VoFlWZjPIIk8qB5ACQTlioO0cfebA9+anoA5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKKAOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqukooA5v8A4WP4I/6HLw//AODSD/4quf8AAPj7wfZ/Dbw1a3nizQ4LiHSbWOWKXUoVeNhCoKsC2QQRgg16JXN/Dj/klnhT/sC2f/ohKAD/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq6SigDm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrpKKAOb/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qukooA5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq6SigDm/8AhY/gj/ocvD//AINIP/iqP+Fj+CP+hy8P/wDg0g/+KrpKKAOb/wCFj+CP+hy8P/8Ag0g/+Ko/4WP4I/6HLw//AODSD/4qukooA5v/AIWP4I/6HLw//wCDSD/4qj/hY/gj/ocvD/8A4NIP/iq6SigDzvw54+8Hwa94skn8WaHGlxq0ckLPqUIEi/YbVdyktyNysMjupHaug/4WP4I/6HLw/wD+DSD/AOKo8L/8jF4z/wCw1H/6b7OukoA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq6SigDm/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qukooA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAOb/4WP4I/wChy8P/APg0g/8AiqP+Fj+CP+hy8P8A/g0g/wDiq6SigDm/+Fj+CP8AocvD/wD4NIP/AIqj/hY/gj/ocvD/AP4NIP8A4qukooA5v/hY/gj/AKHLw/8A+DSD/wCKo/4WP4I/6HLw/wD+DSD/AOKrpKKAPO/APj7wfZ/Dbw1a3nizQ4LiHSbWOWKXUoVeNhCoKsC2QQRgg10H/Cx/BH/Q5eH/APwaQf8AxVHw4/5JZ4U/7Atn/wCiErpKAOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqukooA5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKKAOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqP+Fj+CP8AocvD/wD4NIP/AIqukooA5v8A4WP4I/6HLw//AODSD/4qj/hY/gj/AKHLw/8A+DSD/wCKrpKKAOb/AOFj+CP+hy8P/wDg0g/+Ko/4WP4I/wChy8P/APg0g/8Aiq6SigDm/wDhY/gj/ocvD/8A4NIP/iqzbbxHofiD4p6R/YOs6fqfkaLqHm/YrpJvL3T2WN20nGcHGfQ121c3ff8AJU9C/wCwLqX/AKPsaAOkooooAK5v4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISgDpKKKKACvP8AxpoOoal4jnv9Lt5Deafp0VzYy7TtaeOZm8vd/tLlSPRq9AopdU10H0a7nm+g6dqV94h0jxNqenXNtd6nPcTTQyxndZw+SVhifj5Tjkg/xO1Q6GLoHwhpUul6pFJoxmS+naykSKM+RIo2uRh8k8FcjoCQSBXp1FU/Im2h47DpFzF4U1Sx8PaPM1qs1m896uky2F5qESygzRyLIFeZ/LBJcYDbyMZznfUaZpUujaroPh/U7LR7W7nElvDpkysu+HaHS2C71TcMHCDnLYwSx9DoouN6nmWiafqb3Xh6dtNvLUjV9WncTwkGFZDMYy/UAHcMeuazPCmjXcWpeHnTSdQsdZtTOfEl/Jaun2oGNwP3pGJ8uVZdpbaBjjpXsFRRXVvNPNBDPFJLAQs0aOC0ZIyAw7ZBB57UX1B6tvu7nkEWiXP/AAjd3p3hnTHhxfae0WrtoctpczOLgEtOkihpigG8yYCncemDVjU9J1SXwXptpFpcsBtNUY69HdWEt8t5+7bMxjUq1yjMUOFPoCPlK165RRfS39dP8v6sHW/9dTzLw9pNzBqHhl4POuLSLULuTCaPPp8VmjQEBFilJZE3Zxk4y2B6V6bRRQ3clKwUUUUijm/iP/ySzxX/ANgW8/8ARD10lc38R/8Aklniv/sC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA8K0nQvEni3wZp6afpNo1rb+F7Kwsri+u5LZklaGOVpogIXDgMsQzleUIz6djoukL4r8T2es+K/D585dEtsx31sSkNyJZN+AwxuBwQeoByODz0Hw4/5JZ4U/7Atn/6ISukoWlv67/5jbvf+u3+R5HZ+FrGHwddaNZ+HJLO6HiCJrtYNOeDzYPt5ZCJFUB1WLurEKOuKvat4UWO11fR9O0iSHSpNY02SO2tYWSIJviMrIF4A4JYj3J716dRVKW3rf8AL/IXf+u/+Z5H8RtEaGGXT9A8OQQi208nTXg0aa6xL8xxAYmWO1cHB3nliwwDjFR+OY723u9WmmsZJoryfSY/Kljl8u8ClzJERGjs4I4ZVVjzyMZr2CqGr6LYa7aJb6nC0iRyCWNo5XikicdGR0IZTyeQQeam7svW/wCINJ/j+R5p4T0eztrDTDodjBHKPEj3V9a2dnLCLLdBLtRlkRHCgMoDMqjDDAAIFP8AC0F5B48t9SfSBpkbW9wNR2aXPCythSqzXUjlbkjBw4GBzg816RpGiWGh28kWnROvmv5kskszzSStgDc8jksxwAMkngAVbnghureS3uYkmhlUpJHIoZXUjBBB4IPpTfl/Wlh77/1q3+pU0PV4te0Gz1W2hmghvIVmjjuFCuFIyMgEjp71fpFVUQKihVUYAAwAKWh2voIKKKKQBRRRQAVzfw4/5JZ4U/7Atn/6ISukrm/hx/ySzwp/2BbP/wBEJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/8AkYvGf/Yaj/8ATfZ10lc34X/5GLxn/wBhqP8A9N9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/klnhT/sC2f/ohK6Sub+HH/JLPCn/YFs//AEQldJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc3ff8AJU9C/wCwLqX/AKPsa6Subvv+Sp6F/wBgXUv/AEfY0AdJRRRQAVzfw4/5JZ4U/wCwLZ/+iErpK5v4cf8AJLPCn/YFs/8A0QlAHSUUUUAFFFFABRRRQBzXxA12+8O+EZb7S4mkuWuIIFKhSUEkqoWAchcgNxuIGcZOK43W4/E174eWDWbjWdOhi1jTza3V2LA3Eu6dQwYQh48K2GU4UngEEA59UmhiuYHhuIklikUq8cihlYHsQeorLtvCXhyy0650+z8P6Xb2V3j7RbRWUaxzY/vqBhvxpx0d/NP7rf1cHqcd4n8S6ro+oEadqOp3iabPbW10fs9okBZymRMzlZGZlfI8lQASOD0re8Nf8jz4x/6+rb/0mStV/C3h+SeCZ9C01pbeIQwyGzjLRRjoinHCjsBxWhFa28M808MEUcs5DTSIgDSEDALHvgADntR/X5AS0UUUgCiiigAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA8y8JePLPRPh3odvNpWqXMem6DYTXt1bwo0UEbwKdxy4LYwcqoZvY10b+P7G3gu5dR0zUrD7J5LyJcRxhjDK+xZ+HOEBByDhlAOVrB8HeEv7U+EtvH9t8r+3PDljb58rd5G22C7uo3fezjjpXSax4atrqTV7y/L3NteaSLGW1jiLMyqZGJGDkk78AAdRRdJXY0r/ANea/wCD/W9ibxTAt1qNtZWF9qE+nvHE6Wsatvkdd4QEsACFwSWKqNw55rIuvFs15feGW07z7KO81aazvra4jTzFKQTMUbG4DDIpyp5xwSDWZoXgS9u/hlp1lql0Bqk0gvr7+0Lbzo7iRlwY54Qy71ClRtyOUHpWhpvw9XSLTS0t7uEDTNSn1FYbazWCNzJFInloobCAGTIPPTHvVaRbv0/r/MS1WnW/6/8AACP4lW17eR21lo+qLHdWtxdWuoSRQmCSOIfM+3zg5GSowQCcjoOavXPjIaZodrqF3p2oXsJs0u7u7tbZUigQrkuQ8meOSVQyMB68E+f+ANC1K2mt7KbT5mluLOa2vJLuwvI200MpJ2SzSGGQM4AIgVFPDcACum8RfCxdfsorWW/snjXTksd17pouWgKqQJYCXAiY554YnAwRjNFrb+X6/wDADTmt01/T/gnoKsHUMpyCMg+teeQeNdQtda8S6lrVprEel6VcpZw2sUdq8blvKwflYytITJnqF2kcbuK6zRYtXTUtTbUn22IeOKwhwhIRUAaQlefmYngk4CjpnFUbrwf9pttYi+3bf7T1KC/z5OfL8vyfk+9znyevGN3TjlK1/l+q/S4LbUfe+LpdP01Ly58Na0oEbTXEYSBmtowTl2Il2ngZ2ozPj+GnXHjK0TVvsFjYahqbpDHPcSWcSsttHJnYzbmBbOCdqBmwM4rO8ZeAF8XXZklubMxPbG3MV/p4uxD9795CC4EcnzcsQ2QB0xU8XhDUNP1g3ui61HaC4toLe9SSyEpk8oEK8Z3jY2CQdwcdOKFruEvL+tv+D/W8Om+Obl7XXbrWdDvbO20u7eFZAYT5igqAuFlY7vmyTgDGO/FaWseMbDRH1RbqC6kOmWcV5N5MYbckjOoCjOS2UPH061Vl8IXE9vr1lJqUf2DVnaaNFtiJreUhcnfv2suVBC7B7k1VfwPqN9/a02s67Fc3Wp2kFqWgsPKjiEUjuCqmRic7+csefbgJbK/ZfeLbm/D7/wDIvT+M/Ja2tx4f1eTUbiN5l09BB5ywqQDIxMoRQSRgFtxz93g429M1G21fS7fULFi9vcRiRCylTg9iDyD7VzXi7wDa+J9WtNU8vS5Lu2ha32atpi30DIxDZ2F0IYEcMG6Egg10ek2I0zSLWyCWsYgjCbbO38iEY/uR5O0e2T9aa213/r/gD6lyub+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISkB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/wDkYvGf/Yaj/wDTfZ10lc34X/5GLxn/ANhqP/032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/JU9C/7Aupf+j7Gukrm77/AJKnoX/YF1L/ANH2NAHSUUUUAFc38OP+SWeFP+wLZ/8AohK6Sub+HH/JLPCn/YFs/wD0QlAHSUUUUAFFFFADZZUhheWVgqIpZmPYDqa4uLxrc6l4i0mK0sNQsLG7trm4WS7gj2XSKqlHXaxI652tsbB5Fdjc26XdpNbTZ8uZGjbBwcEYNctp3g7Ure806TUNeS7g0y2ltbaJLEREoyhQztvO5wFHICqf7oqXez/rv/wB9V/X9dR+meNDeQ6PDDYXep3l/YxXsrWsUUCwxvwHZZJuBnPyq0hGO/GXN8QNMXU/I+y3v2IXo086nsT7MLnO3yvvb87vl3bdueM5qpN4EupdK0PSzqNj9l0mCGNZ200m7DxgAvFL5uItwGMbW4J5OaRfh7ILo27asG0P+1P7VFj9l/eifzPM2+dvx5e/5tuzP+1jitXy8/lf8L/5X+f3E68vn/wH+tvl95of8JxZifVt+nailnpDOl1fNGnlB1UNtUb97khhjCkZ4OKzo/HLxa/qEms2d/pGn2OlLdSW95DGWyZGG5TGzhsgAbQxOeCAa1ZPCcc+i63p012+3VbiSfzI0AaEsFxjOQcFQeevpWbd+A7rXI9SHijWY706hp4sWW1shAkYDlg4DM5JyeQSQcdAOKzXT0/G3+Y+/r+F/wDIsT+P7Sy0+7uNU0jVbGa1WKQ2csUbTSJLII1dAjsp+Y4IzuHccjPQ6ddy31jHcXFhc6fI+c290YzIvPfy2ZeevB+uDxXH2Pw4Frpt1aAeH7MzSW7ibSNCFm5EUqyYfErb87cdsZJ56V3VVpYAooopAFFFFAHN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfw4/5JZ4U/7Atn/wCiErZn1bTrXUrfT7m/tYb26BNvbSTKskwHJ2qTlse1eN6J4m1mD4e+ZZawNMTw34X066gtfJjcXrNbBsyF1LbCV2DYVOc8ngV2mgWl3P8AFTVdRn1G7TdpVk7WRSHyxuM3yZ8vfhSCR82ck5yMAOKvqD0X9eX+Z3TMFUsxAAGST2plvcQ3dtHcWssc8Eqh45Y2DK6kZBBHBBHeuIisLj/haniO4/ti88pdLtWNpsh8tgftACk+XvwCCRhgck5JGAMrwnfazoPhvwyzalJqUF5obSiyaCNFiaKFGQRlRu5zg7i2eox0pOyi5Ppb9f8AIdtbL+tv8z1ColuYHupLZJ42njVXeIOCyK2dpI6gHacHvg+lcF4B1nxXq8un32pQahLp1/ZmeaW6FksMUhClRB5LmTacsMSAngcg5BZrkepp428T3ulavLpzWWi2s+2OCOTzmU3BCtvU/JxyFw3owpyXLuKPvbHotFeY614gvbSbWdStJ7TT7n+ztJf7W1tGfLEs7q+5iMsoHYnA5xgkmtzRtbuNN8Ua5pus64l9p1hZwXhv7oRRGAyGTcjsiqm0BAwyMgHkmm4tOwr3V1/W3+Z2VFc54y1e50PTrDV7e58uyt72L7coVWEkDnYTkjI2l1bIx92uU8P+Mdb1LWtP0a5vV+2Xd2dRIESBl01oi6KVxx85WPd1OCc5qVr/AF/X9Jjeiv8A1/X+aPTqK8zE+q3Xg2z1XWdT/tFrrWLaJbaazgMMKfbQgKjZnft/iJ4IyMHmrV5PrHna7pmu6tqNtc3VndS2SQR2ptjCp4MZ8syBwpQMJDjLHbnjCekHL1/BJ/qOKu0vT8T0Kiuc8HNHp3hPQ7S91dru4urVGg+1NEsjjywSqBFUMFHsTjqTXR1co8smiIS5ophXN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJUlHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc34X/wCRi8Z/9hqP/wBN9nXSVzfhf/kYvGf/AGGo/wD032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jQB0lFFFABXN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCUAdJRRRQAUUUUAFFFFABRWD4187/hFbkQWJvtzIHiCSPhNw3MY4yHkAHJjHLAY7159o/h+6u9Bn0670xxpzeJLaWGCDTJbCEW/lxlmSBmLRpu3ZBPXdkDJFEdX935pfqD0V/U9fqhp+rwajfalaQJIsmm3C28xcABmMaSZXB5GHHXHOa8/udBbT4NVsI9Gm/wCEch12KSTT7e1Zo3tTbIXEcKj50805KqDnDcE5Fbfw70+Kxm8RNY6VcaXp9xqKSWcM8DQ5j+zxDKo3KrkEBcDGMYGMVSSd/T/L/N/cNq39ev8AXzO0oooqRBRRRQAUUUUAc38R/wDklniv/sC3n/oh66Sub+I//JLPFf8A2Bbz/wBEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHGeBdC0jUfh14MvdQ0qyuru10azME89ujyRfuU+6xGV/CuuW2gS6kuUgjWeRVR5QgDOq52gnqQNxwO2T61gfDj/klnhT/sC2f/AKISukoApz6Ppt1qUOoXOnWk17AhSG5kgVpI1PBCsRkA5OQKki0+ygFsIbOCMWqeXbhIlHkrgDanHyjAAwPSrFFAGXZ+GdB07VJNS0/RNOtb+XIkuoLSNJXycnLgZOT71dextJJJ5JLWFnuIxFMzRgmVBnCse4G5uDxyfWi1vI7xZGhWZRHI0TedA8RJU4JAYDI9GGQexNT0dLB1MXXPDFnrGlyWkccFq0rW++VYASyQyh1Q9MjggDoNx4ptx4P0SXQptGtLCDTrC4kV54LGFIVmAYEqwC4IbGD3IJ5rcqho2r2+uaaL6zSRYGkkSNpAB5gViu8YJ+U4yD3GKA6WLN1ZWt9ZSWd9bQ3NrKuySCaMOjr6FTwR7VHFpWnwXwvIbC2julhFuJ0hUOIgchN2M7Qe3SrVFAFb+zbH7Klt9it/s8biRIvKXYrhtwYDGAQ3OfXmq9h4e0XSrq5udL0iwsp7o5uJbe2SNpjnOWKgFuSTz61o0UAYtp4R0bT9Utb3T7KKzFokiwW1tEkUKNIRvk2KB85CgZ9M+praoooAK5v4cf8AJLPCn/YFs/8A0QldJXN/Dj/klnhT/sC2f/ohKAOkooooAKKKKACiiigAooooAKKKKACiiigAooooA5vwv/yMXjP/ALDUf/pvs66Sub8L/wDIxeM/+w1H/wCm+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/wAks8Kf9gWz/wDRCV0lc38OP+SWeFP+wLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigArm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iEoA6SiiigAooqtqVzJZ6Vd3UMXmyQwvIkY/jIUkD8cUm0ldjSu7Is0V5lL4m1nTfh1D4gbxFDfXWo21tL5UkEQjs/NkRWkTYATGgc8PuOQMt2ovtf8AEOmHxDpFvrbXkli2nm31Oe3iLo1xNteN1RVRsKMjABw341bi07fIlO9mj02ivPdS1bXtG07xTZJrUl3c6fbW81re3FvFvRpSwIKoqqwBXjjPPJPWoNc8SeIPCcPiG3F9LrMtrZ2lzBLNBEjxNNM8bcKEUqoUMN3vlsc1I1rt/XQ9JorzCfX/ABhpemvHerf2tvdXlnbQanqwsjNF5shWQ7bdjHgDbtLActyGxVrX9Nvptc8KW/8Awlt5LJFqk0RuIYrUSA/ZZW+cGIrvAyOFUYb7ucGqUb/16f5ibt/Xr/kei0V5vPr03hv7XrLyw2+l2/iJ4NTCW8aBonRUWV2Cg5VyhLE5xnOcDGf/AMJX4r1C50m1g/tMDVLa41KM6ZFZrOsXmgQx/wCklUwEZS3BYlhyBUrVJrr/AJX/ACH3v/Wtvz/NHrFFZ+gzalP4fspNdtxbai0Q+0xAqdr9/ulh+RP1NaFN6MAooopAc38R/wDklniv/sC3n/oh66Sub+I//JLPFf8A2Bbz/wBEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHgNhpE954Lt/tui32o3tz4Y05PDl1BbPKtrKLcbtsgGIG34YuxXIxycYr0vRvDUUnjrUNV1nT1uLyG3s1t7uaLcFcIwdoyRgNk4JHPar/w4/5JZ4U/7Atn/wCiErpKForCerOB8UWUH/Cf6ffQ6Y2r3y+RGsF1pEs0UCiQkyw3O3y4HGSxySW2KMA4NcxDYQX15cLpWjX3/CQL4nkkj1QWz7I4Fusy4nwVVNgZTHkFifunOa9lqtY6da6bFLHZReUsszzuNxOXdizHk9yScdKcXZp9v80/0KlrG39bNfqeeN4bbVJNKtdV0qWe0/4SbUJ545YW2GJluNrOOhRiV68HIHOazta8P6lFo9pZ29jt0Sz1q6MtnNpct7EICD5X+jIytJGGPCrkDg4wOPXaKX9fl/kDd3f+uv8Amcp4QspbTwK8ENxJMSZjAG06awEIJO2NYZiXRV6AE4xjHGK4qCxtLr4UeDGuLJ9QuLawUR2E2jTahbTSbVDCRUUiNsghXYjbljgjIr2CqunabaaTatb6fD5MLSvLsDEgM7Fmxk8Akk4HAzxTvv8AL8L/AOYLT8fxPJfEui6reeKL6fVY1slnggGmTp4dudUksMRjeIZIHAhYPk5K/NxyQMB+uaHqs3jbU5dUl8p5biE6XqC+G7m/mgjCJnypoXCwfOGyGXnJJ3Dgew0UJ2JaurAOlFFFIYUUUUAFc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf/AJGLxn/2Go//AE32ddJXN+F/+Ri8Z/8AYaj/APTfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfw4/5JZ4U/7Atn/6ISukrm/hx/ySzwp/2BbP/wBEJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NAHSUUUUAFc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJQB0lFFFABRRRQBnWvh3RLIXYs9HsLcXpJuhFaonnk9d+B8340tpoGjWGmjT7HSbG2sg4kFtDbIke4EMG2gYzkA59RWhVbUbmSy0y5uYLaS6khiZ1hjKhpCB0G4qPzI+tJuyuNasJdNsZ2nM9nbyG4VVmLxKfNC52hsjkDJxnpmnNY2jzSzPawtLNGIpXMYLSIM4Vj3A3NweOT61yWieNL7UtD8MXuoWT6ZLqzASJJCkglH2dpSyFJjsU7TgtubjBUZyLcPjy3l8ONrj6RqUVi5iFo7mDN75rBU2ASnbklf8AWbMZ5xg4uUWm0yU+qNKz8I+G9Ps7q0sPD+lWtteKFuYYbKNEnAzgOoXDDk9fWpH8M6DJpEelSaJpz6dGwZLNrSMwoR0ITG0H8KjtPEKz6lZ6fdadeWF5dW0tyIbgxMY1jdFIYxuy5O9SME8dcHiqLeOLN7TTn0/T7/ULrUo3lt7G3EQlMaEB3Jd1QAEjq3cYyaX9fd/wwzam0nTrizuLS40+1ltrolriF4VZJicZLKRhug6+lR6loOj6zZx2msaVY39tGQUhurZJUQgYGFYEDin6VqltrOlw39kWMMwOA67WUgkMpHYgggj1FXKVugLyIrS0t7C0itbG3itreFQkUMKBERR0AUcAe1S0UUAFFFFAHN/Ef/klniv/ALAt5/6Ieukrm/iP/wAks8V/9gW8/wDRD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBw/wAOvEWnDwT4U0dWuZbwaNZb/Js5pI4ibdGAeVVKISOcMwPI9RW7Z+MNDv8AUmsrW8ZpAXVZGt5EhkKffCSsoRyuDkKxxg56VxngXQtVuPD/AIQv7OC1sLUaRZefdw6hKZLtBbICj2/liPPYOXLADjril0X4ZXGnCDTr2BbqytUlSC/bX7xnj3o6BhZsphVsORw2OSR6UtbD0ubupfEvQ7TQbrUrD7TfiBVZEjs5wJlLBd6N5Z3pz99cr055Fai+KLU3i+YUtrP7A168l2stvLGqtglo3jG1fUswP+zjmsOHw54lm8By+HL7+yYxb2SW1rNBLI3nsmNrOCg8sELyo34znPGC/wAQeENS8V214uoPa2D3ujSWDrBK04ilZwwIJRdy8dwD2x3qnZS021/J2/GxCv18vzV/wNSDx34duLG/u1vpI4tPg+03IntZoXWHBIkCOgZkODhlBBxwat6P4n0rXppodMnkaSFQ7JNbyQkoc4dQ6jchwcMuVOOtcpe+DNf12HVrrVzplrf3OitpVtFazSSRcncZHcopGTj5QpwB1Oa6qLSZ08XHVC8fkHT1tdoJ3bg5bOMYxg+tPTT+u/56fePW39eX/B+4z/FnjNPDN1p1rDYvf3F5cxRyIkgQW8TyLH5rHB43OAB1Jz6Ejoru6gsbOa6u5VhggQySSOcBFAySfwrifE/w7u9Wuru90vxHqFrPeXdrNLC4tzEqwyIwCloGcYCllXdt3HngmtfVvD2o+Ire803VdRNrp4lgktJrHb9ofYAWEwkRoyC4BwFwR1qfs+d/8itLmSnxAvLrwVq3iCPSTYjSrvbLb3TFne2XY7PgY2MY33BTnB4NdyjrJGrocqwyD6ivM9a8O6j4e8C+MIr3WbjVJdclMNms6xAl5USFSfLiT5ix5AyMKCMHOfSLWH7PZwwk5Mcapn1wMVWltPL77akq/Xz+6+hLRRRUjCiiigArm/hx/wAks8Kf9gWz/wDRCV0lc38OP+SWeFP+wLZ/+iEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C//IxeM/8AsNR/+m+zrpK5vwv/AMjF4z/7DUf/AKb7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/ACSzwp/2BbP/ANEJXSVzfw4/5JZ4U/7Atn/6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACubvv+Sp6F/2BdS/9H2NdJXN33/JU9C/7Aupf+j7GgDpKKKKACuJ8OW3jfw/4V0rRv7E8P3H9nWUNp539tzp5nloE3bfshxnGcZNdtXG6J4j8Y69oGn6vZ+G9DS31C1juoll12YOquoYBgLQjODzgmgC99u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHTJbrxtLC8beHtAAdSpxr03f/tzp/27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0mrqzDY5LTfDnxFs9P0C2ubPwxP/YMpNsyalcJvj8hoVVwbc5Yb8lhgHGNo61FZ+GviVax6rKNM8Dfa9TCLJGktytmwBO5ng8ol5GBwW3jgLwcc9l9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdU227sNji7Twn8RtMh0x9Ig8M295Zxzws76hO8PlTOrskcf2ceWFKqEG5goGCGqpe/Drxdd6boscmh+D7680iCS3STVruS7glV2DEtD9mXDZUYKsMZPGDiu/wDt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6G7/1/XcChokfjbSNFtrBfDPhKLyVxssNUmtoRzn5I/srbRz0yav/AG7xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh0m76iSsrB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAw+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDoAzfEdt438QeFdV0b+xPD9v8A2jZTWnnf23O/l+YhTdt+yDOM5xkVpfbvG/8A0L3h/wD8H0//AMh1R1vxH4x0HQNQ1e88N6G9vp9rJdSrFrsxdlRSxCg2gGcDjJFXvt3jf/oXvD//AIPp/wD5DoAPt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AD7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgA+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoAPt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AD7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgA+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoAPt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AM3w5beN/D/hXStG/sTw/cf2dZQ2nnf23OnmeWgTdt+yHGcZxk1pfbvG//QveH/8AwfT/APyHVHRPEfjHXtA0/V7Pw3oaW+oWsd1EsuuzB1V1DAMBaEZwecE1e+3eN/8AoXvD/wD4Pp//AJDoAPt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6AD7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOgA+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDoAPt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5Do+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6AD7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6Pt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOgA+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOj7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDoAPt3jf8A6F7w/wD+D6f/AOQ6zfDlt438P+FdK0b+xPD9x/Z1lDaed/bc6eZ5aBN237IcZxnGTWl9u8b/APQveH//AAfT/wDyHVHRPEfjHXtA0/V7Pw3oaW+oWsd1EsuuzB1V1DAMBaEZwecE0AXvt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AD7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgA+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoAPt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AD7d43/6F7w//AOD6f/5Do+3eN/8AoXvD/wD4Pp//AJDo+3eN/wDoXvD/AP4Pp/8A5Do+3eN/+he8P/8Ag+n/APkOgA+3eN/+he8P/wDg+n/+Q6Pt3jf/AKF7w/8A+D6f/wCQ6Pt3jf8A6F7w/wD+D6f/AOQ6Pt3jf/oXvD//AIPp/wD5DoAPt3jf/oXvD/8A4Pp//kOj7d43/wChe8P/APg+n/8AkOj7d43/AOhe8P8A/g+n/wDkOj7d43/6F7w//wCD6f8A+Q6AM3S7bxvpuo6zdf2J4fl/tS9W72/23OPKxbww7c/ZOf8AU7s8fex2ydL7d43/AOhe8P8A/g+n/wDkOqNh4j8Y6je6naweG9DV9NultZi+uzAMxhjmyuLTkbZVHOOQfqb327xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAB9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIdAGb4ctvG/h/wAK6Vo39ieH7j+zrKG087+2508zy0Cbtv2Q4zjOMmtL7d43/wChe8P/APg+n/8AkOqOieI/GOvaBp+r2fhvQ0t9QtY7qJZddmDqrqGAYC0Izg84Jq99u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHR9u8b/APQveH//AAfT/wDyHQAfbvG//QveH/8AwfT/APyHUVjY+I7zxpZ6vrljpdjb2en3Nqq2eoSXLyNNJbsCQ0EYAAgPc/eFS/bvG/8A0L3h/wD8H0//AMh0afr2uf8ACVW2ja9pGn2n2qynu4prLUnuf9U8KFWVoI8Z88EEE9DQB0lFFFABXnfgG88Yr8NvDS2ehaHLbjSbURSS61MjsvkrgsotWCkjqATj1PWvRK5v4cf8ks8Kf9gWz/8ARCUAH27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh10lFAHN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHXSUUAc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIddJRQBzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh10lFAHN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHXSUUAc39u8b/9C94f/wDB9P8A/IdH27xv/wBC94f/APB9P/8AIddJRQBzf27xv/0L3h//AMH0/wD8h0fbvG//AEL3h/8A8H0//wAh10lFAHN/bvG//QveH/8AwfT/APyHR9u8b/8AQveH/wDwfT//ACHXSUUAed+Przxi3w28SreaFocVudJuhLJFrUzuq+S2Sqm1UMQOgJGfUda6D7d43/6F7w//AOD6f/5Do+I//JLPFf8A2Bbz/wBEPXSUAc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IddJRQBzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h10lFAHN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHXSUUAc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IddJRQBzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h10lFAHN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHXSUUAc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IddJRQB534BvPGK/Dbw0tnoWhy240m1EUkutTI7L5K4LKLVgpI6gE49T1roPt3jf/oXvD//AIPp/wD5Do+HH/JLPCn/AGBbP/0QldJQBzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIddJRQBzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIddJRQBzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIddJRQBzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIddJRQBzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIddJRQBzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIddJRQBzf27xv/ANC94f8A/B9P/wDIdc/4BvPGK/Dbw0tnoWhy240m1EUkutTI7L5K4LKLVgpI6gE49T1r0Sub+HH/ACSzwp/2BbP/ANEJQAfbvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHN/bvG//AEL3h/8A8H0//wAh0fbvG/8A0L3h/wD8H0//AMh10lFAHnfhy88YjXvFhg0LQ3dtWjMyvrUyhG+w2vCkWp3DbtOSBySMcZPQfbvG/wD0L3h//wAH0/8A8h0eF/8AkYvGf/Yaj/8ATfZ10lAHN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h10lFAHN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h10lFAHN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h10lFAHN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h10lFAHN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h10lFAHN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h10lFAHN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h10lFAHnfgG88Yr8NvDS2ehaHLbjSbURSS61MjsvkrgsotWCkjqATj1PWug+3eN/wDoXvD/AP4Pp/8A5Do+HH/JLPCn/YFs/wD0QldJQBzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIddJRQBzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIddJRQBzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIddJRQBzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIddJRQBzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIddJRQBzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIddJRQBzf27xv/wBC94f/APB9P/8AIdH27xv/ANC94f8A/B9P/wDIddJRQBzf27xv/wBC94f/APB9P/8AIdZttPrk3xT0j+3tO0+yxouoeV9iv3ud/wC/ss7t0Me3HGMZzk9Mc9tXN33/ACVPQv8AsC6l/wCj7GgDpKKKKACub+HH/JLPCn/YFs//AEQldJXN/Dj/AJJZ4U/7Atn/AOiEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8ks8V/wDYFvP/AEQ9dJXN/Ef/AJJZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISukoAKKKKACiiigAooooAKKKKACiiigAooooAK5v4cf8AJLPCn/YFs/8A0QldJXN/Dj/klnhT/sC2f/ohKAOkooooAKKzvEOrf2D4Z1LV/J+0fYbWS48rft37FLYzg4zjrg1mXPj3QLC4+zX93JFcJDHNOiW0si26OMqzuqFUXg/MxAGOSKNw2V/6/rU6Siuct/GdpP42vfDhtbxHtYIphc/ZZvKbdvJy+zYoAQYYthiSBypp1t468PXcVzLDfP5VvbvdGSS1lRZYU+9JEzKBKo45TcOR6igN3Y6GiucXx5oL2cN1FJfSx3DFYFi0u5d5gACXRBGWdMMPnUFeRzUJ8dWv/CUalogs7tZLG0S5E8lpcLExYOxDP5RVAAg+bJySQASpFD03Dc6miuVtfHNvN4hsdHksrjzrywS7E0FtcSwgtjC+Z5QG3n77bcdCATipI/HWkw6LZX+qTCM3UPnkWcU9ykcfPzswiBROPvOqgc07f1/XoJO+x01FYVjrs93441HR9sJtLawtrqKRQdzNK0oOTnBGI1xx3NbtDVhhRRRSA5vwv/yMXjP/ALDUf/pvs66Sub8L/wDIxeM/+w1H/wCm+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/wAks8Kf9gWz/wDRCV0lc38OP+SWeFP+wLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigArm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4cf8AJLPCn/YFs/8A0QldJXN/Dj/klnhT/sC2f/ohK6SgAooooAKKKKACiiigAooooAKKKKACiiigArm/hx/ySzwp/wBgWz/9EJXSVzfw4/5JZ4U/7Atn/wCiEoA6SiiigDJ8VaXPrnhDV9KtGjSe9s5YI2lJChmQgEkAnHPoaxL7wjf3Ok+JrWOa2D6tpsdpAWZsK6xMhLfLwMsOmeO1djRQNNpp9v6/Q5Sbw5qLeIr2Rfsr6fqemR2Ny5nZJoCglwyLsIcHzO7LjHeuc034c6la6PPp1xbQSSx6XNY2t/J4gvbgZaPYD9mkUpEDxnaxxjAzXp1FD1v5/wDB/wAxR91prp/wP8kcr4j0HUr7TNPt9Ms7N7m3j2revqMtpJatgDdH5cbFxxypKg4AOQeGTeHtaXXL2eN7O6g1LSo7K4mllaKSOSMS4YIEYMGMnPzLjHeutooeqafUFpa3Q5W00DVtO1bRbm3Wznig0tdPvA87oyYKnfHhDv5UjB2/XtXPXvgLxHL4ZsdHjvIZIYtN+yOianc2iQy4YGX90oMwIIGxyoG3vmvS6KJe9v8A1v8A5sIe4tPL8P8AhjmtD8OXemeJ7jUZ5IWhl0qzslVGJYPCZSx5GMHeMc568Culoopyk5O7ElYKKKKQzm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/ySzwp/2BbP/wBEJXSVzfw4/wCSWeFP+wLZ/wDohK6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5u+/5KnoX/YF1L/0fY10lc3ff8lT0L/sC6l/6PsaAOkooooAK5v4cf8AJLPCn/YFs/8A0QldJXN/Dj/klnhT/sC2f/ohKAOkooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPXSVzfxH/AOSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/ySzwp/2BbP/wBEJXSVzfw4/wCSWeFP+wLZ/wDohK6SgAooooAKKKKACiiigAooooAKKKKACiiigArm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iEoA6SiiigArkdc1nxEvie603Q30yGC001L15LyCSVnYvINgCuoAIT73b0bPHXVTfSrKS/nvXhzcXFuLaR97fNGCxC4zgcs3PXmk79Clbr/Wq/Q4G/8AiVqM15b2+kWpif8Asq31GRf7Ju7/AMwyhisQMA/d/dPztnrwpwauXvizxNLHq13p1vp1nb6XYQXz29/DIZnLRs7wkh1EZG3G4g4PVTXQXPgvRLmO1UQ3VsbSBbaKSyv57aQRL91C8TqzKPRieeazpvh9puo+ItRvdYia4t7iG3hjQXcymRI1YFZgGAkUk5w+4HnNVKzvy/1/WhEbq3N8/wAP+D9/3Yc2ra0fFGta1of2GBF0GyvJY72J5Gcf6Q3ljay7SeRuOcf3TW7a67rmr+LWsrI2FtpsOn2t5MZYXkmfzTJlFIdQvCD5sHHoc8b0mhadLNeSvbDffWy2twQ7DfEu7auAeMb25GDz7Cn2mj2NjdyXNrBsmkgit2bexzHHu2LgnHG9uepzzTk072+X4/8AADW39eX/AATz/wAO33iC+17wo9tqcMFlc6LLcT2s0c9wXIli3fO8+S3zYVm3bRu+9nizH4k1iz8N6Vc2zQ2VlK1w13qF1b3GoLAVlIVWHmh1Ujcd7MVXbjAGMdWvhLRo/wCzPJt5oTpS7LRobqWMomQSjFWBdSVXKtkHAyKjufBmi3dnBZyxXa2sG8C3i1C4jicM25hIiuBICSeHBGCR04outPn+bG/ibNxGDorKQwIyCOhpaRVCKFUBVUYAA6ClqQQUUUUAc34X/wCRi8Z/9hqP/wBN9nXSVzfhf/kYvGf/AGGo/wD032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jQB0lFFFABXz14NvtRHhfQzbya3bXBuNNtbfUpNSf+z4kNtbkwtAJCMsCwGYsbnHzA19C1wvgLwzpF58HtCtLmz3wahpllcXC+Y4LyCCLDAg5UjYvTHSnHSV/63X6XFK7Vl/Wj/UqT/EHVX8T31tp9jJNa2F+tk1tHo93M8/3d8guUHlR43E7WByF5K54tQeKvEX2g3twNMOl/222liCOGTz2XzjEsnmF9oIOMrtOeuR0roZ/CWkzasdSC3lvcs6ySG01C4t0mZcAGRI3VXOAB8wOQMHirH/CPaX9m+z/Zf3X2z7dt8xv9fv8AM39f73OOntiiOlr/AD/C/wCv3jlqnb5fc/8AgfccxP41vIfGlrYJJbXNjcXpsmSCwuW8tsN8xu/9TuBXBixkc/McVY8C3K2Xw1F07xRrDJeSFp32IuJ5DlmwcD1OK1f+EN0MasupfZZfPWf7Si/apfKSXnLrFu2KxyckKM5Oc1dttD0200Z9JhtV+wyCQPA5LqwckuDuJyCWP50vs26g7c9+hwq/EHVotO8RMy21zPp+mG/tZDpl1Zxk5YbCJTmVflH7xCAc9BWpL4q1nQl1f/hIEsLtrPSzqUX2KN4gBlgYm3M27lR8425z90Vqw+BtAht7yH7LPMt7bG1na4vZ5neLn5NzuWAGTjBGO1aU+jafc3Es9zapK81t9kkDksrxZJ2FTwRye1PSy/rvb9AW/wDXl/wfvOV0wa2Piba/2/NYTM2jTNG1lC8QGZosqVZmzjj5gRn0FXda8U3unW/i2SCK3Y6LYrc2+9WO9jG7YfB5GVHTFaOk+EdG0W/+26fbSi68kwCaa6lmYRkg7Mux+UEDA6DtjJpmteC9B8Q3Lz6vZyTNLD5EqrcyxpMnOA6IwV8ZONwOCcjFGlkvX82xQVpcz8vySM9NX12/8TajaQvp8GmWNtDLJuhkaaUyIxKqwdQmMD5sH0x3rK0nXvEd9YaDZ6K+nW/2jQU1Caa/We5YP8o2jMoZgcnlnJHX5q7aHSrKC4uZ4odsl0iJM29juVQQo68YBPSobLw/pmnfZvsdt5f2W0FlD+8Y7YRjC8nnoOTz70u9v60f6tAr2V9/+Cv0ucZqfxDvl8L6dqtgbSGafTU1CWz+w3N9IQVJ2nyceUhwQJXyOvy8Vqxa74g1bxRLZaQ2m2tlDp1teM1zbySyO0vmfINsigD5B83Pfg54vT+A/DtxZ21q9lKkFvbC0WOK7mjDwgYEcm1x5ijJwH3dT61q2mj2NjePdWsHlzSQRW7NvY5jj3bFwTjje3PU55qnZ3/D8f8AgDfl/W3/AATmPC3ja68TahpttFBBGwsZJtVXkm3mWTyhGvPGXSXrnhK7Suc8K+GP7Cv9ev547dLrWNQa5f7OSQEACoCSBzgbj2yx610dJ6pf1/Vtg6v+v67hRRRSA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/YFs//AEQldJXN/Dj/AJJZ4U/7Atn/AOiErpKACiiigAooooAKKKKACiiigAooooAKKKKACub+HH/JLPCn/YFs/wD0QldJXN/Dj/klnhT/ALAtn/6ISgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/8AIxeM/wDsNR/+m+zrpK5vwv8A8jF4z/7DUf8A6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/YFs/wD0QldJXN/Dj/klnhT/ALAtn/6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACubvv+Sp6F/wBgXUv/AEfY10lc3ff8lT0L/sC6l/6PsaAOkooooAK4zwjq8GifB3wld3aSPG2m6bbgRAE7pUijU8kcZYZ9vWuzrwDwpo0dx8PPDn2nw9fXPiDzNMnj1COzdlFoHhZf34G3YqDmPOQQTt/ipxV5JP8ArVD6XPeLa7jummESzKYZDE3mwPHkgA5XcBuHP3lyPfip68z1vSYptK1IatbXJX+3ZbiCB9Gn1CC5/dgDzYY1JZOSQcgBgDnIrI1nTJ7uadte8KXT+foUEeiWtnaNNHp90A+5VKDEDAmPEh2gAYzxS+yn6flcEru3r+dv+Cex1RvdWgsdS06ymSQyahI8cRUDapVC53c+inpnmuO0jwtJP4wkvvEFgt3f2mjWCQ3dxFvQXK+dvZCRjeCRyOQD71jeHNHji1zwrLD4evrXWLbzRrN9JZvGrzG3YFnkPEpLnhxuAHGRnBpqza7f1/XyIu+W/oesUV434R0LU7bWbZtWf7PrMZnN88Phu6WS9JR/lkvt7RSLyrDgYKqAF6VcXwhpGm/C3QI7jSnt7sxQS3MB0Oa/FzMISNt1DGpZgNxxuI2kLg8YpW0v6fjf/IrrY9YorP8AD5lPhzT/AD9Pj0yT7Om6yjAC2/yj5ABwAOmK0KGrOwlsFFFFIYUUUUAFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/+Ri8Z/8AYaj/APTfZ10lc34X/wCRi8Z/9hqP/wBN9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/JU9C/7Aupf+j7Gukrm77/kqehf9gXUv/R9jQB0lFFFABXN/Dj/AJJZ4U/7Atn/AOiErpK878A+CtLuvht4auJbrXFebSbV2EWv30aAmFSdqLMFUegAAHQCgD0Siub/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH6AOkorm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+gDpKK5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfoA6Siub/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH6AOkorm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+gDpKK5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfoA6Siub/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH6AOkorm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+gA+I//JLPFf8A2Bbz/wBEPXSV534+8FaXa/DbxLcRXWuM8Ok3TqJdfvpEJELEbkaYqw9QQQehFdB/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AdJRXN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P0AHw4/5JZ4U/7Atn/6ISukrzvwD4K0u6+G3hq4lutcV5tJtXYRa/fRoCYVJ2oswVR6AAAdAK6D/hA9I/5/PEH/AIUeof8Ax+gDpKK5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6AOkorm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gDpKK5v/hA9I/5/PEH/hR6h/8AH6P+ED0j/n88Qf8AhR6h/wDH6AOkorm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gDpK5v4cf8ks8Kf9gWz/8ARCUf8IHpH/P54g/8KPUP/j9c/wCAfBWl3Xw28NXEt1rivNpNq7CLX76NATCpO1FmCqPQAADoBQB6JRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AHhf8A5GLxn/2Go/8A032ddJXnfhzwVpc2veLEe61wCHVo0Upr98pI+w2rfMRMCxyx5bJxgZwAB0H/AAgekf8AP54g/wDCj1D/AOP0AdJRXN/8IHpH/P54g/8ACj1D/wCP0f8ACB6R/wA/niD/AMKPUP8A4/QB0lFc3/wgekf8/niD/wAKPUP/AI/R/wAIHpH/AD+eIP8Awo9Q/wDj9AHSUVzf/CB6R/z+eIP/AAo9Q/8Aj9H/AAgekf8AP54g/wDCj1D/AOP0AdJRXN/8IHpH/P54g/8ACj1D/wCP0f8ACB6R/wA/niD/AMKPUP8A4/QB0lFc3/wgekf8/niD/wAKPUP/AI/R/wAIHpH/AD+eIP8Awo9Q/wDj9AHSUVzf/CB6R/z+eIP/AAo9Q/8Aj9H/AAgekf8AP54g/wDCj1D/AOP0AdJRXN/8IHpH/P54g/8ACj1D/wCP0f8ACB6R/wA/niD/AMKPUP8A4/QAfDj/AJJZ4U/7Atn/AOiErpK878A+CtLuvht4auJbrXFebSbV2EWv30aAmFSdqLMFUegAAHQCug/4QPSP+fzxB/4Ueof/AB+gDpKK5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfoA6Siub/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH6AOkorm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+gDpKK5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfoA6Siub/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH6AOkorm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+gDpKK5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfoA6Subvv+Sp6F/2BdS/9H2NH/CB6R/z+eIP/AAo9Q/8Aj9ZttoNponxT0j7FNqEvnaLqG77bqVxd4xPZY2+c7bevOMZ4z0FAHbUUUUAFc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/wDklniv/sC3n/oh66Sub+I//JLPFf8A2Bbz/wBEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/AJJZ4U/7Atn/AOiErpK5v4cf8ks8Kf8AYFs//RCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf8A5GLxn/2Go/8A032ddJXN+F/+Ri8Z/wDYaj/9N9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jQB0lFFFABXivw905734VSat/bWrWd5p9lALaWPUZvJhVLGFgPILeURknIK969qrznwF4E8P3nw78O3d3bXMxutKs5bi3e/nNtK/wBnjXLQb/KPAHVewpd/T/IO3r/mO0zxNrV9b3d9Z2Pm6i2h6ddiAvKyq8pk3nyi4X5QucKFZsYJ6YsJ4u1a9n0fSNJvtNn1LUFuJZb2bTZoYoFhK5Q2zS+YHy6jBcY5OO1dTdeHdOu5LqV0nhlu4o4ZpbW6lgcpGWKANGylcFm+6RnODkVSm8D6BPY29q9rOBbyNLFOl7MlwrtwzeeHEhLDgktyOtXJpybS0EtEl/Wxz1h4y8Q+IF0SDSo9Nsri9N6l3LcwyTJG1tIIy0aq6FgxzwSOCOeMGp4o1PW9X01rhH09NJt9etbQwmF/PYx3kamTfu24LAjZt6c7u1d1aeHtKsXsWs7NIDYRPFbBCQI1cgsMZwclQcnJ/M1TuvBPh+91Jr65sXeVpkuCguZRF5qMGWTyg2zflR82MnoTiiLSmn2/z/yKvp/Xn/wDmJ/iDqr+J7620+xkmtbC/Wya2j0e7mef7u+QXKDyo8bidrA5C8lc8aVlrniq9stc1CCHTp4rO4ubayso4H82Vo5CodnMmOgPyhef7wzitmfwlpM+rtqYW8t7p3WSQ2moT26SsuMF0jdVc4AHzA5AweKtDQ7FNNubGFZoIbqV5pTBcyROXdtzEOrBlySehFT9nzt/l/wfvD/P8Nf+AUNB1x7rw3PfXt7DfTWxfzvIsJLNoyq7tjQyuzq2PU85HFc/oXjHX7+40Br5NNFt4ls5LizWCJ99kyoHUSEuRKCDyVCYIx3zXY6Votjo1m9tYROEkcvI00zzSSsRgs7uSzHAAySeABVHR/Bmg6DefatLsmilVGji3zySLAjHJWJXYrEpOMhAAcD0p6Xf9f10+4nWxh/DPS7q28J3F7NJpzahqE00j3UNi0bOwkcAykyMZMHpyuBx71gWsniWfwz4Vmu9Ssr29k1xhBJJbyIEAW4B35kYv04A28AD3r07T9PttLsktLGLyoELFU3FsZJY8kk9Saz7Xwno9m6Nb28wEd2byNHupXSKUhgSisxVB87fKoC85xS6/d+ALRfJ/ijlNR8f6ppdilncxQSao2rtpn2m2sJ54vlh83zRbxlpD8vGwMeed2K6fwlrN7rekSTalaywTQztD5j2U1oLhRgiRYpfnUHOMHPIPJ61NdeFdHvYbiKe0b/SLn7W7pNIkizbQu9HVgyNtAGVI/U1c0zTINJsxa2sl1JGGLbru7luXyf9uVmbHtnFNba+X36f8ENf6+f/AAPuLdFFFIYUUUUAc38R/wDklniv/sC3n/oh66Sub+I//JLPFf8A2Bbz/wBEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/AJJZ4U/7Atn/AOiErpK5v4cf8ks8Kf8AYFs//RCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf8A5GLxn/2Go/8A032ddJXN+F/+Ri8Z/wDYaj/9N9nXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jQB0lFFFABXN/Dj/klnhT/sC2f/AKISukrxDwN4TuZPgjc3+kaeY/EF1p8S2l06YlMZtoRiNiQVDAH7pAJ755o/y/y/zDt6/wCZ7fRXizaYln4I8TyQKYoHso0fT7Pw5daShcP98GZyHkIOCykHgZPQ1cvdDS9h8SjwzoWoadpVzpsUMtubOS2NxdeaSzrGQGZgnBkGd3GCcZp9RXsn/X9f8A9dorzbxP4c0zTtf0iG68ONeeFI7S4V7Gy09riNbpmQrI8MaksSA4DkHBOSRnNUbPRp7fTfDkfjrRr7VbaKwljSH7O14YLgyAx7wu4q4j+USHhSD8wzyun9ef8Al+KHt/X9fP0Z6Vo+qQ61pMGo2qyJDOpZVkADDkjnBPpV2vMdAiuvDkHhS9vdJ1MQw6Vc2bwxWsk8sMjSRsiuqhiMhCNx+XPU85qjb6UVh8Nv4t0DUL3SU02aP7ELF7n7PdmUFWeNAxDbchXxhefmGcl9V8/1/wAvxQf1+X9fI9QOrWf267sxIzXNnCk80SRMzKjbtpGB8xOxuBk8dORVi3nS6top4xIqSoHUSxtGwBGeVYAqfYgEV5zNoGnW3jbVbz/hHJFur7RYlsrr+z2mdZVSYSK0yq219pjUlmBbgAtWbfaJrEM2n6NY6Zcmx8UafawalKsJC2jQhRKZD/CXhygz3UCmkm7en6/5Cbt/Xp/meuVWu9RtbGW1jupfLa7m8iAbSd77S2OBxwpOTxxXlF5oOof8J5fSaiRbTtqUb6dep4cur2WO3Gzakd1E+yFeGVlZQOWJyDXWfEXRdO1FdDvNV0RdWt7HUQ06iwN26RNG6nEaqzMN2zIAPQE9OJWqT72/Qrq12v8Ar/XmdpRXntt4ehhuvGOtJ4fN1qLTsLDejQyPH9liXbE/BQE7gSuDkY6jjmLLSdbOm+J4tFsXtra4tbN0jsdHn0tZiJn89VjlcsZTGMFvlLfL7Eu35J/eI9gu9RtbGW1jupfLa7m8iAbSd77S2OBxwpOTxxVmvLNW0Dwtd6bpF3Y+DJhpVnqivNby6JJkRtEysUtihcLv2bsIMkbucZrqfHKl/DMMUOmLeW0kyrKj2ktykMe0/M1tHh5lzgeX75PSk9F8/wDIdtVbt/mdVRXk2k+Gp9R0rw7p+s6S8tjDrt07W5sZLeFIDDNs/dMzbIiWACsSOQvtVqbRUtNPtrTU9Eubnw7aazdeZp8dm86CEhvJxAoJeIMeAqkDg4wMh2/r7v8AMX9fn/kb3jTVYNV+FPjRrdZFFtp1/bPvAGWSFwSME8V2NeYSWP2D4H+OIl0+50+FrfVJIILlSriNo3KnBJ4I6c8dOMYr0+l0XovyDq/V/mFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeOeAtd1HUvhtp902sahpGm6VZ2ljHHpWmi8mldbaNmeQGKU7ctgBVGAMluePY6838D+DIbj4e+H77TNX1LRpr7RbL7YLFoitwRbooZlljcBsADcu0kAZPApDNFfiLbW2m3Esi/bhFpEWpWlxGpiGoq+VwqMMod+0YOfvj6U6+8c6pZXGqsfD8TWWjmL7bOb/AA+HjRz5aeX8xXd3KggcHJwIdV8A20+seDbWys3Gm6FuLzGUf6tFXy4mGdz5dUfoQPL55xXQXnhSxvrbW4ZZbgLrRU3BVlymI1QbOOOFHXPNW+W9/X89PwJ6f1/X/DnNaz8WdM0jxDe6ez6b5enSpFdC41NIblmZVb9zAVJlADDPzL3AyRitq08VXmo61ew6fpKy6Xp90bS5vGugkgkChmKxbcMi7gCS4PXCmppfCYXWLjUNK1nUdJa7kWW7htRA0dw6qFDMJYnIO1QDtK5x680sXhKC31241C11LULeG6mFxcWEciCCWXAG8/LvGQBlQwU45B5qen9b6fhv+A3/AF/XfYydI+IMuo3Wjvc6QLbTNeZ10y5FzvkfajOPMj2DZuVSRhm98VBYePde1CHSpIvCsCjWY3ay3aoOCo3Ey/u/kUjJBXefVRWnpHgDTdHvLSWO8vri308udPs7iRDFZbwQ2zChjwSBvZsA4GKvWHhWy0+HRY4Zbhl0ZGS33sp3Bl2ndxzx6Yp6dAMq58dtD4Vt9X+zafatJLJBN/aeqLa28MkblGXzSpLZZTtwnOOcVGPiAbq30GXTrOzVNYhEqy6hf/Z4wcgeWjrG4kk6kLxkDOavN4Gs0S1NjqN/ZXFrNcSx3MJiL4nkMkifOjLgnHIG4ADB65bL4Fgk0O10VdY1OPSoYvJltAYSLlc5+d2jL57ZVl/PmjS/zB7aGLeeJ/ElsfG8l3Dbx2OkqWtpbW8Hnx/uEdQFe3K85LEtu2k4wwGa0Na8fR6B4gs9NvEsNk8sMA83U41u5DIwUPHbhSWUM3JJU8EgECr+oeC7XUJtXLahfQ2+sW/k3drEY/LJ2BBICyFgwUAfe28fdzUV74Dsr3UJZ/7S1GGCe6hvJrOJoxFJNEUKuSUL/wDLNQV3bfbPNONrxv8AMb12OooooqRBRRRQBzfhf/kYvGf/AGGo/wD032ddJXN+F/8AkYvGf/Yaj/8ATfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfw4/5JZ4U/7Atn/wCiErpK5v4cf8ks8Kf9gWz/APRCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/5KnoX/YF1L/0fY0AdJRRRQAVzfw4/wCSWeFP+wLZ/wDohK6SvNvAXxB8M2Xw68N2l1qLRyW+mWlvM5tpfKil+zoQjSbdiscjAJ+bOBmgD0DUNPttUsJbK/i823lADpuK55z1BB7VZrDi8Y6JNpMmoJcT+VFN5DxNZzLOJMZ2eSU8wsQcgbckcjimTeOPD9vpdpfy3kghvJmt4FFrK0jSqGJj8sLvDjY3ykA5GMZ4oA36K57T/Hfh3VLyC1sb6SSWdzGubWZVWQZzEzMoCSDB/dsQ3HSopviJ4Xgu5bebUXRoZ2tnc2k3lrMpIMXmbNu844XOW4wDkUAdNRWLH4u0aTR21NLibyFlMJjNpKJ/MH/LPySvmb++3bnHaoZvHXh+Cxs7t7yYpeyPDbxpZzPK8iZ3J5QQuHGDlSoPB4oA6CishfFWjtYtd/a2ES3i2LBoZA4nLBQhQruByw7Ywc9Oaq+JPGFt4a1TSLO5s7y4/tKZ4t9taTTeWFjZs4jRsnKgbeDgluimnZsDoaK59vF9jaQ3MuosFEd81nDHZxzXMsrBQ2PLWPduxkkKGAAzu64sL4o0x9St7BPtj3M6I+xdPnPlBhlfNITERODxIVPFILmxRWbH4h0ua3gnjusx3F21nE3lt80ysylenHKMMnjjrVe28X6Jeax/Zlvdu9x5jRK/2eQQvIud0azFfLZxg5UMSMHjg0AbVFFFABRRRQBzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP8AklnhT/sC2f8A6ISukrm/hx/ySzwp/wBgWz/9EJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/wDkYvGf/Yaj/wDTfZ10lc34X/5GLxn/ANhqP/032ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/JU9C/7Aupf+j7Gukrm77/AJKnoX/YF1L/ANH2NAHSUUUUAFeW+AfCl9N8HfD8Ky24aeTTdSUlmwIkWByDx97CHjp05r1Kub+HH/JLPCn/AGBbP/0QlNO0uZf1qn+gnqrf1s1+pQ1XwxrctxrE+mXUSi+vopzAt3JbGaJYFjaMzIpeI7hu3ICcDHGTiDQvBWpaaukG4mgJs9XuL+UfaZZ22SRSIFEkgLOwLjJY8gE+1d1RQtNv6/qxUve3/r+rnJR+Fb5LCKAy2+5NefUydzY8ozM+On3sEcdM96I/Ct8lhFAZbfcmvPqZO5seUZmfHT72COOme9dbRSWm39bf5IUvevfr/wAH/NnF3/hfXCmsNpt1EpvtUW7MK3clsZofISMxmZFLxHcm7KAnAAzycR+HPBeo6TPpkl3LA32W+u7lx9plnbbMuFAeQbnIzyWP+FdxRR/lb8v8glrv/W/+Z5z/AGGbj43TC3uFOnRQxatd2wByLva0EZJ6YKAnHqgNdP4m0vUb250e+0dLWW40y8M/kXUzRJIrRPGRvVHII35+6c4xx1rfopp2SXb+v+B6A9W3/X9dfmcXfeF9RNhfRw2FhfzXOqSXkTSalNZtbhkChkljjZg/BHGOCee1NTw34hGq6VOZLVZ7aOFb3Vo72VZbsL99HthH5bA8gMzkrkkY6V21FJaW8rfhp/XcVt/n+Opwtv4V8QQXdnZhtNGlWesSais3myGeVXeR9hTYFUgyHnc2QOi1V8P/AA+u9E1i2Se3S+sra7kuYbp9fvFKFmZgfsZUw5G7GdwB64B4r0Sihaf1/XYb1/r1/wAwooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPXSVzfxH/AOSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/ySzwp/2BbP/wBEJXSVzfw4/wCSWeFP+wLZ/wDohK6SgAooooAKKKKACiiigAooooAKKKKACiiigArm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C//ACMXjP8A7DUf/pvs66Sub8L/APIxeM/+w1H/AOm+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf8AYF1L/wBH2NdJXN33/JU9C/7Aupf+j7GgDpKKKKACub+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/iP8A8ks8V/8AYFvP/RD10lc38R/+SWeK/wDsC3n/AKIeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/YFs/wD0QldJXN/Dj/klnhT/ALAtn/6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAK5v4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/APIxeM/+w1H/AOm+zrpK5vwv/wAjF4z/AOw1H/6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/YFs//AEQldJXN/Dj/AJJZ4U/7Atn/AOiErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigArm/hx/wAks8Kf9gWz/wDRCV0lc38OP+SWeFP+wLZ/+iEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/YFs//AEQldJXN/Dj/AJJZ4U/7Atn/AOiErpKACiiigAooooAKKKKACiiigAooooAKKKKACub+HH/JLPCn/YFs/wD0QldJXN/Dj/klnhT/ALAtn/6ISgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/8AIxeM/wDsNR/+m+zrpK5vwv8A8jF4z/7DUf8A6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/YFs/wD0QldJXN/Dj/klnhT/ALAtn/6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACubvv+Sp6F/wBgXUv/AEfY10lc3ff8lT0L/sC6l/6PsaAOkooooAK878A+I9Ug+G3hqKLwXrlykek2qrNFNYhJAIVAZd1yGweoyAfUCvRK5v4cf8ks8Kf9gWz/APRCUAH/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVdJRQBzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVdJRQBzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAed+PvEeqT/AA28SxS+C9ctkk0m6VppZrEpGDCwLNtuS2B1OAT6A10H/CUav/0IniD/AL/6f/8AJVHxH/5JZ4r/AOwLef8Aoh66SgDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqukooA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqukooA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAPO/APiPVIPht4aii8F65cpHpNqqzRTWISQCFQGXdchsHqMgH1AroP8AhKNX/wChE8Qf9/8AT/8A5Ko+HH/JLPCn/YFs/wD0QldJQBzf/CUav/0IniD/AL/6f/8AJVH/AAlGr/8AQieIP+/+n/8AyVXSUUAc3/wlGr/9CJ4g/wC/+n//ACVR/wAJRq//AEIniD/v/p//AMlV0lFAHN/8JRq//QieIP8Av/p//wAlUf8ACUav/wBCJ4g/7/6f/wDJVdJRQBzf/CUav/0IniD/AL/6f/8AJVH/AAlGr/8AQieIP+/+n/8AyVXSUUAc3/wlGr/9CJ4g/wC/+n//ACVR/wAJRq//AEIniD/v/p//AMlV0lFAHN/8JRq//QieIP8Av/p//wAlUf8ACUav/wBCJ4g/7/6f/wDJVdJRQBzf/CUav/0IniD/AL/6f/8AJVc/4B8R6pB8NvDUUXgvXLlI9JtVWaKaxCSAQqAy7rkNg9RkA+oFeiV5B8NfGNzNpeiaLL4k8O6alrY6dBDp91CTd3StaQuSp89eSXKjEZ6d6Fq7B0bO7/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqii8eWc8/7nTNSezklkgtr4JH5NzMm7MafPuySjAMyqpI4bkZkPj7RFs7K7d5lt7vTpNS8woMQwIFLF+eDlwMDPOfSgLa2F/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqoJfiBZ2mn3l1qek6pYNa232tYJo4zJcQ7gu9AjsOpHysQwyMjmug0y9l1CxW4n0+609mJxDdbN+Ox+RmAz6Zz6gU7CujG/4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SikM5v/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSq6SigDm/+Eo1f/oRPEH/AH/0/wD+SqP+Eo1f/oRPEH/f/T//AJKrpKKAOb/4SjV/+hE8Qf8Af/T/AP5Ko/4SjV/+hE8Qf9/9P/8AkqukooA5v/hKNX/6ETxB/wB/9P8A/kqj/hKNX/6ETxB/3/0//wCSq6SigDzvw54j1SPXvFjJ4L1yUyatGzIk1jmI/YbUbWzcgZwA3y5GGHOcgdB/wlGr/wDQieIP+/8Ap/8A8lUeF/8AkYvGf/Yaj/8ATfZ10lAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVdJRQBzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVdJRQBzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lV0lFAHN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVXSUUAed+AfEeqQfDbw1FF4L1y5SPSbVVmimsQkgEKgMu65DYPUZAPqBXQf8JRq//QieIP8Av/p//wAlUfDj/klnhT/sC2f/AKISukoA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqukooA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5Ko/4SjV/+hE8Qf8Af/T/AP5KrpKKAOb/AOEo1f8A6ETxB/3/ANP/APkqj/hKNX/6ETxB/wB/9P8A/kqukooA5v8A4SjV/wDoRPEH/f8A0/8A+SqP+Eo1f/oRPEH/AH/0/wD+Sq6SigDm/wDhKNX/AOhE8Qf9/wDT/wD5KrNttUu9S+KekfbNC1DSPL0XUNv22S3bzcz2Wdvkyv0xznHUYzzjtq5u+/5KnoX/AGBdS/8AR9jQB0lFFFABXN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/klnhT/sC2f/ohK6Sub+HH/JLPCn/YFs//AEQldJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVw/wk0b+zPh/pl35/m/2np9jcbNmPLxZwx7c55/1ec8dcV3Fc38OP+SWeFP+wLZ/+iEoAydD+Gdp4f19Lyyg0B7dJ5Jlkm0RTfKXJOBciQdC2AShOOOetFh8LrK3tvElpe3811a60kkEUWwJ9igdncxocnPzyM2SPQY4ruqKOlh31ucFY/DRLPTL+yVfD1qLqFYVuNM0EWs2Awb94wlIfp0AXnn2rp5l1iTxda+S3k6PDayGfIQ+fMzAIB/ENoDEngHcOvONainfUlJLYKKKKQwooooAKKKKACiiigAooooA5vwv/wAjF4z/AOw1H/6b7OukrhBrv/COy+N76O2N5cf25BDbWofYZ5XsbNUTdg4ySOcHAya1rbx3o58J6ZruoSPZxagREkXlvK6zYOYsIpJYFWHTkjHUgUeYHS0ViL4v0VtJGorcTNCZTAIhaTGfzRyY/I2+ZuAGdu3OOcUybxtoEGn2V4967RX7OlssdtK8kroDuQRqpfeMHK43ZBGM0Ab1FcjfeP8ATYZdEuLScTafqMs8TlbaV5g8aE7FiA378ggqVLcYwK2LHxRo+pS2cVneB3vYpJYFMbqWEbBZAcgbWUkAqcMOeODTswNaiuWg8Z2114iijt54Do7aZNetdOjIQY5QhOTj5fvc454IOKvW3jHQ7mzvbn7Y1vFYKHuftdvJbtGpztbbIqkqcHDAEHBwTS6X/rewr62/rv8AqbdFcfqHxJ0mzGnNBb6lcreXf2Z1XTLoSQfIXyY/KLZOBhSAWBJGQDWifFthbR6lPqMsUEFjdLajy/Nkkd2RHC+X5YO87xhU359c5AP6/L/ND2/r+uxv0VQtdb0+70d9UiuNlnGrNI8yNEYtv3t6uAykYOQQCKwNT8e2dta6Xe2q3CWdzqK2kz3mn3ELFTG7Axq6qzklVAIDA5wOaOth+fr+B11FYh8Y6GNFOqteOtsJvIKtbyibzc48vySvmb/9jbu9qb/wmmgnRxqYvWMBm+zhBbyecZv+eXk7fM3/AOxt3e1AjdorlZvHFlFq1m32mFNIm0+5upZ5UdHR4pIk2lTgg5dgVK7sgDrxXTQTJc28c0YcJIoZQ6FGwfVWAIPsRmnZ2v8A12/QOtjn/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iErpKQBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jQB0lFFFABXN/Dj/klnhT/ALAtn/6ISukrz/wT4w0XTPh34Xsrie4luI9FsjKlpZzXPkAwJgyGJGEYxzlscUAegUVHBPFdW8dxbyLLDKgdHU5DKRkEVJQAUUUUAFFUNc1eDQNAvtXvEke3sYHnkWIAuVUZIAJAzx6ik1TXLHRtH/tPUnkjtsov7uF5XLOwVVCICxJLAYAPWgdjQorFsPFuj6lHdfZJbgzWcfmz2stlNHcqvOD5DIJCDg4wpz2zWxFIJoUkQMFdQwDoVIB9QeQfY80CHUUUUAFFUbfVoLnWr3S0SQT2ccUkjEDaRJu24Oc/wHPHpV6gAooooAKKKKAOb+I//JLPFf8A2Bbz/wBEPXSVzfxH/wCSWeK/+wLef+iHrpKACiiigAoornfEniLUNJ1bR9M0jTba+utUeVV+1XjW6RiNN5JKxyE5+lAHRUVkWup31pp9xeeLYtL0iKHnzIdRaaML3LO8Ue39frWdrPxF8M6R4dj1r+17G8spLqO1SW2u4mUuzBfvbsfKCWPoFJ7UAdRRWVF4gstuoXFzf6bHZWexmuEvVYIjIG3S5AEfXI5ORg55xS2/ifQLy38+01zTZ4d0aeZFdxsu5zhBkHGWPA9T0oA1KKr/AG+z+1TW32uDz7eMSTReYN0aHOGYdQDtOCfQ+lQaXruk65HJJomqWWopE2yRrS4SUI3oSpOD7UAX6KKKACiiigDm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iErpKACiiigAoorD03xhpOr3/wBk08ajK3mPH5x0q6SDchIYec0Yj4KkZ3cnpQBuUVSudVgtdXstOkWQzXqyNGygbRsAJzznvx1q7QAUUUUAFFFFABRRRQAV4j8NdT1rRvAn9o2RsG0+E6cs8EsbmaXfZWina4YBMZzyrZ6fL1r26uI+Hvh7S5vhNoUUlrlNQ0yxuLkeY37yRYIgD144jTgYHHuacXZ38v1X+QPa39dRJPGt+mtTaCIbYasNYjtYgUbY1qyeb5uN2ciNXXOcbl6Y4qvB4w8RJDa6reR6Y+mz6y+l/ZoYpBMB9oaFZd5fHGBlNvqdw6DdXwx5nxKk8T3EVt+601bK2ZSTIcuWctxgD7oGCerVT8OfD/T9Lk+2ahCJr9b65u0K3MrQqZJXZX8okJ5gVgN23PbOKcbWV/6/4dK/lcJdbf1o/wAnp8jI0D4harresW7R2Mj6fc3ctuIU0e7UwIpYCVrojyWBKDKgDG77xIwa82p+Jtb8H6Dq16+kia81KzktbeKCRFi+c5LuXbdkYOAq46ZPWu0tvCWk2eqm/s1vLeQyNIYYdQnS3LNncTAH8skkkn5eTz1qxH4f0yHTbHT47bFrYOkltH5jfu2T7pznJx75qV09V+DuEtVJLqn+pyza/qcubHVTBJd2Ov21lJPZma3SVXRJA2wSEjh8FWZlOOQQcVR1jVda1uGwvs2CaQPEUNssHlOJ18q68veZN205ZPu7RgH7x6V2zeHdLe4lna1zLNdpeyN5jczIqqrdewVRjpx0qo/gnw/JqYv3sWMwuBdKv2iURJMDnzFj3bFcnqwAJ5znNVFpNN9Gn/6T/k/62U1dNLqrfn/mjnp/GWvWOg6/r92mnSWWn3U9pa2kcTrJI6zeWjvKXIUZ6gIfXI6VL/wk3ii0vtX0ae2sNR1S0soL2CWzgeONlkdkYGJpGJK7S2Aw3Dj5TXUnw/pbaVeabJZpJZXryPcQyEsshkJZ85Pck8du1UrXwXotlY3Ntax3kf2oIJrgajcfaGCfdXz9/mADnADYGSO5qen9f1v/AJFNq9/P9f8ALQxoNduryfQHW5i1K5le6DeRFPYrvSIkI0DyEg9ARJuweQAa0/B+tX2rW9wusXFv9uiK+ZZx2Etq9rkH5W8x28wZBxIuFbBxV238K6RawwJBbyqbcyNHKbmUybpF2uxkLbmYj+Ikn3rNu/AWmzWK2lvJcLFJdwXF29zcS3U1wsTb0j82V2YDcAepGNwAGc09LkWf9f1/wDqaKKKRQUUUUAeaHw1qHiPx1rbQarJpllp+ui5eS2CNM039nWax4WSN02gM5ORnOMeou6R4D1XSLuOH+01vbCDXDqkUlyQJsPE4lUqiKgPmOWGABgnp32vC/wDyMXjP/sNR/wDpvs66Shabf11/Qd7/ANev+bOJ1Dwtrhi1H+zrmLbd6qbt7dL6WzM0RiVNhnjUvGQy7vlBzjGeTWLb6FrnhiTwvY2n2G6v1v8AUJ9s9zMY3SQO4UysGfdhh8xDcg9a9Qop3dren4E20t53/r7zjND8H6hYXun317NaG4F9eX14sJbYrTqQFjyPmA4GTjOCcc4rn/F3h7UNI8H2rWd3DDra69K+numWVvtczqVIwDkRyknsCmeQK9TopeXTT7l0KTav56/PX/M42TwZeWdzB/wj95FZR2uhPpltIQWeOTchVsYwRheTnOe1Ycfw31e6h1pr2eG2lvre0WFX1S51DbLBM8nzSTANsYlflUADnjufTqKfM/69b/mSlbb+rW/yOS1HTvFGqWen3c9tpEeoaffrdR2iXcphdQjIQZjFkH5yf9X2x71Tv/BuqzT3WoW0lmbxdbj1a1hkkcRvtt0iMbsFyucNggNj5Tg9K7mihO239bf5Ie6s/wCt/wDNmaialc6BMmqWmny3ksbg2qysYGyDhGcpkjsW2f8AAe1czpvhPWkfT2u5Le3gtNTW7jslvpbtYIxDIhVJZEVjlnBCkAKBgV3FFLrcOlvX8ThtS8GapLcSahYy2bXkGu/2raxTOwjkXyBEUdgpKnG4ggNjjr0qsPAusRyprcclg2tDWW1ZrQyuLY7oPI8rzNm7hed+zr/DXoVFNNrb+tv8kH9fff8AzZwniDwVq/ibUdL1S9uLK01DTraZoWgLukVwZI3j4YDegCEMTgnOQB27WzN01jCdQSJLooPOWByyB8c7SQCRn1Aqaii+lg63Ob+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISukpAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/JU9C/7Aupf+j7Gukrm77/AJKnoX/YF1L/ANH2NAHSUUUUAFeHfD86l4e+E9nYH+3bK7ureK/sr/SdNF4LoPAhWNz5UoTaSF+YLwow2M17jXN/Dj/klnhT/sC2f/ohKB3/AK/r1OA8RaTrt/qlnc+Jo0kgfR7dEeXw/Pqht7v5jMypbuphk5Uh8dsAjGDe1bwib2w8TXt1YT6nqcGj240+9ltXWVp0hf8AeRKeVk3Y6fMCcV6rRVX10JirNN62/wCB/keO+KdE1S68WahNqj+Uk0MI0u9Hhy61Oa0xGAxieFx5Dh8k5XnjkgYHSxeHUHiHxXrc2ifb9STYLCSVTGz4tUUiJz9wscqWXB7E8V3tFT0sVF2Z4mmkag+g+MY9P0hooL3QnCQ2eh3FiJbjL5BSRmaWTBAL4G7jrXoHjeOb/hCYDFbXE7QXdjK8dvA8sm1LiNmIRAWOACcAE8V1lFVzNW8v87gtHf8Arp/keZeIobzxVqV9qulaZqEdpa+Hr60D3NpJBJdSy7dqJE4EhxsPJUAlhjNWLyxji8baTdw6W2pX4jt4nS80eV1tFA5khuyvlxEAksuSWIA4Nei0UtreX/Bf6ilqrf10/wAjyDw5ot6muaGw0i+tvEVvqc8muanJbOi3EBEmAZyNsqtmPagLbcDhcVfg8KfZfBGoXUGiyf2jdatK16VhIuZ7T7cWdBn5ipjyQo4OeAc8+oUUX0/r+reQbv8Arz/HXf0PHrzQ7mSx8Tf8ITot1pVlc/2eY4pLGSFZolkYzhISUYDbnKDYTz03Al8Hhz7X4WurS2ieWzuNV08tp9p4eutKigVZ0MjLHKScFeWZcAbcnkk169RQnZ39Pwt/kK2ljznWtD0zS/GOlNo2gxXckAhihsX0R3t7VPMJMkFwFEVu43Fm5JbaowDg16NRRRfSw+oUUUUgOb+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh66SgAooooAK4vxnoT634x8KK8V99khkumnms55oDFmH5cyRFWXJ46jPSu0ooA4vxPYyeH9BsY9HsrjUIl1COSea7WfVZrROcyxo7NIzAgAbT8u4nBwRXCzadq95J4uvf7P1eaOXUNJvYnn05onuI4pFaQpGqAkgKflIL8DIyRXt1FNNp3/AK6f5A7P+vX/ADPJL/TNQm8TaprP9l31xpkWvWV/JB9kffcQraBdyxkBnKOVYqBnKEYyMVn6gjaxrXiy90XR70LDqWj3ksP2Ro5pljcO7iIgPu2j7pG446c165rGiWGvWi22pwtIkcgljaOV4nicdGR0IZW5PIIPNJpGh6foVvJFpsLJ5r+ZLJLK80krYxueRyWY4AGSTwAKIu23S1vlb/L+uhL3t/63/wA/66+WeItP1fxbfeM59H0vVIYbnT9OSAz2pt2u1jlkeVEEq4ztJG1x3GRg89N4RsIbjxYdYW68UXcyWJtml1bTorKILuVgm0QxO7DHBwygFuea72ihO39fIHr/AF6f5BRRRSAKKKKAOb+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISukoAKKKKACvNPBzXlrDdaeb/AMRpevLe+TY3OjtHZxsZZGRhP9nHbBBMpBz34Fel0UmrqwdbnlXhvSIIte0KXSPD1/p19BY3EWpXc9m8KtclE5djxKxYE+YNwP8Ae7Vl+E9B1K3RRqG631hbCdL9IfDd1FJeyGMjEt4XaKbDYII+gxyK9popy96/n/wdvvBaW8jy/TPh7pA1PQYLjw8ps5dDb7eksLFJrhTDs87PDyAGTbvyRzjpWRrdhqt54P0mzvdEkmvI9HXyZ7vSri+kE4DDYoVlFvIMKfNc5Ocdq9nopybl/Xr/AJhD3Vb0/T/Iq6WZjo9mbnd53kJ5m8YbdtGc++atUUUN3dxRVlYKKKKQwrm/hx/ySzwp/wBgWz/9EJXSV4L4TtL+ew8GXdro/k3MMOmBrhdJnlme38uMM4vN3lpGQTmIKcck46gWslHuKTtFy7HvVBOATXmOj+FFsV0zVYdIkh1ZvENyZ7nyWE32dpp+GPUREFTj7vIPU5rmvDNnp+qePrXUNZs7OKe31m+aDUZrSeSW9YvIkcPnNCIvkwCu2Vz8gAA5o/r8v8xy0v8A13/yPbbO7jvrOO5gWZY5BlRPC8Lj6o4DD8QKmryEaS8eneEV8VaFe6jocOkyxT2S2Elz5V0SmxpIVUtnaHAYjCk9s5qnd+H9fXTPDS+I7cXNjBp8qSQ32jzawIZjIDHvhhcNvEeFD/MBg9Cc03/X4/5fihtWdj2a4mW3tpZ3BKxoXIHXAGah0zUItW0m01G3V1hu4EnRZAAwVlBAOCeea8xuNGTyYo/Eenal4ii/sWKHS5xps29JwZN52tlrdyDH8zlTxjdnNUtW0LU3j8OnVbRH0yHQoIUiutAuNU+z3QHznyoXVo327QHIOMEAg9Ta/wDXf/JE63Xp/l/m/uZ7LRXkt54O/tC11ibUbO51i6t/DNqlje3FnJHJJcKs53ojcrKCVP8AfUtjvWo+hNoM12dE0SV47rRQ1zHH5ifaZw4BLuPmaTaWJ53MOKJKzt/XX/IfRP8Arp/n+B6NRXlvhC9PhG31+/u7BodL/wBE+ywWOiyaaksjsyERwTOTvLFAeRng45yfUqGrCTuFFFFIYUUUUAc34X/5GLxn/wBhqP8A9N9nXSVzfhf/AJGLxn/2Go//AE32ddJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/8AohK6Sub+HH/JLPCn/YFs/wD0QldJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc3ff8lT0L/sC6l/6Psa6Subvv+Sp6F/2BdS/9H2NAHSUUUUAFc38OP8AklnhT/sC2f8A6ISukrm/hx/ySzwp/wBgWz/9EJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/wCSWeK/+wLef+iHrpK5v4j/APJLPFf/AGBbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/8AohK6Sub+HH/JLPCn/YFs/wD0QldJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfw4/5JZ4U/7Atn/6ISukrz7wJ4ojsfAng+yudM1FLeXTLG3GoGNBB5rQptTlt5ycDcEK5OM0dbBsrnoNYNp4K0Gx1Fb22tZleOQzRwtdzNBE55LpCXMaNknlVB5PqaqWHjy0v7+KEaVqkFtNeS2Md9NFGIWnRnUoMOX52Nhtu3tkHihviBpi6n5H2W9+xC9GnnU9ifZhc52+V97fnd8u7btzxnNNXvp/X9afgD0Wv9b/AOT/ABOporll8fWXl6ncS6bqUNjpsslvLevHH5ckqPs8tFD72JJGMLjtkHikk8fWdpazy6rpepadJavD9pgnSJngilJVZmKSMvl5U5IJIwcgYpA9DqqK5m08XRareaU2m71s72e4jR5bbd9pWNSd8bCQbVJHBKtuA6AEGrWm+KYr/Whps2mahp8ssLT2zXkaKLiNSoZlAYsuC68OFPPTrTt0A3KKKKQEc1tBc+X9ohjl8txInmIG2MOjDPQj1qSiigAooooAKKKKAOb8L/8AIxeM/wDsNR/+m+zrpK5vwv8A8jF4z/7DUf8A6b7OukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+HH/JLPCn/YFs/wD0QldJXN/Dj/klnhT/ALAtn/6ISukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACubvv+Sp6F/wBgXUv/AEfY10lc3ff8lT0L/sC6l/6PsaAOkooooAK5v4cf8ks8Kf8AYFs//RCV0lc38OP+SWeFP+wLZ/8AohKAOkooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4cf8ks8Kf9gWz/APRCV0lc38OP+SWeFP8AsC2f/ohK6SgAooooAKKKKACiiigAooooAKKKKACiiigAryLwP8N1v/C/hHWZLuyYx2en3iSy6cJLtNkUZ8oXBf5Y+CAoUYz1PQ+u1zfw4/5JZ4U/7Atn/wCiEoWjTXQHqmmJbeEPs+nWNr9u3fZNVk1Hd5ON++SR9mN3GPMxn26c1nr8PZBdG3bVg2h/2p/aosfsv70T+Z5m3zt+PL3/ADbdmf8AaxxXa0U07O6/rb/JA9d/63/zZy134GtNR8J6noOoT+dDf3kt3u8ofIzTeaoKnIYA4Bz19Bms21+HHl6Nd6Y50Gyt754hd/2Lof2FriFSS0TnzWzuzjPYFuOcju6KQ229TldM8FNpselwLqbvbaU84tV8vDpDIhVY9+7nYDgNjkADHc4+l/Dy48MahJrlg9leahBYT20SWunpbTXbOUKvPMzt5kmU5Y4B3E4Hf0Kii7vcS0KekQ31votnDq10Lu+jgRbm4CBBLIANzYGAMnPAq5RRTbu7iSsrBRRRSGFFFFABRRRQBzfhf/kYvGf/AGGo/wD032ddJXN+F/8AkYvGf/Yaj/8ATfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfw4/5JZ4U/7Atn/wCiErpK5v4cf8ks8Kf9gWz/APRCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/5KnoX/YF1L/0fY0AdJRRRQAVzfw4/wCSWeFP+wLZ/wDohK6Sub+HH/JLPCn/AGBbP/0QlAHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfw4/5JZ4U/7Atn/wCiErpK5v4cf8ks8Kf9gWz/APRCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXjngHxBq9v4B0O10dbX7RPPY6er3rzSoiHTY5SwXfwQf4V2qfYktXsdcR8OfDul/wDCt/Ct19l/fGxs74t5jf64WiRb8Zx9zjHTvjPNNb6/1qv0uPp/XZ/qQQeKfE8DGfU/7Je1tdXTSrhbeCVXnLuqCVcuRHgyL8h35wfmHSmzeMPEVtBLq00emNpkOtHTDbJHIJ3Q3AhWQOX2hgSCV2nOOq5wOufw9pckMkT2uUlvFvnHmNzMrKwfr6opx046VhaL4A060vri/wBTgE92+pT3sYS5lMWWkLIzRZCGRQQNxUkY4NEbaX+f/kt//bvv+5PZ27//ACX/AADMvfHWswyahqlvDYnRtP1hNKktXjc3MpLpG0gk37Vwz8IUOQM7hmqreJde8NReM9V1G8g1K2s9SWC2tEtJQyO6QBMHzH+Qb+VVMk7iOu2uvl8F6BNrbarJYk3LyrO6+fIInlXG2Rod3ls4wMOV3DA54qWXwpo895f3M1q7tqKbLqJp5PJl4A3GLds34VRvA3cDmhaLzt/l/k/S4+vz/wA/687HJL448QJoepv9jSe6tntRb3dzpF3p0ExmmEbJ5c3z5XruBI+YcdqsX/jLW9Ci1Kz1KOwvdRgmsoreW3ieGJjdSeWu5Szn5SCSQ3I9K6K38IaTb2Utoft9zBK8cjJeanc3OGjYMm0ySMVwQDgYzjnNT33hvSdS+3fbrNZvt8ccdxuZvnEZJTHPykEkgjBz9BRp/XyEctr/AIr8QeHZtN0m8azl1C/eVlvbPSbq6jWKNVJJtomZ9xL4+/jA3Z/hrpvC+rXWteH4b3ULOWzuGZ0eOWCSEttcqHCSAOoYAMAwyAart4J0NrBLUwXXySmZbj7fP9pDkAFvP3+b0AH3ugA6VrafYxabYx2lu9w8cedrXNzJO5yc8vIzMevcmjSwdizRRRSAKKKKACiiigDm/C//ACMXjP8A7DUf/pvs66Sub8L/APIxeM/+w1H/AOm+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf8AYF1L/wBH2NdJXN33/JU9C/7Aupf+j7GgDpKKKKACvO/ANn4xb4beGms9d0OK3Ok2pijl0WZ3VfJXAZhdKGIHUgDPoOleiVzfw4/5JZ4U/wCwLZ/+iEoAPsPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDm/sPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TK6SigDzvx9Z+MV+G3iVrzXdDltxpN0ZY4tFmR2XyWyFY3TBSR0JBx6HpXQfYfG//Qw+H/8AwQz/APyZR8R/+SWeK/8AsC3n/oh66SgDm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrpKKAOb+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkyukooA5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TK6SigDm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrpKKAOb+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkyukooA5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TK6SigDm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MrpKKAPO/ANn4xb4beGms9d0OK3Ok2pijl0WZ3VfJXAZhdKGIHUgDPoOldB9h8b/APQw+H//AAQz/wDyZR8OP+SWeFP+wLZ/+iErpKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMo+w+N/wDoYfD/AP4IZ/8A5MrpKKAOb+w+N/8AoYfD/wD4IZ//AJMrn/ANn4xb4beGms9d0OK3Ok2pijl0WZ3VfJXAZhdKGIHUgDPoOleiVzfw4/5JZ4U/7Atn/wCiEoAPsPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyukooA5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMrpKKAOb+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTK6SigDm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyukooA5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMrpKKAOb+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTK6SigDm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyukooA878OWfjE694sEGu6Gjrq0YmZ9FmYO32G15UC6G0bdowSeQTnnA6D7D43/AOhh8P8A/ghn/wDkyjwv/wAjF4z/AOw1H/6b7OukoA5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyukooA5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyukooA5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyukooA5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyukooA5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyukooA5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyukooA5v7D43/wChh8P/APghn/8Akyj7D43/AOhh8P8A/ghn/wDkyukooA878A2fjFvht4aaz13Q4rc6TamKOXRZndV8lcBmF0oYgdSAM+g6V0H2Hxv/ANDD4f8A/BDP/wDJlHw4/wCSWeFP+wLZ/wDohK6SgDm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyukooA5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMrpKKAOb+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTK6SigDm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyukooA5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMrpKKAOb+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTK6SigDm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyukooA5v7D43/6GHw//AOCGf/5MrNtoNch+Kekf29qOn3udF1DyvsVg9ts/f2Wd26aTdnjGMYweueO2rm77/kqehf8AYF1L/wBH2NAHSUUUUAFc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN+F/+Ri8Z/8AYaj/APTfZ10lef2Wt3GmfELUrKBImi1PxJ5MxcEsqrpFvINuDwcoOueM1raL4+stZksj/Zmp2NvqCM1pdXkcaxzFVLMBtcsCACcsACBwTQB1VFcpH8QbGTQrzWv7K1VdLt7R72G7MKbLuJepjw+QT2DhCeoyAalk8ahFtYxoGrNf3gd7fTwIBM8SbcynMoRV+ZeGYNk4xninZgdNRXNXPja2i0iLUrTStUv7Vommme3hUfZkUkPv3suSpUgou5uOlWV8URXGvJpmn6feXv7uOWa5iMSxQJICVLb3VjkA/cVqQG5RXN2XjeyvtQihjsb5LK4uHtbfUnRBbzyruyq4feOVYBigU44JyM5dx43nvvEHh630uyv7ewvtQeI3ksUZhvI1hlJCkMWX5kUgsFJxxkZppXHbc7iiuX1jX5dL8d2FtcXSwaWdJvLu5DKMZieHDZxkYDNwD3+lQP8AEWxt7N7m/wBJ1Syj8j7VF58cQM1vuVWmUCQ4Vd6sQ21gD93tQldK3X/Nr9GJ6f1/Xc6+iue1Lxrpum3d7byRXU0lp5C4gQN50sxIjiTnlzgE5wAGBJ64zdT8XzzWln9ihutLvE1m1s7y1u0jMiJIwJGVLqQykYZWP1BBpLVpeaX3/wDDibsm/n+p2dFYujeJF1y9uY7PTb1bS3kki+3yGIRSSI+xlVRIZAQQfvIBx16Zpa3480/Q767t3sr+8TToVn1Ce1jRkso2zhn3MCeAThAxAGSOlAzp6K4u113VdU+KE2nwpqEOkWdnDOrxC1MNwZPMwzlmMu35QFCBTkNu4xntKdrB1Ob+HH/JLPCn/YFs/wD0QldJXN/Dj/klnhT/ALAtn/6ISukpAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN33/ACVPQv8AsC6l/wCj7Gukrm77/kqehf8AYF1L/wBH2NAHSUUUUAFc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHCaboX9qeO9Zv/tHlf2X4h87Zs3ebu0q2jxnIxjfnPPTFalp4MW207w9ZyXvmpoqurHyseeGiaP8AvfL97PfpT/C//IxeM/8AsNR/+m+zrfW5ge6ktknjaeNVd4g4LIrZ2kjqAdpwe+D6UbqwHIW/gbUYvB914Yl1+N9M+wNY2arYhZIkIwrSNvPmFRwNoQHnOTyJ/F3gK08UXun3zpp0l3YxPCi6ppwvbdkcqTmMsp3DYMEMMZPXNdbUK3ds95JaJcRNcxIskkIcF0ViQrFeoBKnB74PpTbb3A4TV/hcmrWFvavJoscUdobZrf8AsUNbwElj5ltEZMQv83JO/OB0rWuvB9zd6ppM0t9Yrb6WIvKePTyLz5MZUT+bgIxHzLs5HGe9dXRS63E1fT5HCaH8MrTw/ryXllBoD26TyTLJNoim+XeScC5Eg6FsAlCccc9atWPge+tLrR0fXEk0zRLkzWdqLILIVMboFkk3ndgScEKvTkE812NFNO2w+/mc9rvhGDxBrCXd5ORb/wBm3WnS26py6zmPLBs8YCdMHr7VkeHvhva6MtzbzWvh1rae0e0L2Ohra3Lo2AfMlEhD5A5AVcnnjpXZXN3bWUQkvLiK3jZ1jDyuFBZiFVcnuSQAO5NTUulvl+f+Y7v+v68jz+2+FVuPAp0HVNRGqXbXSXb311aKyyvHtWMPESQyhEVCM8gE5BNXbLwCLbS4LT/iS2Rh1KG+P9j6P9jjk8sg7WTzWyTjG7PHpXZ0U7u9/wCtLf5Imyat/Wv/AA5zem+GLq38Xz67e3liXkjaIR2FgbYyqSCDMxkfzWUDAOFxluOcCjrvgS41TUdXksdZFlZ67bpb6nA1r5ruFUruifeAjFTgkq44HArrre5gu4fNtZo54ySu+Nwy5BIIyPQgg+4qSl2HfqZGn6Amna/d6jDNmOezt7VYNn+rERkwd2ec+Z6cY75rXooptt7itY5v4cf8ks8Kf9gWz/8ARCV0lc38OP8AklnhT/sC2f8A6ISukpDCiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigArm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4cf8AJLPCn/YFs/8A0QldJXN/Dj/klnhT/sC2f/ohK6SgAooooAKKKKACiiigAooooAKKKKACiiigArm/hx/ySzwp/wBgWz/9EJXSVzfw4/5JZ4U/7Atn/wCiEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDzA6jqH/CxtX0Ow1B9Ki1LWXeW9iSNpAY9NsiI08xWXLZJ5U8KceoW7GqnxHr9/p3iPZJZ6Fazme2tomW7dTckbtwYBDg5C4Powre0rSNN1rV/GdprOn2uoWx1uJvJuoFlTI0+zwdrAiumXTLBBIEsbZRLEIJAIVG+MZwh45UbmwOnJ9aNeV23Gmr6/1qee6x4p1m6vNVFtrK6Kmk6HBqiKsMbi6dw5IfzFJ8sbAuFKtlvvdKoaj4n1LTb7XtftrTGoSeH9KcxYB8ppJZgxwxA+XcTyQOOSK9KvPD2i6jJayahpFhdPZ4+zNPbI5gx02Ej5eg6elWWsLNp5p2tIDLPGIpZDGN0iDOFY9wNzcHjk+tVda2/rf+vkJba/1t/k/vOFtZvHcul38KQ6qir5LwXN8dPF5ICW85YxEWhyAFKlwBkkHPWoIhLrXjDwneWniLVgotL1H82G1Du0ckYdXAixkn5TtwMKNpHJPWJ4G8JRWc1nH4X0VLadleWBdPiCSMudpZduCRk4z0yauzaBo9zbWlvcaTYywWTq9rFJbIy27L90oCMKR2IxildXv/W1gOD0LxJ4u1rXXu7ex1JrSPVZbOaE/Yls4oEkZC2S/wBo8wABumD0C4w1I+veIbDwGmuXOuPNPqGoR2amS3iWGxje6MXmABMswXuxK5xwOa7qXwzoM+spq8+iadJqUZBS9e0jMykdMORuH51abTbFtPewaytzZuCrWxiXy2BOSCuMHJJzSWiQPWTfT+v68zzDW9R1F7bVdG1DUG1SLS9d0lYb2SONJG3zxMyP5aqhK8dFHDDPqe08Y6jc2sFpaadcX8d3dSNsj06GB55FUZba1wREuOpLZ46c1qW+gaPaabHp9ppNjBZRyCVLaK2RY1cNuDBQMAhgDn1Gak1PSNN1q1FtrGn2uoW4YMIrqBZUyOhwwIzTb93l8/0S/QOpwWla7r/iWDwxDHrE2mNewXpu5YYIHlcwyKikZDorc5ONy8nHYiaw17WNaGi6bJrLabJPFeyTX0MMW+Y28wjAAkVkGQSzYHbjFdzBpdhamE21jbQmAOIjHCq+WHOWC4HGSMnHWobnQNGvbJLO80mxuLWOTzUgltkZFfJO4KRgHJJz1yaNP6+f9fISvZGJ8M3MngK0czpclp7kmeMYWT/SJPmABPB69TXV1Fb20FnAIbSCOCIEkJEgVQSck4HqST+NS0N3YRVlYKKKKQzm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf8AYF1L/wBH2NdJXN33/JU9C/7Aupf+j7GgDpKKKKACub+HH/JLPCn/AGBbP/0QldJXnXwy8Vy3fgjw9p9l4e1W5itNPsrWe+R7ZYUb7PExOGmEhADDOE+gNC1dg2PRaKojW9KaKORdTszHK7xxuLhMOyZ3qDnkrtbI7bTnpUVt4j0fUGuYtL1Sxvp7WPzJYbe5SRkBGRuCkkZ7ZoeiuBp0VzumeNdJuPC+jaxrF5ZaP/a0EcsMN1douWdQdiltu489h+FaV5r+j6fdw2t/q1ja3E5UQwzXKI8hYkKFBOTkggY64NNxadmBoUVmDxJobTXsK6zp7S6ehe8jF0ha2UDJMgz8g9zis/RfHWjeIrHTbvRZ0u47+XysR3MBa3fYX2uvmZ3YH3V3HvjGSEtQOjoqhDrukXOrS6Xb6rZS6hAMy2cdwjTRj1ZAcjr3FMtPEWiX+oGwsdY0+5vApc28N0jyBQcE7Qc4zxmgDSoqhY67pGqXlzaaZqlleXNodtxDb3CSPCc4w6gkr0PX0q/QAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38OP+SWeFP8AsC2f/ohK6Sub+HH/ACSzwp/2BbP/ANEJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc38OP8AklnhT/sC2f8A6ISukrm/hx/ySzwp/wBgWz/9EJQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHn1t4y0Lwx4x8Q2muahb2b6jrypEZp0jC7dNtWLNuYYXgLkZ5ZR3rqL7xZotiLqMajZ3F3axPK9nHeQrNtUZbh3UDGRksQBnkiuQe1v28Y6rqOnWEuof2d4nWWa3gkjWQo2kwR5XzGVTguCcsOM4z0q/eeGL5/CHjW2t7FRe6xNcPAAyAzho1VMtnA6Y5IxTVn/Xp/mHVf13/y/E6K/wDFnh7SbmK11jXNN066lUMtvd3kUchB6fKW5/CmaP4lt9V1C/sn8q3ntbyS2jjMwLThFRmcLgHA8wZ64455ry+4aVfGmuXN/Hcf2Bb69azT3FtbROUniihVVMjTB8bsAqsLdThuTWt4n0zVdA0jVPEdtAo1Cy1831jG0oAuo5USEpkZxu3HAPOVHFCtv3X58tvzfy1Jd72X9aS/VI9CufEeh2Vqtzeazp9vA0xgWWW6RVMgJBQEnG4EEY65FPu9e0iwvrazvtVsra6u/wDj3gmuER5v9xSct+FcTB4W1HwzqOh3cGlPr0dvpUtjcJHJEjrNI6u8uJGUFXIbdg56cGs/WvB2sPrWrMYNabTdYggja30N9P2wKkYQxMblQwAOSpjPcnANFtbf1v8A0x7/ANf1/SO+vvFOi2MtxbvqVnJfQRvIbFbuJZjsXew2uwAwpByxAAIJIHNVPEXjXSvDmiS3d3c2qXosnu4NOmu445Z9qFiq4Jz0xldw+tZTeGb1dI8cpHZj7Tq7OLVi6bp1+yRxrk54+YMOcdz0NZfiDw7rb6X4j0630Aao2t2EccE5nhVLdkgCbH3ndwwLKVDDLc7etCt+RcbXV+7/AE/4J3N14h0jT2tI9U1OysZ7zAghuLlI2lJxwoYgsee1Pm13SLfV4dKuNUsotRnG6Kze4RZpBzyqE7j0PQdq8/8AEXhPWZPEeo3SprVzYapp8NpJFpB0/coQMGR/tY+6d2QUbqTkdDWybTUNK8ULcaXZ6jaWZWM6ldXkts1rPGkYG/hzKJAABkBVODnPBo0IV7fI7aiszw7qs2ueHrTU7izaya6TzFgZtxVSTtJOB1XBxgYzitOhpp2Y9wooopAFFFFAHN/Dj/klnhT/ALAtn/6ISukrm/hx/wAks8Kf9gWz/wDRCV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzd9/yVPQv+wLqX/o+xrpK5u+/wCSp6F/2BdS/wDR9jQB0lFFFABXjfwn0i8sNG0e7uNB1+YXVvZzQ3drqypZiM2kK7ng+0rnBDZzETwOvFeyVzfw4/5JZ4U/7Atn/wCiEoWjv/X9aCaurHIDwvq+n+Jda8R3GnItnqMN4gtRIpNh8gxMPmKky+X823kZX/aqfwxpOpakfDN1/YA0i10rRpIRJ50RW5MsaALGEOdvG4lwpzjA6mvSpI0ljaOVFdHBVlYZDA9QRRFFHBCkUKLHHGoVEQYCgcAAdhSt7rj5Jfn/AJj+0pev6f5HlOmeFfEGi2WnmbQTqjS+GYdJkgW4hH2OZc7t29wDG24ZKbj8g4NdH4U8J3mh6vZyXyJcNZ+H7XTxeEglpEZy4Gfmx90578eldrRVuTbb7/8AB/zYf1+X+SPOPDuh+JV8X6beara3EEFnBcRSJ/oaWsbOFx9nWIebsJX/AJaHPTirGiaLrKWHhG0utKmtW0O7dLiR5omV0+zyoJE2uSVLMowQG55UV39FJOw2738zy/Q/CeuQy+HdNu9K+zjQ9TnvZtVM8ZW7VxLjYAxfc3mLu3Ko4PJ4rT07wre2Wn+FlXTo4pLHVbi6vAjICquk43ZB+YkunTJ556Gu9oouLrf5fn/mcl4NtNUsLie1NhfafokcYFra6i9u8kTZ5WMws2Y8f3yWz7V1tFFIOtwooooAKKKKACiiigDm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/wAks8Kf9gWz/wDRCV0lc38OP+SWeFP+wLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACub+HH/JLPCn/AGBbP/0QldJXN/Dj/klnhT/sC2f/AKISgDpKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8L/wDIxeM/+w1H/wCm+zrpK81GvXmjeP8AVorS2urxLzXmSS1tY0Z5SulWjKMuQF5HUso9TXUaf4103ULjT4RFc2734uAnnoqiOWBtskTEMfnHzdMghWIPqAaEvhzQ59ZTV59G0+TUo8bL17VDMuPRyNw6+tXLmztr2NEvLeK4RJFlRZUDBXU5VhnoQRkHtXMJ8QbW5jtDpmi6vqEl5avdwx28cWWiV9m7c0iqM8MATkg+vFOf4haZLb2EmkWd/rEl9ateJBZxoHjhU4Z38xkAweNuSxOcA4NH9f19z+4P6/r7zq6K5V/H9jKLE6Ppupax9vsvt8P2KJAPKyASxkdAp56E5POMnip7vxpaw6NbarZaZqWpWU9sLtprWFQIYSM723suSB/Cu5v9mna39f12f3Atdjo6K5SPxfeSeOJtJj0a5l01bCK7W+Qw4+Yv8xzKG2/KAAE3ZBzxg0y0+IVreaJZ6kmi6siaiyJp0EiQiW9LIXwi+Z8uApJLlRgZyRzRZ2Db+vK511FctN48tIrS0ZdK1Oa7ubx7H7BHHGZop1jaQo/z7B8q/eDFeQc45pNO8fWmo3NvH/ZOq2sU1y1m1xcwoscVyCQYWw5JOVI3KGTPG7NFv6/r+tu4dL/1/Wj+5nVUVzNn4pnk0X7XHp17q8zXdxCsVjbJEQIpWQ5MkuwY29S4LdQo+6NvStTt9Z0m21GyLeRcxiRN67WAPYjsR0pAW6KKKACiiigDm/hx/wAks8Kf9gWz/wDRCV0lc38OP+SWeFP+wLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm77/kqehf9gXUv/R9jXSVzd9/yVPQv+wLqX/o+xoA6SiiigArm/hx/ySzwp/2BbP8A9EJXSV534B8FaXdfDbw1cS3WuK82k2rsItfvo0BMKk7UWYKo9AAAOgFAHolFc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP0AdJRXN/8IHpH/P54g/8KPUP/j9RJ4M0GS4lgj1LXHmhwZI18TX5ZM9Mjz+M44oA6miub/4QPSP+fzxB/wCFHqH/AMfqFPBugS3UttHqetvPCFMsS+Jr8sgbO0kefkZwcZ64oA6qiub/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH6AOkorm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+gDpKK5v8A4QPSP+fzxB/4Ueof/H6iXwboDXb2q6lrhuI0WR4R4mv96qxIDEefkAlTg+x9KAOporm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfoA6Siub/4QPSP+fzxB/4Ueof/AB+j/hA9I/5/PEH/AIUeof8Ax+gA+I//ACSzxX/2Bbz/ANEPXSV534+8FaXa/DbxLcRXWuM8Ok3TqJdfvpEJELEbkaYqw9QQQehFdB/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AdJRXN/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0AHw4/5JZ4U/wCwLZ/+iErpK878A+CtLuvht4auJbrXFebSbV2EWv30aAmFSdqLMFUegAAHQCug/wCED0j/AJ/PEH/hR6h/8foA6Siub/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8foA6Siub/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8foA6Siub/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8foA6Siub/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8foA6Siub/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8foA6Siub/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8foA6Sub+HH/ACSzwp/2BbP/ANEJR/wgekf8/niD/wAKPUP/AI/XP+AfBWl3Xw28NXEt1rivNpNq7CLX76NATCpO1FmCqPQAADoBQB6JRXN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9AHSUVzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/QB0lFc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP0AdJRXN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9AHSUVzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/QB0lFc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP0AdJRXN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9AGbouk/bfHuv6h52z+z9bJ8vZnzN+mWi9c8Y696zvF/gy4Hg2HTtMnuZNRk1tri2uraDm3FxM5kJ6gKIpJAWPt0OKf4c8FaXNr3ixHutcAh1aNFKa/fKSPsNq3zETAscseWycYGcAAdB/wgekf8/niD/wo9Q/+P0DTaVl/Wlv1My+0DVovGFlH4Zuk0u3tdGNsss1ibiHAkUBeGTDADI+b6gilj+H0+lnTpfDetfY7m1sDp88l3a/aBcRlt5bAdNrhiSDkj5jlTWl/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9HSz8/xv8A5slK23l+Fv8AINE8G2+gvYrZXLtBZaX/AGciSLlmG4NvLDvx0x3rn9Q+FK3+i6fpsuoWdzFaaalgft+mC5CbQR50KlwIpDnkndwAO1dB/wAIHpH/AD+eIP8Awo9Q/wDj9H/CB6R/z+eIP/Cj1D/4/Q9VZ/1v/myk2tv6/qwJ4XurfWbe8s9RhWL+zksLqKW1LmVU3FWRg42HLHOQ2Rjp1qhqfw6tNU8H6Fo1zLbXEuhrH5El5ZCeCVliMf7yEt8ykEnG4EHGDxV//hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ndv+vX/ADYtv6+RBpngoWEejgHSrU6beyXZj0nTPskMu6J48bPMbB+fJbJzjGBU6eEdlnHB9tzs1htU3eV1zKZPL+9/tY3fpR/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP0Xd0/wCv60FbTl/rr/mzLvfh19r0y2tDe2dykN1dTtBqOn/abaQTymTmLeAXTOFYk45O3njpPDOiL4b8M2OjpMJls4/LEgjEYYZ/ujgfQVn/APCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/SHudJRXN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9AHSUVzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/QAfDj/klnhT/sC2f/AKISukrzvwD4K0u6+G3hq4lutcV5tJtXYRa/fRoCYVJ2oswVR6AAAdAK6D/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkorm/8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+gDpKK5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8foA6Siub/wCED0j/AJ/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/H6AOkrm77/kqehf9gXUv/R9jR/wgekf8/niD/wo9Q/+P1m22g2mifFPSPsU2oS+douobvtupXF3jE9ljb5ztt684xnjPQUAdtRRRQAV8+/DXU4vBOjWnie8kddLvre3sr/qwSRLGB4HAzxn504HJZa+gq4/4faTp1x8JvDUVxp9rLHNpVlNKjwqyySCGPDsCOWG1eTzwPShaO/lb8hPVW/rZ/qcPa3ereEU8W655Lya1f2dheXEbEN5LzTSpjDELiNNo5IB2cnqa09a/wCEnu/A2vQaxJrFnaRxQSW95ffYPtErFzvQiDfHsHyEHAbkjJxXpzWVq800rW0LSTxiOVzGMyIM4Vj3A3NwfU+tULHwp4e0u1ubbTNB0yzgvF2XMVvZxxrOuCMOAAGHJ6+ppt3uFrnF+N/EGr+HLG6XS9V1W9n0ixF1OyW9mFJJbabhpNmVbaRthUMMHuRUOtXt9b654u1LT/ES6TLY6bbXgt/KicSlY3I8zeCfLJ+X5dpz0btXcSeEfDcsVtHL4e0p0tEaO2VrKMiFD1VBt+UHPIFTXfhvQ7+7jur7RtPubiNlZJprVHdCv3SCRkEdvSh7WHpdf1/Xqefaz4v16WPxBew6mNGbQdKt72Ox8mNxdPJGXIkLqW2ZGwbCpyDyeBRqty8mpeJJ57eEvKuil4Z4VlUbpcEbXBGRk84yDyMEV6JeaFpGo31ve6hpVldXVqcwTz26PJD/ALrEZX8Kll0ywmkleaytpHmKGVniUmTYcpuOOdp5GenandCttfp/X9epyM2pazpuvammr397G0sFxJpsUcdubRkRcjB2+cJFGCdx2nPGegztPfxVd32j2M3i+4H9qaO1/NMljbhoZEMQxFlCAp83kOHPHBXNdvbeG9Dsry6u7PRtPt7m8z9pmitUV58nJ3sBls55zVtLG0jkhkjtYUeCIwxMsYBjjOMop7L8q8DjgelStN/63/zX3Der0/rb/g/eYGneIpJfhjB4g1GdLeY6eJ5ZhCXVG28tsBBIzzjP41yI8V+I4LLxTaPc38N1ZWVtc2s2pw2jSxNK7qfltyUKfKCA2G5Oexr06KztYLIWcNtDHaqmwQJGAgX+7t6Y9qo2fhjQdPtZLaw0TTbWCVQskUFpGiuASQCAMEZJP1Jp3V2we1kcjqGu634dm12xm1dr9re1s54bu6gjU25nmeJzhFVSihQwzk9ck1Y8LwT2vxO123utafWJI9LsgZpkiWRMyTna3lqq55yPlHBHXqezextJJppZLWF5J4xFK7RgmRBnCse4G5uDxyfWoNN0PSdGj2aPpdnYJtCbbW3SIbQSQPlA4yxP4n1ppjdrNLy/T/IvUUUVIgooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/hx/ySzwp/2BbP8A9EJXSVzfw4/5JZ4U/wCwLZ/+iErpKACiiigAooooAKKKKACiiigAooooAKKKKACub+HH/JLPCn/YFs//AEQldJXN/Dj/AJJZ4U/7Atn/AOiEoA6SiiigAooooAKKKKACiiigAooooAKKKKACiiigDm/C/wDyMXjP/sNR/wDpvs66Sub8L/8AIxeM/wDsNR/+m+zrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDyH4eT67DZ2f9habp14p8M6P5hvNQe2KnyXxgLDJn9Kdo3iy58G+A/Cmo3z/APEon0+aGaMKDsuQC8WGxn5troB3JXjNdn8NraBPhp4ZuEgjWaXRLJZJAgDOFgXAJ6kDJx9TVvWvCtrqun6bp0IgtNPsryK5a2jtxtcRncqLggJ8wU5weARjmj/gf1+ILRM5Zb7xFJqUel6n4q/sy4h0GK+nMdvBuabe+8/OpAQYAIA6Y5ByTStfF2veIIbUS6qPD7x+HItYdooIz9okbcCCJVbEa7RkDDfOPmHftb7wfpmreJJNU1i1tNQja2igS2urVZBGyO7BwWzz8+OnGOtaGoaDpGrG3Oq6VY3ptmDQfabZJPKI7ruB2n6UPVf15/5r7vuel/u/S/5P7/v4KHXPEuvwxXMerSaLt8NwanJbwW0T5nfzCQTIrEL8oBHX0I5zYtvEWraV5NxrWt+dFf6FJqbM1mmyzkTy+I0TDMv73ozMfl+9zXetZWryySvbQtJJEIXcxgl4xnCE915PHTk03+zbHMZ+xW/7uEwJ+6X5YjjKDjhTtHHTgelVdXbt/Wv+a+4nt8v0/wAn955fL418Q6XZeJIJ31Dz7OCzltm1GC1e4UzytGQqWxKsMAFFb588HORVi1vvFos7iQ6/qggu9atrTT7jU9Mhhl+zkDzGMXlIQSxYZYDhQQPXqNY8AaNe+GbnR9IsrHR0nMZb7NZII3CSbwkiLt3oTnK5GQx5GaTwt4GtvDzXMky6e5uJI5BbWFgLW1hZM4eOHc+1znlt2TgdMUK17+n5octtP60/z1Od1TxTr+iaLq9nHdT6jc2mtW+nRXpigWcRypE5Yg7It4MhUEhV+7kHnNpZfHT6JKrR6rbrDdg+dL9g/tCW38sk7Qpa33CTHULlc8Z5PcSaZYTRXUctjbPHeHNyjQqROdoX5xj5uABz2AFZn/CDeEvsH2H/AIRfRfsnm+d9n/s+Ly/Mxjft243Y4z1xS6fd+n+T+8btfQ4rxR41vYNA/tHw3qeqXa2Wlx3ztHa2iqwYMVa5aUrlW2n5YVDDB9QKl1bxL4uvfFGrWvh6y1JzpkcJt4LUWQhuGeMPmYzuJNuTtHl4xgnJPA7u98N6HqUkEmo6Np929uhjhae1RzEpGCqkjgEcYFN1PwxoGtyQyazoem6g8AxE13aRymMeilgcfhTur/MXQ4zXNV8SpP4mvrLXWs49Hlt1t7L7JFJGxaKNmEjEbmXLnG1lPvjgN1u81G0j1nR9TvV1hLeTTJ45by0hOPOudrJsCBSBsypILDPUkA16A+m2Mi3CyWVu63JBnDRKRKQAAW4+bAAHPoKJtNsbiSSSeyt5XlCCRniUlwjbkySOdpJI9CciktA6nCat4p1O28X27WNzfzWB1SLTpV8i1S0UsQrKSzfaGkGc7lGz26mvRKzpPD2izar/AGnLo9g+ofL/AKW1qhl+Ugr8+M8EAjnjFaNJfDbr/wAMJ/Ffp/w4Vzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jQM6SiiigArifhz4i0QeAPCWmHWNPF++kWqLafak81mECEgJnJI9MV21ePeBPCt6/wZ0oQafH9qurnS75WDIGeJBbEuTnsqNweeMY5px1lZ/1ql+t/kH9fgz1htSsUjeR723VI5hA7GVQFkJACE54YlgMdcketY+nePPDep32rWlvq9mJdJdlug9zH8qqqlpOG4QFtpY4wwI7Vzmq6Rr7SX2lWmiyTwXOuW+oi/wDtMSxiJZYXZdpbfvGxuNuCP4s8VLq2h6xcad460qLSpZRrCyTWdyJYhFIWt44/LILhg2UPVduP4u1OKTV32/HT/N/cP/P8NTopfGeiJiSHULS4tFSZpruK8gMUHlAbw2XByNw6A4/ixkZj0fxtpGv6dpd7o0yXcOpP5Y8u4hLQP5ZkKON+dwA5VdzDrjGTTL7Rbh/EejS2duqWlpYXVu5UqqxlxEEGOuPlPQcYrE0nRdZfRvBtrc6ZPZS6JIYblpJYmG1bSSISpsc5UswwDhvVRQrWf9d/+ALon6nYW2u6Re6lPp9nqtlcXtt/r7aK4RpIv95Qcr+NMsPEeiapeNaaZrGn3lyiCRobe6SR1U9GKgk4964Lw14U1yCXwrZXulfYh4badp9Q8+Nlvt6OvyBWL/MWDtvC8jv1rU0Hwte6bp/gqM2EcEmmGU3oRkHll4XBPB+bLkZxnnmiy7iex12pazpmjRxPq+o2lgsziOJrqdYhI56KNxGT7Cs7RPFUWsW2nyG28k31tJcg+fGVjVGCngsHPUchSB3IyM1Nes7+HxXa6rbaOdYgNlLZtCksatCXdW3HzCAUIXDYJPA+U1h6R4Uv7Sx0iHUtH8y3ttBvLK6tLaaPlpJIyIkJZRyqsAeAO5FStfx/X/JfeV1t6fp/XyOwg8U+H7rTbjUbbXdNmsbVts91HeRtFCfRnBwp+tPbxHoiaVHqb6zp66fL/q7s3SCJ+CeHzg8Anr2NcNPo3ii70/TppLC7ubbSNViuoNNv5bYXUsKoylS0beUSrMCmWydo3HPNSWPhDUpbiK9vdNWKO68S/wBqvYySRt9kjFuUBbBKlt4DEKTy3U9adk3/AF5f5v7hf1+f+S+86TxB460PQ9Blvxqen3ErWUl5Z2321Fa8VULfu+u4HHUA1o3XiHSNPa0j1TU7KxnvMCCG4uUjaUnHChiCx57Vxvi7QdYuY/FdnZ6CNVGvWoW3uDNEiQFYtoR95DcNllKhhludvWqniLwnrMniPUbpU1q5sNU0+G0ki0g6fuUIGDI/2sfdO7IKN1JyOho0sN2sv67f8E9AfXtIj1ZNLfVbFdQclUtDcIJmIXcQEzk/KQenTmr9c14Z0OXTNe127mtigu5LcQzSMrSSRpAi/MR6MG/HJHWuloYgooopAc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHN/Dj/klnhT/sC2f/AKISukrm/hx/ySzwp/2BbP8A9EJXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc38OP+SWeFP+wLZ/+iErpK5v4cf8ks8Kf9gWz/8ARCUAdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfhf/AJGLxn/2Go//AE32ddJXN+F/+Ri8Z/8AYaj/APTfZ10lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBwnw41+I+FPDmjqihbTwzY3d1cNJtEW6IBFxjnIRyTkYwPWukj8WeHJtIk1WLX9LfTon8uS8W9jMKNx8pfOAeRxnvXmnw9s0n0G5sb+ymvotQ8JaS620Lqrzx/Z2jZFLMoBz6sANw5rRv9B8X6lb6XfS/2og0u/eSCANY/bzE0OwE7g1uWVi2OQdh67qOn9dw6/wBdv1PQbjxBo1npCard6tYwadIAUvJblFhYHoQ5O05+tXIrmCe1W5gmjkgdd6yo4KsvXII4x715hceENZittE1HTP8AhII3s7i7muLZm077YXmI+dQQbbru4GDhzznIPV6JoqWfw/m065sdUuFmS4MtneyW/wBok8xmZkzEwiGdxxggAEdKHs2C3Rq2niXQr/T7i/sda0+5s7UkT3EN0jxxEDJDMDhePWlTxHokminWI9Y09tMXOb1bpDCMHB+fO3r71w2oeH/FGteD3syt/braX9vcWcF29obtoo2DMhK74SQR8m7Odo3HvUQ8Mav5lnrS6frd5c22rrfXVlqktgstyBbtEGj8giLIyp+Ygnb16U9Nf67f5/gH9fn/AF8zrpPHvhqPxBYaOdYsjc6hbme2YXUe2QblVQPmyS275QAc7W9Kt/8ACUaVDpLalql3b6XarO8BlvLqFU3K5T76uV5IPGcjoQDkVipaalF4o0XV4vDrwQNbXNvcW1vLButWlljcSP8AMqn7jFthY5PG7rWLD4c1zSb7RtV/siTUlsbrU/MsIpohIBcTs0cqb3VCdvBBYEBz34p2Vl8/zf8AwPvDr/XY7q98RaLptrHc6jrFhaW8qGSOWe6REdRjLAk4I+Yc+49auwTw3VvHPbSpNDIoZJI2DKwPQgjgiuC8MeDL/S7rw22oWsLrYrqEr4ZWW1aeVXjRc88KWXIGOD61u+HNI1Gw8EyaaGXT70vdeS5USiHfK5jbaDggBlOMj04pPRB1SLOn+LNP1PxVqGgWi3D3GnxLJNMY8QkkkFFbPLDvxgZxnORS+LPFeneDdAl1bVRNJFGcLDbJvllOM4VcjOACTyAACT0rmfDvhXxL4b8RCV7nTr6xg0swr5Fk0Dzyb2fBZp3IYsdxcgg57HmofF/hfxV4n0ifUbeWztLqbRntl0a5tvPaCWRT5gSdZkTceF3lSAB6E5Fsvx+9/wCXyHGznZ7f8N/mdeNfUeKLfR5YNgu7Jru2m3/f2sA6FccEB0PU5yemOdeuJliuz4+8JWt20U15Z6fdTXUsMZjQAiNBhSzYBY9Mn7prtqHt9/5slX6/1oFFFFIYVzd9/wAlT0L/ALAupf8Ao+xrpK5u+/5KnoX/AGBdS/8AR9jQB0lFFFABXG6J4c8Y6DoGn6RZ+JNDe30+1jtYml0KYuyooUFiLsDOBzgCiigC99h8b/8AQw+H/wDwQz//ACZR9h8b/wDQw+H/APwQz/8AyZRRQAfYfG//AEMPh/8A8EM//wAmUfYfG/8A0MPh/wD8EM//AMmUUUAH2Hxv/wBDD4f/APBDP/8AJlH2Hxv/ANDD4f8A/BDP/wDJlFFAB9h8b/8AQw+H/wDwQz//ACZR9h8b/wDQw+H/APwQz/8AyZRRQAfYfG//AEMPh/8A8EM//wAmUfYfG/8A0MPh/wD8EM//AMmUUUAH2Hxv/wBDD4f/APBDP/8AJlH2Hxv/ANDD4f8A/BDP/wDJlFFAB9h8b/8AQw+H/wDwQz//ACZR9h8b/wDQw+H/APwQz/8AyZRRQAfYfG//AEMPh/8A8EM//wAmUfYfG/8A0MPh/wD8EM//AMmUUUAUdb8OeMde0DUNIvPEmhpb6hayWsrRaFMHVXUqSpN2RnB4yDV77D43/wChh8P/APghn/8AkyiigA+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKKKAD7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoooAPsPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyiigA+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKKKAD7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoooAPsPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkyiigA+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKKKAKOieHPGOg6Bp+kWfiTQ3t9PtY7WJpdCmLsqKFBYi7Azgc4Aq99h8b/8AQw+H/wDwQz//ACZRRQAfYfG//Qw+H/8AwQz/APyZR9h8b/8AQw+H/wDwQz//ACZRRQAfYfG//Qw+H/8AwQz/APyZR9h8b/8AQw+H/wDwQz//ACZRRQAfYfG//Qw+H/8AwQz/APyZR9h8b/8AQw+H/wDwQz//ACZRRQAfYfG//Qw+H/8AwQz/APyZR9h8b/8AQw+H/wDwQz//ACZRRQAfYfG//Qw+H/8AwQz/APyZR9h8b/8AQw+H/wDwQz//ACZRRQAfYfG//Qw+H/8AwQz/APyZR9h8b/8AQw+H/wDwQz//ACZRRQAfYfG//Qw+H/8AwQz/APyZVHRPDnjHQdA0/SLPxJob2+n2sdrE0uhTF2VFCgsRdgZwOcAUUUAXvsPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TKKKAD7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kyiigA+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoooAPsPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TKKKAD7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kyiigA+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoooAPsPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TKKKAKNh4c8Y6de6ndQeJNDZ9Sulupg+hTEKwhjhwuLvgbYlPOeSfoL32Hxv/wBDD4f/APBDP/8AJlFFAB9h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlFFAB9h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlFFAB9h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlFFAB9h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlFFAB9h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlFFAB9h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlFFAB9h8b/9DD4f/wDBDP8A/JlH2Hxv/wBDD4f/APBDP/8AJlFFAGZo3hLxToel6ZZWuu+H5P7Ms0soLibw/KZfKVVXBYXY67VJxgEjpWn9h8b/APQw+H//AAQz/wDyZRRQAfYfG/8A0MPh/wD8EM//AMmUfYfG/wD0MPh//wAEM/8A8mUUUAH2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJlFFAB9h8b/wDQw+H/APwQz/8AyZR9h8b/APQw+H//AAQz/wDyZRRQAfYfG/8A0MPh/wD8EM//AMmUfYfG/wD0MPh//wAEM/8A8mUUUAH2Hxv/ANDD4f8A/BDP/wDJlH2Hxv8A9DD4f/8ABDP/APJlFFAEI0fxet490uteGxcOgjaYeHpt7KCSFLfa8kAk8e5qb7D43/6GHw//AOCGf/5MoooAPsPjf/oYfD//AIIZ/wD5Mo+w+N/+hh8P/wDghn/+TKKKAD7D43/6GHw//wCCGf8A+TKNP0HXP+EqttZ17V9Pu/stlPaRQ2Wmvbf614XLMzTyZx5AAAA6miigDpKKKKAP/9k=" alt="" width="785" height="759" vspace="0" hspace="0" border="0" style="width:785px;height:759px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>Reporting of suspected adverse reactions :</p><p>إذا كان لديك سؤال عن هذا المستحضر او ترغب في كتابة تقرير حول عرض جانبي نرجو الاتصال على:<br />If you have questions about this product or if you wish to report an adverse event<br />Saudi Vagilance Center المركز الوطني للتيقظ والسلامة الدوائية<br />فاكس: 5660502110 Fax:0112057662<br />npc.drug@sfda.gov.sa</p><p>Report adverse reactions allows continuous monitoring of risk / benefit ratio of the drug after its placing on the market. As healthcare professionals you must report all suspected adverse reactions to your Regional Pharmacovigilance Centre using the form ( Cerfa No. 10011 * 02) available on the website of the National Security Agency of Medicines and Products health ( MSNA ) www.ansm.sante.fr .<br />You can also report any adverse event by contacting us by phone at 0800394000 (toll Sanofi France ) .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The effects of overdose on lansoprazole in humans are not known (although the acute toxicity is likely to be small ) , and therefore no action to be taken for treatment can not be given. However, daily doses up to 180 mg of lansoprazole orally and up to 90 mg of lansoprazole intravenously have been administered in clinical trials without significant undesirable effects .<br />Please refer to section 4.8 for possible symptoms of lansoprazole overdose .<br />In the case of suspected overdose , the patient should be monitored. Lansoprazole is not significantly removed by hemodialysis. If necessary , gastric emptying, charcoal and symptomatic therapy is recommended .</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: inhibitors of the proton pump , ATC code: A02BC03<br />Lansoprazole is an inhibitor of gastric proton pump . It inhibits the final stage of gastric acid formation by inhibiting the activity of proton pump H + / K + ATPase in the parietal cells of the stomach. The inhibition is dose -dependent. Exert its effects on both basal and stimulated secretion of gastric acid. Lansoprazole is concentrated in the parietal cells and becomes active in their acidic environment and reacts with sulfohydrique group of proton pump H + / K + ATPase causing inhibition of the enzyme activity .<br />Effect on gastric acid secretion :<br />Lansoprazole is a specific inhibitor of the proton pump of the parietal cells . A single oral dose of lansoprazole inhibits about 80% of gastric acid secretion stimulated by pentagastrin . After repeated daily administration for a period of seven days, about 90% of gastric secretion is inhibited. It has a similar effect on the basal secretion of gastric acid. A single oral dose of 30 mg reduces basal secretion by about 70%, the patients&#39; symptoms are consequently relieved after the first dose . After 8 days of repeated administration the reduction is about 85 %. Rapid relief of symptoms is obtained by one capsule ( 30 mg ) per day in most patients with duodenal ulcer heal within 2 weeks, patients with gastric ulcer and gastroesophageal reflux in 4 weeks. By reducing gastric acidity, lansoprazole creates an environment in which appropriate antibiotics can be effective against H. pylori .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lansoprazole is a racemate of two active enantiomers are metabolized into the active form in the acidic environment of the parietal cells . Since lansoprazole is rapidly inactivated by gastric acid , it is administered orally in gastro - resistant form for systemic absorption .<br />Absorption and Distribution :<br />The bioavailability of lansoprazole in a single dose is high ( 80-90%) . Peak plasma concentrations are reached within 1.5 to 2.0 hours. Intake of food slows the rate of absorption of lansoprazole and reduced bioavailability by approximately 50 % . The plasma protein binding is 97 %.<br />Studies have shown that the microgranules from the opening of a capsule provide an area under the curve (AUC ) equivalent to the intact capsule if the microgranules are mixed in a small amount of orange juice , apple juice or tomato juice or mixed with a tablespoon of applesauce or pear , or sprinkled on a tablespoon of yoghurt, custard or cream cheese . Equivalent AUC has also been found for mixed with apple juice administered by nasogastric tube microgranules .<br />Metabolism and Elimination<br />Lansoprazole is extensively metabolized by the liver and the metabolites are excreted by the kidney and biliary tract. The metabolism of lansoprazole is mainly catalysed by the enzyme CYP2C19. The enzyme CYP3A4 also contributes to the metabolism . The half - life in plasma of lansoprazole is between 1.0 and 2.0 hours following single or multiple doses in healthy subjects . There is no evidence of accumulation after multiple doses in healthy subjects . The sulfone derivatives , sulfite and 5 - hydroxy lansoprazole have been identified in plasma. These metabolites have very little or no antisecretory activity.<br />A study with 14C labeled lansoprazole indicated that approximately one third of the administered radiation was excreted in the urine and two-thirds in the faeces.<br />9<br />Pharmacokinetics in elderly patients<br />The clearance of lansoprazole is reduced in the elderly, with an elimination half-life increased by approximately 50 % to 100 % . Peak plasma concentrations are not increased in the elderly .<br />Pharmacokinetics in children<br />The evaluation of the pharmacokinetics in children aged 1-17 years showed a similar exposure to adults with doses of 15 mg for those weighing less than 30 kg and 30 mg for those above . The study of a dose of 17 mg/m2 body surface or 1 mg / kg body weight showed comparable exposure of lansoprazole in children aged 2-3 months to a year compared to adults.<br />Higher exposure to lansoprazole in comparison to adults has been reported in children under 2-3 months with doses of 1.0 mg / kg and 0.5 mg / kg of body weight given as a single dose.<br />Pharmacokinetics in patients with hepatic impairment<br />The exposure of lansoprazole is doubled in patients with mild hepatic impairment and even higher in patients with moderate to severe hepatic impairment.<br />CYP2C19 poor metabolisers<br />CYP2C19 is subject to genetic polymorphism and 2-6 % of the population , called poor metabolisers ( PMs), are homozygote for a mutant CYP2C19 allele and therefore has a functional CYP2C19 enzyme functional . The exposure of lansoprazole is several-fold higher in PMs than in extensive metabolisers (EMs ) .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data from conventional studies of safety pharmacology, repeated dose toxicity , toxicity to reproduction or genotoxicity revealed no special hazard for humans.<br />Two carcinogenicity studies in rats, lansoprazole produced gastric enterochromaffin cell hyperplasia (ECL ) related to dose and ECL cell carcinoids associated with hypergastrinemia in relation to inhibition of acid secretion. Intestinal metaplasia was also observed , as well as Leydig cell hyperplasia and benign Leydig cell tumors . After 18 months of treatment retinal atrophy was observed . This was not seen in monkeys , dogs and mice.<br />Mice during the carcinogenicity studies appeared gastric ECL cell hyperplasia (ECL ) related to the dose , liver tumors and adenoma of rete testis . The clinical relevance of this finding is not known .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Heavy magnesium carbonate , neutral microgranules ( sucrose , corn starch) , sucrose , corn starch, hydroxypropyl cellulose of low substitution degree hydroxypropylcellulose , copolymer of methacrylic acid and ethyl acrylate ( 1 : 1 ) ( dispersion 30 percent ) ( Eudragit L30 D -55 ) , talc , macrogol 6000 , titanium dioxide , polysorbate 80 , anhydrous colloidal silica .<br />Capsule shell :<br />- Head ( orange): gelatin, titanium dioxide, erythrosine , iron oxide yellow .<br />- Body (blue): gelatin, titanium dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at a temperature not exceeding 25 &deg; C<br />Keep the bottle tightly closed in order to protect from moisture<br />Keep the blisters in the outer carton to protect from moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>7, 14 , 28 and 60 capsules in blister packs (PVC / PVDC / Aluminium) .<br />14 and vial 15 capsules (PE ) .<br />All presentations may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements .</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SANOFI- AVENTIS FRANCE
1-13 bd Romain Rolland
75014 PARIS
www.sanofi.fr
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                July 2013/V1
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>